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 ABSTRACT 
 
Head and neck cancer (H&NC) and its possible treatment options are diverse and 
multifaceted. This thesis demonstrates these complexities and describes three 
studies that have used different methodological approaches to include, rather than 
overlook these aspects.   
The first established which aspects of patients’ experiences are overlooked if 
health care professionals rely upon health related quality of life questionnaires to 
represent the experience of patients.   
The second identified that the multi-disciplinary team (MDT) working with the 
patients use humane judgement, not technical expertise, to predict patients’ 
symptoms pre treatment.   
The third, with reference to the previous two, used Q-Methodology to explore the 
experience of H&NC patients during and after their treatment. Five interpretations 
were identified: 
 Meaning and attachment to illness 
 Overwhelmed by the disease 
 Change and recovery 
 Surviving or not 
 Keep control- for the greater good of others 
This unique study has developed a framework through which the MDT can start to 
translate H&NC patients’ experiences and help enable them to influence their care 
directly. It also suggests ways in which the framework can be applied to the clinical 
environment.  
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GLOSSARY OF TECHNICAL TERMS 
Alternative method of feeding a different way of a patient being fed or hydrated 
that does not rely on eating or drinking such as percutaneous endoscopic 
gastrostomy (PEG) or naso-gastric tube (nose to stomach) 
Aspiration food or drink going below the level of the vocal cords i.e. the voice box 
into the lungs causing an infection as a result of this penetration 
Cancer centre a designated regional specialist hospital that has known experts for 
the treatment of cancer, who will after definitive treatment refer back to local health 
care   
Flap surgical reconstruction using either soft tissue or bone and soft tissue 
(composite) examples include:  
 Anterior lateral thigh flap (ALT) soft tissue flap associated with the outside of 
thigh with blood supply of vein and artery 
 Radial forearm free flap (RFFF) soft tissue and vein and artery from 
underside of forearm as tissue replacement for lesion typically from floor of mouth or 
tongue 
Scapula flap composite flap (containing bone and soft tissue) from shoulder 
used typically to replace mandible (jaw) or maxilla (roof of mouth) 
Glossectomy-total removal by surgery of the tongue 
Head and Neck cancer tumours classified pathologically within one of the structures 
of the head and neck, but excluding brain  
Health related Quality of Life (HRQoL) a set of standardised questions that 
explores a patient’s specific issues relating to their health 
Laryngectomy -total removal by surgery of the larynx 
National Institute of Clinical Excellence (NICE) an independent body set by the 
government to implement guidelines and review best treatment practice 
Neck dissection removal by surgery of designated levels of lymph glands within the 
neck  
Nodal disease relates specifically to neck nodes, which may as a result of the 
tumour in the head and neck develop disease extending into the lymph glands within 
the neck  
Oesophageal speech the vibration of food-tube, oesophagus, to form an energy 
source 
Quality of life questionnaire QoL- a set of standardised questions that explores a 
patient’s specific issues relating to their life  
Tracheostomy Breathing tube placed below level of larynx in order to provide a 
temporary or permanent way of breathing.  Difficult to talk when one is placed due to 
air bypassing laryngeal area   
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 INTRODUCTION 
Cancer is a common disease affecting one in three of the United Kingdom 
population.  Treatments have become more successful at enabling patients to 
survive the disease and a review of cancer data-bases indicates that three million 
people have survived the disease (Maddams et al., 2009).  These researchers have 
predicted that this figure will rise by a rate of three percent per year over the next 
twenty-years.  Whilst treatments might be judged as more effective because patients 
are surviving longer, longevity cannot represent outcome exclusively.  Policy-makers 
and cancer survivors have started to describe the personal consequences of 
surviving cancer and quality of life (QoL) data has been seen as a way of 
supplementing survival statistics. 
This thesis will suggest that for head and neck cancer (H&NC) patients, both survival 
rates and QoL measures are too basic and are poor representations of what the 
patients might experience.  The thesis discusses the limitations of such measures, 
and an argument is developed that the science of QoL research is flawed because it 
is a false assurance to think that they represent the patients’ perspective accurately. 
This lack of ability to reflect the real experience for patients might explain why their 
use has remained limited in clinical settings and is used rarely to form part of 
treatment plans.  The possibility that there are important aspects of the patient 
viewpoint, up to now defined inadequately, is demonstrated by one of the participants 
who was part of the Q study, sort number 10:   
‘I never thought of myself as ill, going in or coming out I limped around couldn’t 
open my mouth properly- all the accoutrements of illness- but without feeling 
particularly ill; so it’s not like I have a long-term disease even though I can still 
visualize a fixed chunk of time as opposed to a chronic condition…some people do 
define themselves by their illness.  This does not define me at all; my values define 
me and none of those include being ill.’  
Sort number 10: Page 2. Line 31 to page 3 line 9   (2.31- 3.9.) 
 
  
2 
Whilst there might be patients who can identify with some or all of participant 10’s  
sentiments, clinical and research environments have invested thought, expertise and 
time generating numerous disease-specific questionnaires that try to capture, in a 
standardised way how patients might be affected.  The science has remained 
unchallenged around how limited it is and cannot answer satisfactorily fundamental 
questions such as:     
 What is the experience for patients of the diagnosis and treatment of head and 
neck cancer?   
 Why do patients with apparently similar disease classification and treatment 
appear to have such different reactions to the treatment?  
 
 
Clinicians and researchers are in danger of reassuring themselves falsely that what 
they are measuring is important to patients.   Porter, a medical historian, who has 
written on the history of hospitals, suggested the following in a commentary (Porter, 
2003 p.151): 
‘In our times cutting-edge medicine has been practiced in purpose-built 
hospitals served by armies of paramedics, technicians, ancillary staff, managers, 
accountants, fund-raisers and other white-collar workers, all held in place by rigid 
professional hierarchies and codes of conduct.  In the light of such massive 
bureaucratisation, it is small wonder that critiques have once again emerged.  The 
hospital was no longer primarily denounced, however, as a gateway to death but as 
soulless, anonymous, wasteful and inefficient medical factory, performing medicine 
as medicine demanded it, not as the patient needed it.’ 
 
Much of the author’s clinical time is spent in intense therapeutic relationships with 
patients, working with them in order to enable them to communicate and swallow as 
well as possible.  It is her strong desire that the portrayal of Porter’s modern-hospital-
medicine should never be a reality.   This thesis intends to reduce the likelihood of 
such a description. The following illustration of a patient’s treatment can help to 
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illustrate how inadequate questionnaires might be, in representing a patient’s real 
experience.   
David aged 62 was diagnosed with laryngeal cancer and it was decided by his 
clinical team that his definitive treatment would involve surgery followed by chemo-
radiotherapy.  Part of his original reconstructive surgery meant that his larynx 
pharynx and upper-oesophagus had to be replaced.  The surgical team decided to 
use an anterior lateral thigh flap and created a tube of free-tissue that could be joined 
into the major-blood vessels within the neck to replace the diseased tissue.  One of 
the peri-operative complications of this procedure was that the flap failed, and was 
therefore not viable.  This meant a second flap had to be harvested to replace the 
necrotic tissues.  For this second flap part of the patient’s unplanned, but necessary 
management was a further operation and the use of part of the patient’s bowel, which 
could be fashioned into a tube to reconstruct the area that it needed to replace.  The 
patient, who was unemployed and lived in, by his own description, a rocky-
relationship, was in hospital for 85 days.  During this time he had a permanent 
tracheostomy.  His main way of communicating was through mouthing words with no 
sound produced, or by writing down, with no possible way of eating or drinking for 
more than three months because of the poor healing process of the first failed-flap 
and then the second healing one.  The patient had three large scars that needed to 
heal: neck, lateral thigh and abdomen.  Once he had recovered from this surgical 
treatment he had to have oncological treatment, which included both chemo and 
radiotherapy.  This meant his total length of actual treatment, from his operation date, 
through to his last day of radiotherapy was 145 days.  This patient consented to a 
semi-structured interview during which he discussed how he had been during this 
treatment period: 
‘Once you let your defences down, that’s when you start to crumble, so it’s as 
though I’m standing on the outside of the building, but I’ve crumbled inside……. 
………There are times in the last few weeks I’ve felt, “oh hell what’s the point?” I’m 
not bothered but I don’t let on.’  
Study 1: Participant 4:16.3.-16.8 
 
David was participant 4 in the part of the study, which helped create the concourse 
for the Q methodology study.  It would seem most unlikely that David would have 
consented, or engaged with completing a questionnaire, or if he had he would have 
been somewhat superficial with the answers, because of not finding it possible to 
concede how difficult life had become. It will be suggested in this study that it is 
important to understand, at an individual-level, how patients are affected by both their 
disease and treatments in order to support them more appropriately. It cannot be 
suggested that another patient would react in the same way that David did, but whilst 
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such treatments with their complications might seem extreme, it is not unusual for  
many patients to have protracted periods of treatment so that  their chances of 
returning to a pre-morbid level of function are remote. 
Patients’ individual needs rather than the system in which they find themselves 
treated should be described. The human aspect of a very personal disease should be 
better represented, so that the specialism is better informed.   The field has to 
progress from the dominating outcomes of temporal and QoL descriptors towards 
individual patient-centred and derived data.  Through this approach patients, 
clinicians and researchers have a more detailed understanding and can therefore 
influence the care of patients. 
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THE STRUCTURE OF THE THESIS 
The work is presented in a progressive format and uses the context of the disease to 
develop the research.   The specific layout of each chapter is as follows: 
 Chapter one presents a review of the epidemiology and aetiology of the 
disease; the likely co-morbidities associated with it, and describes the 
management of the disease, treatment sequelae, complications and 
outcomes.   
 Chapter two presents the modern aspect of outcome measures and describes 
how, within health-policy, patients are experts in their care, in which more 
holistic assessments should be carried out.   
 Chapter three presents two publications by the author.  The first explores why 
QoL measures may not be the best way of measuring patient experiences 
associated with head and neck cancer; the second reports on the judgements 
relating to QoL made by the clinicians working at the author’s cancer centre 
with this patient group.   
 Chapter four reflects upon some of the clinical and research learning the 
author has experienced and explains why Q-methodology was chosen for this 
study.   
 Chapter five presents the Q-methodology study and its results.  
 Chapter six discusses the results, clinical implications of the findings and 
suggests some of the possible post-doctoral research.   
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CHAPTER ONE  
THE FACTS AND MANAGEMENT OF HEAD AND NECK CANCER 
INTRODUCTION 
This chapter will describe in detail the epidemiology, aetiology, treatment choices and 
management for patients who present with head and neck cancer (H&NC).  The 
intention is to demonstrate the diversity of all of these aspects so that there is a 
sense, for the reader, of the diversity and complexity within the disease, which will 
influence the choice of methodology used in the research.  
 
A DEFINITION, INCIDENCE AND INITIAL PRESENTATION 
 H&NC is a collective term for more than thirty specific anatomical sites.  Convention 
around description has meant that the region is subdivided into three areas: oral 
cavity; pharynx; and larynx.  The brain is not included in the classification of this 
cancer group.   Figures 1, 2, and 3 in Appendix 1.1 represent these three regions; 
they describe visually their numerous structures, their three dimensional nature, as 
well as their relative size and locality to one another. At a global-level H&NC 
incidence accounts for six per cent of all cancer and five per cent of all mortalities.  
Every year more than 550,000 people are diagnosed with the disease, and 300,000 
die (Ferlay et al., 2010).  The majority, sixty percent, present with advanced disease 
(Parkin et al., 2005), and late-detection is the main reason for a poor survival rate 
with approximately half of all patients dying within five years of initial presentation.  
The late presentation is, in part, due to poor public-knowledge of the disease, and an 
inability to appreciate that the symptoms experienced are H&NC. In the UK late 
presentation is exacerbated by its comparative rarity, such that its incidence the 
fifteenth most common cancer for males and nineteenth most common cancer for 
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females; other cancer sites such as breast and prostate dominate. Figures from 2004 
show there were 8,000 new cases of newly diagnosed H&NC cancer in the United 
Kingdom for that year and 2,500 deaths in 2005 (Cancer Research UK, 2009). This is 
in contrast to other cancer site incidences for which in 2008, breast cancer 
represented 48,000 cases (32 percent of all cancers diagnosed among women) and 
prostate cancer 37,000 (25 percent of all cancers diagnosed among men) (Cancer 
Research UK, 2009). The implications of these different presentation statistics are 
that there are likely to be ten times more patients diagnosed with breast, or prostate 
cancer, than H&NC.  It becomes even less well identified when it is known that ‘head 
and neck cancer’ is an overarching term and the incidence for each of the three 
individual regions (oral, pharyngeal and laryngeal) is even more rare because these 
are sub sets of H&NC.  UK-based research has identified poor public-awareness and 
gone further by reporting that the public think their symptoms are trivial and will 
resolve (Rogers et al., 2011b, Rogers et al., 2011a).  Whilst the general population 
has poor insight, there is little evidence that health-care professionals have 
redressed the balance by being any better informed.   McCann et al, (2005) reported 
that less than half of medical undergraduate courses included the topic in their 
syllabi.  No specific research has looked at the identification rate of oral cancer by 
dentists in the UK, but research has suggested their skills are at a basic level.  Whilst 
the majority of dentists will carry out a routine visual assessment of oral mucosa, they 
are not confident in their ability to identify oral lesions (Kujan et al., 2006).  This taken 
together with the knowledge that one in five of the UK population does not have 
universal access to an NHS dentist, (McGrath et al., 2001) will mean that H&NC 
remains a disease likely to have a poor-profile in populations and professionals alike.  
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Late detection is only part of the problematic initial presentation.  The UK government 
has recognised since 2000 that the access to specialist cancer centres for patients 
with suspected cancer is not only variable but also cumbersome.   The publication of 
the National Cancer Plan 2000, (Department of Health, 2000), sought to re-dress this 
situation by introducing a two-week referral time from primary care to specialist 
centre for patients who were suspected of having cancer as a way of fast tracking 
patients.  Unfortunately there is little evidence to suggest that this is the process 
through which the majority of cancer patients access cancer centres. The National 
Awareness and Early Diagnosis Initiative reported on data for patients within England 
from 2007 (National Cancer Intelligence Network, 2008).  It reviewed how patients 
accessed cancer services in England prior to their diagnosis.  The results indicated 
that only twenty-five percent of patients were diagnosed through the Two Week-Wait, 
whilst twenty-three percent presented as emergencies. Patients at the more extreme 
age limits of under twenty-five or over seventy-five, were the most likely to present as 
emergencies. A socio-economic gradient was also observed and this suggested that 
more affluent patients were less likely to present as emergencies.  They also were 
able to conclude that the route of referral to the cancer services influenced the overall 
survival rate for all cancer patients, except those diagnosed with leukaemia.  The 
National Audit Office has also reported that nearly one in four cancers are not 
detected until a patient is admitted via an emergency department (Department of 
Health, 2011).   This is certainly the case for H&NC patients (Hobson et al., 2008); 
the minority are seen through the two-week referral route but they are not unique in 
this experience.  The intention is that after assessment in primary care the patient is 
referred for more specialist investigation. The National Audit of Cancer Diagnosis in 
Primary Care (Royal College of General Practitioners, 2011) described a wide 
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variation in referral times, with unacceptable variations between trusts in the two-
week-wait referral route.  It is of note that since the introduction of H&NC guidelines 
in Scotland, Wales and England, there has not been a subsequent improvement in 
the ultimate clinical measure i.e. survival.  However, use of the guidelines may not be 
the main problem for H&NC, but rather, access to the service.  Patients remain 
unable to access the service because of poor recognition of the disease by primary 
care clinicians (Singh and Warnakulasuriya, 2006), exacerbated by a significant 
percentage being unable to access the services via the urgent two-week wait 
pathway (Hobson et al., 2008). It would seem, despite established protocols for 
referrals, the initial referral into the specialist centres is not well used.  The National 
Cancer Patient Survey of 2010 (Department of Health, 2010c) revealed corroborative 
and equally less comforting data from the audit of primary care.  Patients who were 
surveyed revealed that a quarter of them saw their GP three or more times before 
being referred onto a specialist service.  Patients are both complex and individual in 
their initial presentation, and they, as well as the screening clinicians, are poor at 
recognising the implications of the symptoms early.  
 
CLASSIFICATION OF THE DISEASE  
Most of the tumours from the head and neck arise from the epithelial lining of the 
mucosa and as a consequence, approximately 90 per cent have the pathological 
label of squamous cell carcinoma (SCC).  By convention, cancer is classified by 
tumour size (T), nodal spread (N) and distant metastases (M). H&NC is no exception 
to this.  The primary tumour, if detected within the head and neck region, is classified 
by using a universal system of tumours’ classification that is reviewed on a regular 
basis (Greene and Sobin, 2009).  Different suffixes follow the TNM classification and 
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differentiate the tumours’ characteristics further.  These include: “is”, 1, 2, 3 or 4 in 
which size dominates the description of the tumour such that an increasingly large 
number (one to four) signifies a tumour from less than 2cms to greater than 4cms.  
The number four however, is not only based on size of tumour, but represents any 
extension of the tumour into adjoining structures, such as invasion into adjacent 
cartilage or bone.    This means that a tumour can be categorised as a T4 tumour 
based on its invasion into structures rather than using size as thecriteria.  The 
dimensions and extent of the tumour can be assessed clinically and described more 
precisely with pathology and imaging services.   There are other suffixes apart from 
numbers used to describe the tumour.  The suffix, ‘is’, represents tumour 
classification, in pathological terms, as ‘in-situ’ and means that the tumour 
presentation is either non-invasive or in-situ.  At the other end of the spectrum the 
suffixes of “a” or “b” can follow the number 4.  The former denotes that it is possible 
to remove the tumour, the latter that it is not because of its location to vital structures.   
It is unusual not to be able to visualise through imaging a tumour of the head and 
neck; an unknown primary tumour will exist only in 2-3 percent of cases and is 
denoted by the suffix “x”.  Whilst the tumour-size and extent is important to 
investigate and describe, other aspects of the cancer have to be understood at the 
assessment stage, so that the prognosis, and the possibility of the treatment, might 
be understood more completely.   
 
Tumours will spread typically from the head and neck into a complex and rich 
lymphatic drainage system within the neck.  Cervical nodes may have disease, which 
has spread from the primary head site.  If this is the case patients are much more 
likely to have recurrent disease (Roland, 2012).  There is approximately a fifty per 
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cent reduction of five-year survival in patients who are diagnosed with a cervical 
lymph node.  The descriptions of the neck disease are multiple, and establish: 
 The level in the neck the node is located (I-VI);  
 Laterality of the node(s), (ipse-lateral, contra-lateral unilateral or bilateral);  
 Number, single or multiple,  
 Size and spread beyond the node breaching the nodal-structure (extra-
capsular).  
 
Figure1.1 represents the classification of the different levels within the neck. If the 
disease has breached the nodal membrane the disease presentation is more 
aggressive and or more advanced (Roland,2012). 
FIGURE 1.1 SCHEMATIC DIAGRAM OF LYMPH NODE LEVELS (Scottish 
Intercollegiate Guidelines Network, 2006)p77  
 
The final part of the staging for the disease relates to more distant spread of the 
disease known as metastatic disease.  The presence or absence of metastases is 
indicated by M followed by 1 or 0 respectively.  It is unusual for patients, who present 
with H&NC as their primary disease, to have metastatic disease; it is more common 
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for H&NC to be a metastatic extension of other tumour sites such as breast, bowel or 
lung.  It is for this reason that patients need to have a full assessment at 
presentation, to assess the likelihood of another tumour within the body (Roland, 
2012).  
 
TNM nomenclature set out in Appendix 1.2 might be viewed as being very specific in 
its classification of the disease.  There is however, criticism that it is open to 
individual interpretation. For example the concept that bilateral nodes, N2, are of less 
pathological significance than to have a node larger than 6 centimeters -N3, is not 
accurate.   The classification also has other shortfalls, because it: 
 Overlooks prognostic information regarding the tumour’s immunological 
status;  
 Does not denote routinely the presence of extra-capsular spread, peri-neural 
or lympho-vascular invasion within the nodes;  
 Does not denote the volume and the infiltrative nature of tumours within the 
tumour staging.  
 
The above is also further complicated because it depends on clinicians identifying 
correctly the presence of a node and its true dimensions.  It is essential that possible 
nodes identified clinically from neck palpation, have more objective investigation, so 
that it can be established whether there is neck disease, an extension of the tumour 
(Roland, 2012) and whether there is an indication of more extensive disease.  
  
 
 AETIOLOGY 
The overwhelming evidence related to the causes of H&NC is that the disease is 
attributable to an individual’s behaviour with particular reference to their use of 
tobacco and alcohol. Table 1.1 details the main causes of the disease; much of the 
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more recent changes in incidence, particularly from a female perspective, are as a 
result of the different environments women now work in and the increased 
acceptability of them using tobacco or alcohol.  
TABLE 1.1 DESCRIPTION OF CAUSES, BEHAVIOUR AND REFERENCES FOR 
H&NC 
 
Cause Description/behaviour Source of data 
Tobacco Type of tobacco smoked and style in 
which smoked influences site of 
tumour and risk of cancer.   
(Johnson, 2001) 
Alcohol Alcohol intake without tobacco. 
Consumption of more than 3 or more 
drinks a day increases the risk two-
fold Drinking beer and spirits has a 
more pronounced impact than wine  
(Hashibe et al., 
2007) 
(Purdue et al., 2009) 
Tobacco and 
alcohol 
combined 
Synergistic effect 35 times 2 packs of 
cigarettes and 4 alcohol drinks more 
likely to develop oral cancer than non 
smokers and drinkers  
(Blot et al., 1988) 
Human 
papillomavirus 
(HPV) 
The incidence of oral sex has risen as 
a reaction to known sexually 
transmitted diseases.  The 
development of the specific virus into 
oral cancer is not a direct correlation 
but whilst smoking rates have 
decreased oro-pharyngeal cancer with 
HPV positive pathology has increased.   
(Fakhry et al., 2008) 
 
Whilst tobacco-use has been identified as a carcinogen, alcohol-consumption is less 
well recognised.   It would seem, however, that the latter has played a more 
substantial role than had been understood previously.  The aetiology of other cancers 
can give some informative evidence towards this notion.   Smoking incidence has 
reduced greatly in the UK and so proportionately has the incidence of lung cancer 
(Office for National Statistics, 2011).  There has not been however a similar rate of 
reduction in H&NC, which suggests that other factors are influencing its cause within 
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the UK.  These might include environmental pollutants and occupational hazards, as 
well as behaviours relating to alcohol.   Increasing alcohol-intake has been an 
observed trend over the last twenty-years. Data issued on the drinking habits of the 
UK population from 2007, suggested that alcohol consumption continues to be at 
dangerous levels for 25 percent of the English population (Office for National 
Statistics, 2011).  Furthermore the disease presentation has also been identified as 
showing a pathological shift and is likely to explain why, despite a reduction in the 
incidence of smoking, there has been an increase in the number of oral cancers 
identified which is set to continue to rise.  
‘By 2030 it is predicted there will be 9,200 cases of oral cancer in the UK 
every year compared to 6,240 in 2009 and 3,030 in 1984. Rates continue to rise in 
both men and women and in all age groups including the under 50s with more young 
people developing oral cancer than ever before.’ (Cancer Reasearch UK, 2012) 
  
Oral cancer for men has increased by 24 per cent whilst lung and laryngeal cancers 
have declined by 24 per cent and 12 per cent respectively (Cancer Research UK, 
2009).  A review of the world literature between 1957 and 2000 suggests that oral 
cancer now presents in four to six per cent of patients who are under the age of 40, 
which is a new concept.  Llewellyn et al (2001) reported that there were an increased 
number of patients diagnosed under the age of 40 and that the aetiology, as well as 
pathology of the disease, in this group of patients, was likely to be different. A third 
contributor, viruses, has been recognised.  They may be the cause of oral and or 
oral-pharyngeal tumours and these tumours are tested more routinely for their human 
papillomata virus (HPV) status.  It would seem that this part of the disease 
epidemiology may explain why oral cancers continue to increase in incidence for both 
genders, whilst lung and laryngeal cancer, a disease of a smoking population, have 
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declined. The literature would also suggest that there are other associated risk 
factors that might influence the causes of H&NC apart from alcohol and tobacco-use.  
They include:  
 Poor diet (Garavello et al., 2008)  
 Poor oral and dental hygiene (Maier et al., 1993)  
 Occupational exposure (Maier et al., 1991, Dietz et al., 2004) 
 
Whilst behaviours seem to influence the aetiology of the disease, there is a more 
difficult link to be investigated in socio-economical terms. The situation is more 
complex and there are no strong links that could be identified specifically to suggest 
lower status equates to a higher risk of the disease.  Smoking seems to be the major 
influence, Conway et al (2010) carried out a detailed patient questionnaire on a 
cohort of H&NC patients in the West of Scotland to define the impact of socio-
economic status. They identified that those living in the most deprived communities, 
had the largest tumour burden, but they were unable to establish a clear relationship 
with socio-economic status.  It seemed that a higher-level of education had a 
protective effect, and that a lifetime experience of unemployment was associated 
with a higher risk of the disease.   After multivariate analysis, only smoking remained 
as a significant causative factor. The authors suggested that when trying to 
understand the complex relationship between socio-economic status and risk of 
developing oral cancer a lifetime socio-economic profile would be informative.   Such 
a recommendation was made earlier by Wooley et al (2006) when they had looked at 
similar contextual issues.   The impact of deprivation, whilst difficult to isolate from 
causation, may influence outcome in terms of survival and quality of life (QoL).  It has 
been suggested that lack of community support, isolation, bereavement and 
withdrawal from family or other support mechanisms may affect QoL significantly and 
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outcome. Woolley et al (2006) suggested that deprivation becomes an important 
case-mix adjustment measure when reporting outcomes. Their research investigated 
the impact of deprivation on QoL for H&NC patients.  The results suggested that 
patients living in the least deprived areas had better QoL scores than those in the 
most deprived areas.  Stage of disease, and subsequent treatment was not 
influenced by deprivation and they suggested that the lack of an intact social 
network, or the ability to access it due to financial constraints, was influential.  They 
recommended that keeping an updated deprivation index within the cancer database 
could help identify those patients at greatest risk of developing depression after 
treatment.  This aspect of deprivation, a mediator of the disease presentation, will be 
explored more fully in chapter four through the work of Munro, a clinical-academic 
oncologist.  
 
 
MODERN-DAY MANAGEMENT AND PROGNOSIS -A UK PERSPECTIVE  
Implementing the best evidence through the use of guidelines is one of the ways that 
the quality of health care can be assured. Harrison et al (2010) defined them as the 
synthesised evidence (relating to a topic) that has been translated into specific 
practice-orientated recommendations. For many governments and professional 
organisations these guidelines are construed as a way of tackling possible variations 
in practice for disease that might be complex and have protracted management.   
They are also a direct link from local practice to national recommendations with the 
influence of both experts and politicians. Guidelines have been justified as a way of 
trying to consolidate health-care costs by streamlining services, and are set in a 
context of evidence-based medicine, which has sought to eliminate anecdotal or 
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inconsistent approaches to healthcare and improve patient outcome (Scottish 
Intercollegiate Guidelines Network, 2006).  From a H&NC perspective both of these 
issues are most pertinent.  The rarity of presentation, the multiple variables that need 
to be accounted for and the need to address individual patient needs, means that 
guidelines remain recommendations from which clinicians might select treatment 
options too.   In England and Wales they have been regarded as a way of trying to 
diminish disparity in care that might occur, which seemed due to local variability and 
became known by the colloquial term of 'postcode lottery'.  There was evidence 
published by the media that fuelled public unease that possible treatment and 
successful outcome was being affected by where patients lived rather than the 
severity or needs of their disease.    
As a reaction to such circumstances guidelines have been created.  The National 
Institute for Clinical Excellence (NICE), was set up to promote and explore high 
quality health-care and produced the English and Welsh H&NC guidelines (National 
Institue for Clinical Excellence, 2004).   
These guidelines: 
• Defined the recommended assessments 
• Described the limits of its remit in terms of tumour type, and so stated    
explicitly   that they did not include skin cancer, sarcomas, lymphomas or brain 
tumours  
• Detailed the professional groups involved along with their specific roles 
• Described an expectation that peer-review and regular team discussions 
became part of the standard and expected process of patient-care 
 
The guidelines had key recommendations, for cancer networks, which are made up 
from the health service, local authorities and voluntary agencies. The 
recommendations of the guidelines are listed below:  
• The establishment of H&NC centres, (definition of a centre-managing at least 
100 newly diagnosed patients a year, from a population base of more than a 
million 
• The referral process should be streamlined to reduce administrative delay 
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• The need to provide a wide-range of specialist support services from the pre-
treatment stage that should continue until rehabilitation was complete 
• The services after the acute hospital treatment should be community based 
• The multi-diciplinary team MDT should collect data recording the management 
and outcomes of the patients treated 
• An urgent need for the development and expansion of research into the 
effectiveness of management 
 
A general outline of a treatment pathway has been published but the emphasis is on 
broad descriptors rather than intricacies of the individual patients. Scottish guidelines 
(2006) on H&NC and the NICE guidelines (2004) are a synthesis of the available 
data by experts in order to inform the public and the health service.   
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FIGURE 1.2 OUTLINE OF THE PATHWAY OF THE CARE FOR A PATIENT WITH 
SUSPECTED AND THEN CONFIRMED DIAGNOSIS OF HEAD AND NECK 
CANCER. (Scottish Intercollegiate Guidelines Network, 2006) p55 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Decisions about treatment are complex, and must balance treatment success and 
subsequent survival, with possible functional impairment and QoL changes 
(Mehanna et al., 2010).  The H&NC multi-disciplinary-team has developed because 
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no one professional group can manage the patient from diagnosis through treatment 
and follow-up.  It relies upon many specialities liaising with one another, in order to 
formulate a possible treatment-plan.  This cohesion of care and expertise based on 
volume has benefits to outcome, complication and cost (Westin and Stalfors, 2008).  
These factors are likely to be more relevant as there is further advancement or 
refinement in oncological and surgical treatments.  Whilst it is known that teams 
should have the opportunity to discuss the possible treatment options prior to 
decision-making, it has been suggested, by identifying possible co-morbidities and 
having insight into patients’ preferences, that the effectiveness of the decision can be 
improved (Blazeby et al., 2006).  The purpose of such meetings is to determine the 
best way to control the tumour whilst maintaining survival and QoL.  In terms of 
Sackett’s classification of research quality much of the evidence associated with the 
disease does not exceed quality level 2a, systematic reviews of cohort studies 
(Sackett et al., 2000) because of the heterogeneity of the patient group.  This factor  
is evident from a review by Conway et al (2009) which found that of the fifteen 
systematic-review articles that were identified, most were judged to have 
methodological flaws or poor statistical power.   
 
 
 
THE MANAGEMENT OF THE DISEASE 
ASSESSMENT 
The sense of variety of health-care provided and broad, rather than specific 
guidelines will have helped establish that the disease and its management is 
complex.  Diagnosis is very unlikely to be established by a single outpatient 
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appointment.  It is critical to carry out investigations in a logical, sequential way. If 
certain procedures are performed before others there is a possibility that the 
information gathered could be influenced wrongly by the timing of investigations.  
During the assessment process, which will include clinical examination, radiological 
scans, and pathology scrutiny, the disease can be confirmed and classified more 
accurately.  The original assessments have to answer two specific questions:   
1. Is the disease too advanced?  
2. Can the patient tolerate the recommended treatment from a physiological  and 
emotional perspective?   
 
Imaging, in the ideal sequence of assessment, should be carried out before any 
biopsies of the structures so that the scan represents the nature and spread of the 
disease, rather than including localised tissue-trauma from the biopsy.  The imaging 
work-up might include plain X-ray, computerised tomography, (CT) Magnetic 
Resolution Imagery (MRI) or positron emission therapy (PET).  All provide different, 
but complimentary assessment information.  The main aim of these scans is to 
confirm, by corroboration, three aspects of the disease:  
1. The suspected tumour site  
2. Extent of the disease within the neck  
3. The possibility of synchronous tumours not yet identified  
 
The direct examination of the patient and tissue-sample allows for a comprehensive 
and detailed assessment of the patient and the possible disease that will need to be 
confirmed by pathology.   
A possible tumour needs to have confirmation from a pathologist before treatment 
can be formulated.  Any biopsy carried-out might require the patient to have a 
general anaesthetic in order to access the area and take enough tissue to be a 
representative sample. The decision about the use of single or dual-modality 
treatment is based largely on the pathological findings.  It is not until this point that 
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the disease can be staged formally (Roland, 2012) and the need for oncological 
treatment established.   
 
TREATMENT OF HEAD AND NECK CANCER, GENERAL POINTS  
At the time of presentation many patients may have limited or minimal symptoms 
from the tumour.  In broad terms there are two types of treatment that might be used 
solely or in combination, surgical or oncological.  The order and combination selected 
is dependent on many aspects of the disease-presentation and the practices of the 
country in which the patient lives. This chapter will emphasise the UK approach to 
treatment but will also acknowledge the context of the differences from an 
international perspective.  Guidelines were drawn up by NICE (2004) and SIGN 
(2006).  Within the guidelines area framework, it is not possible to be overly 
prescriptive because of the numerous presentations that need to be considered.    
Some of the methods of treating H&NC are affected by international preferences. 
Over the last twenty-years, with the advent of improved surgical and oncological 
techniques, treatments for H&NC have become more sophisticated and intricate.  It is 
possible however because there is little to choose between results from different 
ways of treating patients, that a patient might be offered chemo-radiotherapy in one 
country whilst receiving surgery as the primary and definitive treatment in another.   
Clinical decisions cannot be made purely on the basis of the patient’s tumour 
presentation and have to take into account possible co-existing medical conditions, 
known as co-morbidities. Appendix 1.3 lists some of the national guidelines used for 
H&NC 
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CO-MORBIDITIES AND HEAD AND NECK CANCER 
Patients with any type of cancer can present with co-occurring medical conditions, 
which may range in both presentation and severity.  Co-morbidities have been shown 
to have prognostic importance within the H&NC population (Piccirillo, 1995, Singh et 
al., 1998, Pugliano et al., 1999), which might be more significant than the presenting 
head and neck disease. The prognostic impact of these co-morbidities is thought to 
arise from the physiological burden of the chronic co-morbidity and its ongoing 
treatment to the patient.  It has been established that the severity of co-morbidities is 
high for the H&NC population, with only lung and colorectal patients presenting with a 
greater degree of co-morbidity burden (Piccirillo et al., 2004).  H&NC patients with 
co-morbidities have been reported as having poorer survival, even after taking into 
account other important clinical factors such as age, site and stage of disease (Yung 
and Piccirillo, 2008).  Therefore, despite a patient surviving the initial treatment for 
the cancer, the co-morbidity might still be the dominant variable that will affect 
survival. 
 
 
 
SURGERY  
Surgery in general has been able to progress because of very significant advances.  
These have included the ability to anaesthetise patients safely, control infection and 
the successful use of blood transfusions.  Surgery in the head and neck region has 
progressed in its sophistication over the last twenty years because of micro-vascular 
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techniques.  This means that the reconstruction might include bone as well a soft- 
tissue, and will try, as far as possible, to mimic the pre-morbid shape that it replaces. 
The use of micro-vascular free-flaps has enabled structures to be preserved in part, 
whilst removing the tumour, and enough of a surrounding margin of tissue. Failure of 
the flap to survive is a rare occurrence and has been reported in the UK to have an 
incidence of approximately five percent (Novakovic et al., 2009). There are many 
papers that compare the relative merits and surgical techniques in order to harvest 
and relocate the flaps (Genden et al., 2009, de Bree and Leemans, 2010, Wehage 
and Fansa, 2011).  
 
Surgical intervention, as well as attempted excision of the tumour, will also include 
management of the patient’s neck, which as described within the assessment may, 
or may not, at the time of presentation, have confirmed nodal disease.  A predictable 
pattern of possible nodal involvement has been known about since the mid-nineteen-
sixties (Fisch and Sigel, 1964) and early seventies (Lindberg, 1972).  From such 
work, clinicians are able to perform neck dissections that allow for the preservation of 
some of the anatomical structures within the neck and similarly limit the impact on 
physical function.  The benefit to the patient is that there is disease clearance whilst 
poor range of movement to both the shoulder and neck are minimised.  
 
ONCOLOGY TREATMENT - RADIOTHERAPY 
Radiotherapy has also shown advances from a technical perspective.  There has 
been the more universal use of Intensity Modulated Radio-Therapy (IMRT), which 
enables the radiation dose to be delivered in a three-dimensional way.  The main 
advantage of this technique within the head and neck region is that the structures, 
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which might be sensitive to radiotherapy, can be spared by receiving a much lower 
dose than the ultimate dose delivered to the tumour. The sources of the radiotherapy 
build up and focus on the epicentre of the disease and they might therefore allow the 
salivary glands to be spared.  It has been reported that the main influence on tumour 
control for such a treatment is tumour and nodal volume (Chao et al., 2002).  IMRT 
has been used clinically within Britain since 2001 (Webb, 2005).  However as Webb 
(ibid) discussed there are three reasons why the benefits of the technique are 
unclear and the real impact of the advancement will never be truly reported:   
 The technique was used in the States where there is generally a broader 
acceptance of the use of technology;  
 The long-term effects cannot be known because the technique has not been 
used for long enough.   
 Central to the rationale is the preservation of normal tissue from late radiation 
effects, which makes it difficult to recommend randomised controlled trials.  
 
 
 
CHEMOTHERAPY 
The increasing complexity of surgical management has been replicated within the 
field of oncology.  Chemotherapy is a relatively new treatment for patients and 
concurrent chemo-radiotherapy (simultaneous) or induction (prior to radio-therapy) 
chemotherapy has, for patients with no adverse co-morbidities, almost replaced 
radiotherapy alone (Merlano, 2006, Benasso et al., 1997, Vermorken et al., 2007) 
because of the reported increased survival rates.  Concomitant chemo-radiotherapy 
has also been seen as a viable alternative to surgery and post-operative 
radiotherapy, (Posner, 2005, Posner and Vermorken, 2008).  Induction (prior to 
treatment) chemotherapy, followed by chemo-radiotherapy, has been presented as a 
combination treatment in which the chemotherapy prior to the chemo-radiotherapy 
treats the distant metastatic disease, whilst the more traditional use of the chemo-
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radiotherapy achieves loco-regional control (Posner and Vermorken, 2008, Bhide et 
al., 2008, Vokes, 2010).   
 
The decision as to which combination of treatment is going to be used, and in which 
order, is likely to remain controversial and unanswered.  Seiwert and Cohen, (2005) 
have discussed that a randomised controlled trial is unlikely to be used as a way of 
establishing the answer, because of the inherent bias in patient selection, and the 
difficulty in staging patients in a similar way.  As they further comment, there is a 
place for both approaches, which can and do co-exist.  There are, therefore, for the 
first time, the possibility of two treatment methods available for consideration, with 
the intention to cure: surgery and radiotherapy or chemo-radiotherapy.  It is of note 
that no randomised controlled trial to compare the regimes used across countries has 
been undertaken.  This is due to a belief, by different health organisations, that the 
way they are treating the disease is most appropriate. 
 
The situation is made more complex from the oncological aspect because there are 
many variables within the speciality evident across countries.  This might include total 
dose of treatment delivered, as well as different combinations of chemotherapy drugs 
used.  The difficulty in comparison is compounded because the new combined 
modality therapies often change more than one variable at a time, such as the 
dosage type of chemo-radiotherapy (Choong and Vokes, 2008) as well as how the 
drug-integration is fitted within the radiotherapy regimes (Maluf et al., 2007). In many 
of these studies the results focus on the survival rate and there is very little input from 
a patient perspective in terms of QoL and any symptoms as a result of the treatment.  
This issue is developed more fully within chapter two. Outcomes remain focused on 
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the statistical presentation of survival and loco-regional recurrence, grade of 
mucositus and adherence to complete the treatment. Choong and Vokes (2008) 
wonder if, after further analysis of results, induction chemotherapy may provide 
minimal survival-benefits.   Chemotherapy is used much more routinely as an 
important treatment option for advanced H&NC.  However, phase three clinical trials 
and meta-analyses cannot find any specific and favourable outcomes with reference 
to either loco-regional control or survival (Adelstein, 1998, Adelstein, 1999, Pignon et 
al., 2000, Cohen et al., 2004).  The difficulty seems to lie in the heterogenic nature of 
the disease presentation, such that H&NC sites behave differently in terms of 
lymphatic drainage and propensity for distant metastases in each of the main site 
areas of categorisation -oral cavity, oro-pharynx, larynx and hypo-pharynx (Adelstein, 
2008).  Adjuvant chemotherapy as opposed to radiotherapy only, has been shown to 
improve loco-regional control and, in some cases, survival (Forastiere, 2004, Bernier 
et al., 2006).  However, it is important to note again that these studies did not review 
such issues as swallowing function and patient related symptoms, which are detailed 
in the next section.   
 
 
 
 
TREATMENT SIDE EFFECTS AND COMPLICATIONS 
By this point in the chapter the potential impact that this disease might have on some 
of the most basic and personal functions for patients should be evident. There is 
likelihood that vital structures are likely to be impaired and will, as a consequence, 
compromise patients with far-reaching disease and treatment side-effects.  These 
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delicate, complex, coordinated structures, should they be subjected to any 
treatments, are at risk of having their function impaired. There is every possibility that 
a patient will never have appreciated what the effect will be until functions such as 
eating, breathing and communicating are altered, perhaps irrevocably.   
 
The identification of co-morbidities as discussed earlier will, prior to the start of 
treatment, enable the team to be both proactive and vigilant.  An understanding by 
the team of the repercussions is also important so that the patient and their relatives 
are informed about the possible side effects of the treatment. The intention would be 
to reduce the incidence of treatment complications, which might be equally as life 
threatening as the untreated disease.  The possible complications can be 
categorised broadly into those that are as a result of co-morbidities (hypertension, 
respiratory disease) and those that are as a result of the actual treatments (infection, 
fibrosis, dry mouth, poor taste, reduced range of movement).  This may mean that a 
patient’s function might be affected as a direct result of the treatment sequelae or 
because of their existing co-morbidities.  
 
There is a need to incorporate the patient qualities within the possible outcome of the 
treatment.  From the research it would seem that there are some patient behaviours 
that are better at dealing with symptoms (Scharloo et al., 2005).  Their work detailed 
the types of patients who were likely to feel that they had worse quality of life.  These 
patients tended to focus on symptoms, believed they were at high risk of recurrence, 
had a high score for self-blame and had poor scores relating to the emotional domain 
of QoL questionnaires.  The impact of patient characteristics was also    in work 
carried out by de Leeuw et al (2001).  Reliance on alcohol, denial and fatalism were 
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the patient profiles of people less likely to improve from their symptoms.  The 
symptoms might also be more complex because they are multi-factorial.  Examples 
might include change in body image, communication, ability to socialise, reduction in 
mood and activities.   There has been research to suggest that an impact on speech 
and eating is likely to have the most impact on a patient’s well being (Duffy et al., 
2008).  Again there is a real need to measure these aspects more carefully.  
Research has suggested that to have a prolonged method of alternative method of 
feeding is likely to predict a poor QoL, (Ronis et al., 2008).  Perhaps what should be 
included is detail on the ability to eat, and be integrated socially rather than merely 
the presence or absence of alternative methods of feeding.  Merrick and Farrell’s 
study (2012) investigated, in detail, patients’ attitudes to alternative methods of 
feeding.  Three perspectives to gastrostomy tube-feeding were evident from the 
research: some patients adapted in a constructive way to feeding tube, some were 
ambivalent to the situation and the final group showed much more negative reaction 
to it and were, as a consequence of the procedure, anxious and fearful of the 
treatment used.   The recommendation of this study was that there is a real necessity 
to provide patients who are tube-fed whilst receiving HNC treatment with 
individualised patient centred nutritional care. 
 
 
 FOLLOW-UP POST DEFINITIVE TREATMENT  
Recurrence or late-stage complications such as tissue or bone necrosis can be 
monitored and managed at this stage. Outpatient review for patients with H&NC after 
the initial and acute healing-time is focused principally on surveillance (Vaamonde et 
al., 2003).  There may be a role for re-imaging a patient should there be suspicion of 
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a recurrent tumour, but as documented by Hermans (2008) there is a difficulty in 
differentiating change in tissue from recurrence when using this assessment 
technique. Davidson states that one of the highest predictors of tumour recurrence is 
previous H&NC (Davidson, 2001).  Patients with cancer of the oral cavity and 
pharynx have been described as particularly susceptible to the development of new 
cancers because of the rich blood and lymphatic system. 
 
There is much less success in achieving curative status in patients who present with 
a second primary tumour in the head and neck (Kyrgidis et al., 2010). If a patient has 
already had radiotherapy for a tumour treated previously it will not be possible to offer 
further radiotherapy because the soft tissues will not be able to withstand another 
radiation treatment without being destroyed.  If further treatment cannot be offered, 
the surveillance team will need to manage the progressive and additional  
symptom-burden that follows.  This is most likely to include referral onto specialist 
community palliative care teams to support the patient and their families as the 
disease progresses.   
 
 
 
 
 
PROGNOSIS 
The complexity of the disease presentation and combination of possible treatments 
should have established that advising patients about their prognosis is difficult.  It 
would seem very reasonable that patients can discuss with their team the likelihood 
of recurrence and the expected impact of the treatment on their everyday lives; but it 
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maybe that the answer remains vague and that much of the detail is judged to be too 
individual to be predictive or useful.  The heterogeneity of both the patient and 
disease presentation means that definitive prognostic information is difficult and 
might at an individual level be meaningless.  The variation of tumour site, size, and 
pathological classification, diversity of treatment options, the presence of co 
morbidities, and the precise interpretation of these at a unit level, make discussion 
difficult.  Predictions about treatment success are not amenable to percentage 
answers. There are, however, some broad principles that can be used.  One and   
two-year survival is better in patients who present with smaller volume tumours and 
in tumours situated in the larynx rather than oral cavity or pharynx (Cancer 
Reasearch UK, 2012).  Such a statistic is in part related to how easily cancers are 
identified at initial presentation, and persistent hoarseness, a feature of laryngeal 
cord cancer, is amenable to early detection. 
 
Prognosis is variable and depends on a number of factors. The presence and stage 
of neck disease has already been discussed.  There appears to be a better outlook 
for patients diagnosed with oral cancer that is HPV 16 positive (Fakhry et al., 2008). 
These tumours are more susceptible to induction chemotherapy compared to 
tumours that are HPV negative.  There is also better long-term survival because 
there appears to be less likelihood of recurrence from tumours fitting into this 
pathological classification.  Survival for H&NC patients is hampered by a high 
incidence of distant metastasis, second primary tumours, and co-morbidities (Gleich 
et al., 2003).   Gavilan et al (1992) suggested that predictors of recurrence after 
surgical resection, from a pathological perspective, included: involved margins at the 
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time of the first resection and the presence of neck nodes, which may exhibit extra-
capsular spread.  
 
Although clinical features of the tumour are pivotal in disease-free survival, there are 
other factors such as socio-economical status that have been linked to prognosis.  
Level of deprivation has been shown to impact on survival within the UK.  Patients 
who are classified as having greater wealth have, over time, been shown to have an 
increasing chance of survival.  Five-year survival rates have, for more affluent 
patients, increased from 43-55 per cent between 1971-1975 and 1986-90, compared 
with a corresponding small change from 42-44 percent for more deprived patients 
over the same time intervals (Conway et al., 2007).  Perhaps this has been the real 
impact of population education.  
 
 
THE MODERN CONTEXT FOR HEALTH OUTCOME MEASURES  
Chapter two will describe the context and possible outcome measures that might be 
used in health-care.  However, there is a need to explore this briefly within the 
management of the disease.  Darzi stated in the document ‘High Quality of Care for 
All’ (Dept. of Health, 2008) that a quality outcome should include safe, effective care, 
but should also encompass the broader experience of treatment and care provided to 
both patients and their carers.  
 
It is by no means easy to measure what is useful and meaningful for patients in terms 
of results or outcome post-treatment.   It becomes the job of health professionals and 
researchers alike, to define with patients what the toll might be. As the introduction to 
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this study stated, until recently the way of measuring the personal and service costs 
of cancer in Britain has focussed on the routine measurement of length of survival 
 and the achievement of process-driven targets such as: 
• Referral to first appointment  
• Assessment work-up to diagnosis and agreed treatment plan  
• Length of hospital stay  
• Re-admission-rate   
 
Such measures have been viewed as too minimal and as having little relevance to 
patients in terms of the quality of the care they receive.  In an attempt to address this 
particular issue for cancer services, the coalition government brought out a document 
in January 2011 aimed specifically at discussing outcome measures for cancer 
patients, ‘Improving outcomes: A Strategy for Cancer’ (Dept of Health, 2011).  This 
paper described ways in which it was hoped to deliver world-leading health 
outcomes.  It was noted that whilst temporal targets, length of stay and survival 
intervals, are part of the quality measurements they are not the only way that health 
care outcomes should be measured. Three underpinning ideologies were stipulated, 
which placed patients in the centre or of the issues relating to care:  
 Patients are at the heart of the public services through the principle of ‘no 
decision about me without me’  
 The NHS was re-orientated towards delivering the improvements in outcomes, 
which matter – rather than measuring processes, which do not  
 Local organisations and professionals were encouraged to be innovative (Dept 
of Health, 2011) 
 
 
These statements may be seen as real intentions of care being delivered to the 
highest possible standard and to be moving away from meeting targets that are 
process driven, towards ones that are meaningful to individual patients (Kennedy, 
2003).  The difficulty still remains however around how patients will know whether the 
quality of care they are receiving is good, or even exceptional, rather than just the 
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care they would want. Outcome measures should be orientated towards patient 
needs rather than absolutes of either survival or process.  They are also set within a 
context where more patients are less well but demand either directly, or indirectly, 
more emotional or physical support because of increasing expectations of health-
care.  
 
 
There is a need to draw a distinction between what might be a service outcome, or 
an outcome relating to a treatment and what the personal impact might be upon a 
patient.  From a swallowing perspective this can be demonstrated by thinking through 
an outcome such as being fed by alternative non-oral methods.  The presence or 
absence of a feeding-tube does not take into account the aspects of swallowing at 
either an individual or detailed level. There is no understanding as to whether 
patients have adapted by a change in what they eat, how they eat, how long it takes 
and whether they are in pain or have reduced appetite and taste.   Similarly there 
might be many reasons why a patient does not eat, such as: low-mood, fatigue, poor 
appetite as well as the more predictable reasons of physical limitations from poor 
soft-tissue function. All of these aspects are explanations as to why alternative 
methods of feeding are used but give little substantial explanation as to why there is 
such an effect. The lack of true clinical detail can be illustrated further by a paper by 
Salama et al, (2008), that reviewed the use of chemo-radiotherapy.  Patients should 
be aware that there is a strong possibility that their swallow will be affected.  They 
reported that sixty per cent of patients had a worse swallow after the treatment; 
twenty per cent had no measurable change and twenty per cent had an improved 
swallow. They also noted that older people were more likely to have a detrimental 
swallow post-treatment.  There remains the clinical gap, therefore, between survival 
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success and impaired function.  It would seem really important as survival improves, 
that a review of function and the impact on patients are reported routinely so that 
patients are informed more fully and are able to deal with the impact of the possible 
treatment side effects.  At the moment these issues are not reflected within the 
literature in great detail. There is, as yet, a gap between the outcome measures 
reported, and the specific impact on patients.  In its extreme, this might be seen as a 
conflict between the minimal data set and the rich unspecified patient experience.    
 
 
SUMMARY 
This opening chapter has detailed the diversity of the disease in terms of its aetiology 
and incidence and given some of the main ways in which H&NC is treated, should it 
be considered curative, by progressive and numerous assessments. It is to be hoped 
that, whilst the exact detail of disease and treatments cannot be retained, there is an 
overall sense that the disease is complex, multifaceted and that patients present in 
many diverse ways.  There is, unfortunately, despite a real effort to manage patients 
through an efficient process, delay in diagnosis because of poor recognition of the 
disease by both the population and health-care-professionals.  In England and Wales 
a political intention exists that would suggest that once patients are in a specialist 
environment, the outcome measures used are at a meaningful level rather than 
measuring what is easy to collect.  
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                                           CHAPTER 2 
                                MEASURING OUTCOME 
SETTING THE CONTEXT FOR OUTCOME IN HEALTH-CARE 
The opening chapter has discussed some of the evident variation that might exist for 
H&NC patients, and stated that the outcome measures of survival intervals and time-
to-treat targets have dominated, despite being both minimal and basic in the 
information that they give. This chapter gives the context of the management of 
H&NC within the government documents that have been produced since 2000.  The 
chapter is not a critique of the policy documents but helps inform the reader as to 
why and how the methodology chosen for this study was decided.  It emphasises the 
government’s intention to broaden care and outcome beyond numerical descriptors 
and involve patients directly in the planning of their care. 
 
There has been, over the last decade, increasing political and health-care resources 
spent on producing information gathered directly from patients, which has moved the 
emphasis away from process-driven targets (Department of Health, 2001, Dept of 
Health, 2010, Department of Health, 2011).  Many of the documents produced have 
sought to increase the role of patients, seeing them as important sources of 
meaningful information. The central theme for this chapter is the exploration of key 
health-service documents that discuss and recommend a change in emphasis 
relating to outcome.  Longevity without quality is of limited acceptability and the latter 
needs to be considered rigorously. Part of this change in emphasis has meant that 
the experience of care for a patient has become more central.  Patients’ statistics 
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therefore, which are beyond survival measures have been viewed as important 
sources of data because they depict, the outcome of disease and treatments in more 
detailed ways; they are known generically as Patient Related Outcome Measures 
(PROMS). 
 
 
THE JARGON ASSOCIATED WITH OUTCOME MEASURES 
The vocabulary that exists and is specific to outcome within the context of health-
care should be commented upon.  It is easy to find that vocabulary is used in ways 
that might sanitize the real meaning behind the care of patients; the phrases used 
can make aspects of care abstract and removed from their source, the patients, 
when they should be personal as possible.   Sir Ian Kennedy, an influential member 
of the judiciary, is direct with his criticism of the terminology used (Kennedy, 2004): 
 “We meet ‘patient safety’, ‘patient consent’, ‘patient focus’ and ‘the patient 
experience’… The centrality of concern for patients is undermined. It is replaced by a 
managerial concept: something to be included on an agenda and ticked. It allows the 
object and the objective of the expression, the patient, to be marginalised. It is no 
longer about patients; it is about some abstract notion. Change the language, not 
only to accommodate the principles of grammar but also to stress what is important 
and you have: ‘the experience of patients’, ‘a focus on patients’, ‘the safety of 
patients’. The discourse is completely changed. We are now talking about patients as 
people, whose experiences and safety are what we are concerned with.” 
 
Kennedy urges health-care professionals to re-focus on the personal aspect of 
patients’ care, but is well aware that the terms used are in danger of side-lining the 
patient despite the intention to keep them central rather than marginalised, or 
abstract.  The language used sanitizes the terms, makes them harder to understand 
and leads to health care jargon: 
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 The experience of patients is termed patient experience  
 The satisfaction of patients is termed patient satisfaction 
 Outcome measures reported directly by patients about themselves is 
termed patient reported outcome measure; 
 
Despite such health-care vocabulary, holistic needs-assessment, patient-centred 
care, patient-related outcome measures and patient experience are all methods and 
measures used to represent patients directly, which could inform the future quality of 
care and outcomes.   The experience of patients in relation to their care has been 
acknowledged as highly relevant and important and should not be excluded from 
results (Goodrich and Cornwell, 2008).  In the context of the treatment and 
management of patients a resetting of the way the outcomes of care are reported 
needs to be achieved. The difficulty is that in a culture when results need to be 
understood quickly and represented simply, any that require more than a headline 
explanation are judged as complicated to present or explain.  To move beyond the 
superficial message a deeper, more considered familiarity and understanding has to 
be acquired by both health-care professionals and policy-makers.  
 
Sir Ian Kennedy has spoken and written extensively on the issue of patient-centred 
care and suggested more than thirty-years ago (BBC, 1980)  
 “The power now is with the professional. Only when it is realised that health is too 
important to be left to doctors, that it is a matter for all of us, will conditions be 
created for the necessary redirection of effort and resources. Only then will any real 
movement towards health be achieved”.  
 
Kennedy was used as an objective outsider when he chaired The Bristol Royal 
Infirmary Cardiac Surgery Enquiry in 2000, which can be seen as the genesis of 
clinical governance. He had questioned, within the report, the clinical and cultural 
 39 
practice of what had been believed to be an expert-unit respected nationally 
(Kennedy, 2001  ).  The mortality rate was above average and the enquiry made 
seventy recommendations. In an essay that reflected upon what had been learnt 
from the enquiry, Kennedy, a decade later (2010),  was not reassuring on any 
progress made since the enquiry’s report.  Whilst recognising  ‘generalised failings 
within the NHS’ he observed that much of health-care has been ‘atomised by health 
care workers and managers, with a tendency to describe patients in terms of body-
parts, appointments, or cases-to-treat.’  He noted that, in reality, each professional 
had either labeled the patient as ‘an objective set of things’, or a ‘set of episodes’ to 
be managed.  The patient has become a form of currency, not a person to be 
understood and cared for.  Kennedy warned that  ‘It is not possible to assure oneself 
that there has been much discernible progress in the last thirty years’. 
   
Kennedy’s assertions are not unique to the NHS.  The American health care 
community, via the Picker and Plane Tree Institutes, in their introduction to  ‘Patient 
Centred Care Improvement Guide’ (Plane Tree and Picker Institute, Accessed April 
2012) observe similar issues to Kennedy’s 2010 commentary: 
‘………health care convention has been such that providers are the experts, 
families are visitors, and patients are body parts to be fixed. Indeed, for decades, the 
provision of consumer-focused health care information, opportunities for loved ones’ 
involvement in patient care, a healing physical environment, food, spirituality, and so 
forth have largely been considered expendable when compared to the critical and far 
more pressing demands of quality and patient safety-not to mention maintaining a 
healthy operating margin.’  
 
All of this literature has observed the fractioning of the complex person, which is to 
the detriment of their care, instigated in order to make the systems in which they 
experience care easier to work with, rather than for the benefit of individual patients’ 
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health.  It has also been a system used to allow targets around the processes of care 
to be achieved and monitored, which, whilst important, remain at a basic-level in 
terms of the information that it might offer towards the quality of a patient’s care.  
Quality that can be measured and patient safety have dominated understanding and 
caring for the patient has been overlooked.  The terms used within health care and 
highlighted by (Kennedy, 2004)  are an indication of this.  However, perhaps a 
change of emphasis is emerging.  
 
The next section presents some of the influential documents published since 2000 
that have started to describe and advise the change in health-policy towards data 
that is drawn from the patient directly and is therefore more patient-orientated. The 
documents reviewed have a particular relevance to H&NC patients and intend to 
increase an awareness of the current health-care context in which H&NC patients are 
being treated so that the detail and specifics of what might be relevant to their care 
can be considered.   
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HEALTH DOCUMENTS RELATING TO THE PATIENT ROLE WITHIN THE NHS 
THE EXPERT PATIENT: A NEW APPROACH TO CHRONIC DISEASE 
MANAGEMENT FOR THE 21ST CENTURY (Department of Health, 2001). 
The term ‘expert patient’ was seen as a patient-centred approach, which was 
described as a way of patients driving-up improvements in health-care systems, 
reducing costs by patients doing some of their care and influencing the health-
budget. Patients were seen as having a legal and moral right to autonomy and self-
determination.  They were recommended to have knowledge and information that 
should support them and facilitate their independence from health-care systems. In a 
commentary Donaldson (2003), the chief medical officer at the time, set high 
expectations for the term and described the term ‘expert patient’ as a concept that 
would be:  
“……….ushering in a new era of opportunity for the NHS.  ………..The patient 
as expert and partner in care is an idea whose time has come and has the potential 
to create a new generation of patients who are empowered to take action to improve 
their health in an unprecedented way”.   
 
The notion meant that if people can be engaged in their own care, and taught skills to 
adjust their behaviour, they have the possibility of controlling their own health 
outcome.  The role of the clinician, as a result of this change in emphasis, was 
believed to be shifting, from professional-expert to guide, which would mean that 
giving support and advice whilst navigating the patient through the health-care 
system would be expected.  Conventional self-management might fail; it was 
suggested for four reasons: 
1. Lack of awareness and engagement among patients 
2. Failure by staff to consider low health-literacy or cultural norms  
3. Lack of attention to family and social support 
4. A fragmented approach to health and social care   
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Self-management might bring order into a patient’s life, if there is the possibility that 
both the patient and the health care team start to recognise and monitor the patient’s 
personal boundaries.  It had the potential to lead to personal growth. The reality of 
such expert patient programmes within the cancer-field is hard to approve 
universally.  There are perhaps some assumptions made about patients that need to 
be checked rather than seen as omnipresent.  In a critique of the literature Wilson 
(2008), suggested various clinical practicalities were being overlooked:   
 The patients who might attend such programmes might not be typical of the 
patient population 
 Recruitment can be difficult 
 Clinicians are reticent towards the concept 
 The material used within the programmes is not flexible enough to meet the 
patients’ needs 
 
To truly have patient-led care from a patient who becomes an expert in their own 
condition, with an assessment of both the mental and physical aspects, is a 
significant clinical practicality to engage with for health-care workers as well as 
patients.  Greenhalgh (2009) urges support for clinicians to  engage in the unique 
challenges that all patients might face in trying to maintain their lives, despite chronic-
illness. She recognised however, in an extension of the role of expert patient, that 
self-management programmes, (the most utilised mechanism of the idea) needed to 
be extended so that whole systems of change can be incorporated, she saw this as 
particularly important where health-inequalities with complex  
social-determinants had been identified.  There is a real need to investigate this as a 
valid or possible concept with patients diagnosed with H&NC, particularly with 
patients who might find it more difficult to engage with the health care system they 
find themselves in.  The reality is that they find themselves in a situation in which 
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they have little knowledge of what to expect and little resource, physical, emotional or 
financial to invest in the process, which may include different phases of treatment, 
possibly over many months.   
 
 
 CREATING A PATIENT-LED NHS (Department  Of Health, 2005).  
This document emphasised that patients should have good clinical care and a good 
experience of that care. It consolidated much of the work discussed in the expert 
patient document.  The introduction of the report acknowledged that whilst the NHS 
was more able to cope with some of the capacity issues, which had prevented it 
providing a prompt service, it had also to address, in more detail, some of the quality 
aspects of care.  It stated that the main way of achieving this would be through a 
patient-led service, which would facilitate care to respond to patients’ needs and 
wishes.  
‘ ……..to move from a service that does things to and for its patients to one which is 
patient-led, where the service works with patients to support them with their health 
needs.’ (P3)  
 
‘Patients who are treated considerately, who are not left to endure anxiety and worry, 
who are treated attentively, who are given full and prompt information, who 
understand what they are being told and who are given the opportunity to ask 
questions, are more likely to have better clinical outcomes. A good patient 
experience goes with good clinical care – and patients need both.’ (P8)  
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The vision of a truly patient-led service described within the document has eight 
aspects of care identified, which are summarised in table 2.1. 
TABLE 2.1 ELEMENTS OF A PATIENT-LED SERVICE 
 Elements of a patient-led service 
1 Respecting patients for their knowledge and understanding of 
their own experience, their own clinical condition, their 
experience of the illness and how it impacts on their life 
2 Providing people with the information and choices that allow 
them to feel in control 
3 Ensuring everyone receives not just high quality clinical care but 
care with consideration for their needs at all times 
4 Treating people as human beings and as individuals, not just 
people to be processed 
5 Ensuring people always feel valued by the health service and 
are treated with respect, dignity and compassion 
6 Understanding that the best judge of their experience is the 
individual 
7 Ensuring that the way clinical care is booked, communicated 
and delivered is as trouble free as possible for the patient and 
minimises the disruption to their life 
8 Explaining what happened if and when things go wrong and 
why, and agree the way forward 
 
 CREATING A PATIENT-LED NHS (Department  Of Health, 2005).  
These elements of a patient-led service seem to echo Kennedy’s description of a 
service that is much more focused around the needs of the whole patient and 
attributes high importance to them rather than deferring to the convenience of 
medical processes.  
 
 HIGH QUALITY CARE FOR ALL (Dept. of Health, 2008)  
This document described the expectation of care for patients and introduced the idea 
that a quality outcome should, as well as including safe, effective care, encompass 
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the broader experience of treatment and care provided to both patients and their 
carers.  Darzi emphasised the role of the practicing clinician and recognised that the 
modern health care system has challenges which include:  
1. Relating to rising public expectations 
2. Increasing demand driven by demographics, (an ageing population with co-
morbidities)  
3. The continuing development of an ‘information society’ 
4. Advances in treatments 
5. The changing nature of disease 
6. The changing expectations of the health-workplace   
 
The inference of this document was that information gathered directly from a patient 
would re-dress the balance so that patients are more fully represented, echoing the 
theme from the 2000 document and that there is data gathered beyond the 
effectiveness and safety of clinical interventions. This document emphasised that the 
experience of care was vital for patients and should be seen as equally relevant as 
the other two aspects of safety and quality. 
  
 
 THE NHS OUTCOMES FRAMEWORK. (Dept of Health, 2010)  
This document described what are seen as the key-outcomes and indicators in the 
NHS for the health service.  The Outcomes Framework has been created with the 
intention of capturing the range of activities that the NHS is responsible for delivering. 
Where appropriate, they are not condition-specific.  Instead, they are generic and 
seek to capture those outcomes at an individual level, beyond any specific condition.  
Each domain and a brief description is presented in the table 2.2.  This document 
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builds on previous ones and in particular refers to themes from the High Quality of 
Care for All document (2008) 
TABLE 2.2  OUTCOME FRAMEWORK-DOMAIN AND DESCRIPTION  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Domain Description 
1 
Preventing people 
from dying 
prematurely  
Capture how successfully the NHS is playing its 
part in reducing the number of avoidable deaths, 
……..not all deaths can be prevented through 
healthcare; the major impact on reducing 
mortality will be by preventing people becoming ill 
in the first place. 
2  
Enhancing quality 
of life for people 
with long-term 
conditions 
 
Allow people to live as normal a life as possible. 
The overarching indicator ‘health-related quality 
of life’ was the most valued by people with long 
term conditions:  
(i)Feeling supported to manage their condition -
look after themselves and handle the 
consequences of their conditions  
(ii) Being able to return to employment. 
3     
Helping people to 
recover from   
episodes of ill-
health or following 
injury 
Two complementary objectives:  
(i)Preventing conditions from becoming serious 
requiring emergency admission     
(ii)Helping people to recover effectively. 
4    
Ensuring that 
people have a 
positive experience 
of care 
Ask people to provide direct feedback on the 
quality of their experience, treatment and care. 
5    
Treating and caring 
for people in a safe 
environment and 
protecting them 
from avoidable 
harm 
Patient safety is of paramount importance along 
with  
(i)quality of care  
(ii)delivering better health outcomes.  The pace of 
change is too slow and ‘cultural barriers’ that 
prevent patients being as safe as possible. 
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IMPROVING OUTCOMES: A STRATEGY FOR CANCER (Department of Health, 
2011). 
This report emphasised the holistic nature of the patient experience.  It recognised 
and detailed that as well as the physical aspects of patients’ health there are also 
financial and emotional aspects to be accounted for.  It stated that there was a real 
intention of the government’s health-care-system to facilitate as much independence 
as possible for a patient from both the health-care-system and their informal support-
networks.  Specific aims were set out within the report, one of which was that there 
should be a decrease in the proportion of people who report unmet physical and 
psychological needs post-cancer treatment.  The report expressed the view that both 
disease and treatment symptoms needed to be described in a more representative 
way and that this was best done by work being delivered by government, local 
organisations, patients and professional groups.  
 
 
 HOLISTIC NEEDS ASSESSMENT (National Cancer Action Team, 2011) 
This document was complimentary to the Improving Outcomes Strategy (2011) and 
was a way of describing how holistic needs assessment could be carried out.  The 
document commented that a cultural-shift was needed and detailed the process. The 
publication suggested that if the holistic needs of patients could be identified, patients 
would be more likely to be engaged with their care.  This would facilitate the location 
of possible resources, or services available during the latter stages of treatment.  The 
holistic needs assessment (HNA) of patients was set out as a way of trying to 
achieve this goal through the thorough and meaningful assessment of patients.  In 
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the introduction to the document, the description included how the HNA can enable 
patients to engage fully with their care, offering choices over the course of their 
management.  It is set in the context of ongoing processes that start prior to 
discussion about treatment options, and extend into survivorship or end-of-life care 
pathways. Again this paper builds upon the previous ideas setout within the Expert-
Patient (2001) and Patient-Led Care (2005) documents.   
 
This is not the first time that the government has stressed the need for holistic care 
and the HNA document is a practical application of the earlier recommendations 
presented within the Cancer Reform Strategy (Department  Of Health, 2007) and the 
organisation the National Cancer Survivorship Initiative (NCSI) (Department of Health 
et al., 2010). These initiatives all emphasise the need to assess the patient so that 
the interconnected aspects of physical, social, psychological and spiritual status are 
identified.   The absolute intention is not merely to describe if  patients are affected, 
but how, so that their concerns are considered and supported, rather than assumed, 
overlooked or recorded and never acted upon. There is also awareness, and perhaps 
frustration within the HNA that despite the recommendations made within the reform-
strategy there is limited implementation of the approach at a clinical level.   
The HNA cites the importance of assessment in improving the experience of patients’ 
care.  It suggests that patients should be helped to identify their concerns and to 
raise these so that practical help can be routinely accessed and planned for (National 
Cancer Action Team, 2011).  The HNA paper suggested that there are three 
structured tools that might make the identification of patient distress easier to identify 
and classify more accurately - Table 2.3 details the tools. 
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TABLE 2.3  
SUMMARY OF MAIN POINTS FOR THREE HNA TOOLS USED IN THE NHS  
Assessment Domains Format 
Distress 
Thermometer  
Concerns with:  
Practical aspects;  
Family;  
Emotional; 
Spiritual; 
Physical  
Tick box one side of A4 paper rate level 
of distress 0-10 concerns are ranked 
with a description in free text and an 
action plan  
Sheffield 
Profile for 
Assessment 
and Referral 
to Care -
SPARC 
Communication and 
information issues 
Physical symptoms 
Psychological symptoms 
Spiritual issues 
Independence and activity 
Family and social issues 
Treatment issues  
Personal issues 
Free text for other issues to 
bring up  
Able to have space to write 
questions to ask team 
Yes/no response and 4 point Liikert 
scale ranging from not at all to very 
much; free text box  
Holistic 
needs 
assessment 
PEPSI COLA 
Physical  
Emotional  
Personal  
Social support 
Information/communication;  
Control  
Out of hours  
Living with your illness  
After care 
Each domain is in a grid and the 
health care professional is asked to 
consider with the patient issues 
relating to each area and the possible 
resources available or professionals 
to transfer on to. 
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The full version of these assessments is provided in Appendix 2.1.  It should be 
commented upon that these documents have been seen by policy makers as a way 
of challenging health care professionals to enquire directly from patients details 
relating to the symptoms they experience from both their disease and treatment.  
They are however, somewhat superficial and are in danger of cataloguing patients’ 
symptoms rather than actually improving the quality of the interaction between 
patients and health care professionals.   
 
 
 NHS PATIENT EXPERIENCE FRAMEWORK (Insitute for innovation and 
improvement, 2012).   
In 2012 the NHS National Quality Board (NQB) published the NHS Patient 
Experience Framework (Insitute for innovation and improvement, 2012).  The main 
points of the framework can be summarised: 
 Respect of patient-centred values, preferences, and expressed needs 
including: patients’ cultural issues; dignity, privacy and independence  
 An awareness of quality-of-life issues; and shared decision-making 
 Coordination and integration of care across health and social-care systems 
 Information, communication, and education on clinical status, progress, 
prognosis, and processes of care to create autonomy, self-care and health 
promotion 
 Physical-comfort including pain management, help with activities of daily 
living, and clean, comfortable surroundings 
 Emotional support and alleviation of fear and anxiety about issues as 
clinical status, prognosis, and the impact of illness on patients, families and 
their finances 
 Welcoming the involvement of family and friends, in decision-making and 
demonstrating awareness and accommodation of their needs as care givers 
 Transition and continuity as regards information that will help patients care 
for themselves away from a clinical setting, and coordination, planning, and 
support to ease transitions  
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 Access to care with attention for example, to time spent waiting for 
admission or time between admission and placement in a room in an in-
patient setting, and waiting times for an outpatient appointment 
 
The framework outlines elements critical to patients’ experience of care from the 
NHS.  The National Quality Board sees the elements as fundamental ways of 
addressing patients’ experience. 
  
 WHAT MATTERS TO PATIENTS (King's College London & King's Fund, 2012)   
This document, published in the same year as the patient experience framework, 
was a collaborative piece of work between the King’s Fund and King’s University.  It 
stated that national measures of patient experience should be designed to achieve 
four purposes, which were acknowledged as being derived from the Outcomes 
Framework (2010): 
1. Accountability (reporting upwards) 
2. Transparency (reporting out to patients and the public, which means that the 
measures reported are understood by the public) 
3. Improvement in services 
4. Convince clinical staff, especially doctors, and encourage clinical leadership to 
engage with patient experience  
 
The report had triangulated results from patients, carers and organisations; it 
highlighted that providing a good patient experience should be multi-dimensional, 
consisting of two aspects:   
1. The systems and factual aspects of care, (Functional care) 
2. The interaction of the health-care professionals with patients, (Relational care)    
 
The results of the triangulated sources are presented in table 2.4.  It is of note that 
communication, a relational aspect of the experience, whilst seen as vital by patients, 
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is poorly represented as a reported outcome. Clinical effectiveness or the safety of 
patients continues to dominate reports.  
 
TABLE 2.4 DESCRIPTION OF WHAT ELEMENTS OF CARE MATTER TO 
PATIENTS  
Experience described as being important to the 
patient  
Category 
Good information provision written, oral and time to ask 
questions 
Functional Relational 
Having confidence in health professionals Relational  
Awareness and understanding of specific health 
conditions by the HCP 
Functional  Relational 
Right treatment/right staff/right time, knowing 
limitations, demonstrating working cohesively  
Functional Relational 
Continuity of care Functional Relational 
Caring, dedicated ,respectful staff, treated as a person Relational 
Being in partnership with professionals Relational 
Friendly, kind staff, who listen and spend time with 
patients  
Relational 
Efficient processes Functional  
 
All of these documents are capable of adding greater detail to the outcome measures 
that are gathered routinely and traditionally.  Independently or jointly they can be 
used to describe the experience of care, and give a more complete view of patients’ 
function physically, emotionally and socially.   The patient’s input to this aspect of 
outcome has been seen as essential and can enable the patient experience to be 
represented.   
The documents presented so far in this chapter highlight the need for individual 
experience, whilst identifying the patient as a whole, not segmenting them, or their 
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care, for ease of a process.  The rest of this chapter describes the aspects of health-
care for cancer patients and H&NC patients, set within the outcomes domain 
framework, because of its evident influence on the future way that the NHS will 
describe outcome using the five domain definitions used within the outcomes 
framework document (2010).   
 
 
HEALTH-CARE FOR CANCER PATIENTS: ENSURING PEOPLE HAVE A 
POSITIVE EXPERIENCE OF CARE  
The government has started to emphasise the role that health-care-professionals and 
the care-system can have on the experience of patients and is aware that this will 
impact on patient’s outcome.  Measuring the experience of patients is seen as a way 
of improving their care and safety; what to measure and how to transfer this back into 
real change in the patient care remains a challenge.  It is not unreasonable for any 
prospective patient to ask two key questions: 
 Will the care that I am given be responsive to my psychological needs as 
well as my physical ones? 
 Will my experience and perspective influence the health-care of other 
patients treated in the future?  
 
The inference is that there is a danger that health-care will ignore the person 
attached to the disease and remain ignorant, month after month, and year after year, 
to any experiences that might be seen as ways of reflecting and changing current 
care.  Kennedy’s warning of abstracting the person from the care would then become 
a reality.  
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There is a need for health care professionals to move away from a didactic and 
paternalistic role with patients; instead, they should try to elicit patient preferences in 
order that the quality of care that patients receive can be seen to be truly improving 
by being patient-centred.   There is, however, evidence from the National Cancer 
Patient Experience Survey (Department of Health, 2010b) that a coherent approach 
is not being achieved.  One hundred thousand questionnaires were sent to cancer 
patients treated by the NHS, between January and March 2010.  Sixty-seven 
thousand responded. This document indicated that multi-disciplinary teams still have 
a lot of improvements to make in terms of regarding patients in a holistic way.  The 
return rate for the questionnaires was good, with around 80% of these patients 
responding with a good or excellent rating, but the number of respondents not 
agreeing with this description, or not replying, means that the response might more 
properly be considered to be either mediocre or unknown for 46,000 patients.  This 
figure represents nearly half of all the patients sent the survey.  
From a H&NC perspective, being able to discuss the care that patients have had and 
reviewing how much they understand, in the context of their own care, is important.  
Having the patient at the centre of their care and able to ask timely and repeated 
questions about complex intricate care and is essential.  It is very likely that the 
treatment that patients have will not be well understood prior to the treatment.  It is 
not likely that the patient, their carers or primary care teams will have had much, if 
any, experience of the treatment and recovery of H&NC.  From a health-service point 
of view, patients should be treated by cancer-centres in which there are specialist 
teams who have regular dialogue with the primary care staff so that the patient can 
be supported with any of the ongoing issues that are experienced.   
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TREATING AND CARING FOR PEOPLE IN A SAFE ENVIRONMENT AND 
PROTECTING THEM FROM AVOIDABLE HARM 
In chapter one it has been suggested that outcome measures in H&NC remain fixed 
firmly with survival statistics and quality of life measures.  In England and Wales, part 
of the way of detailing outcome measures for H&NC patients is through the clinical 
biometrics for H&NC patients, which are uploaded to the British Association of Head 
and Neck Oncologists (BAHNO) database.  The information includes both biomedical 
and psychosocial parameters. The outcome measures are limited to tick-box 
categories and intervals of time-to-treat, time to assess and survival information 
rather than more descriptive information. They are, however, an attempt at a more 
complex level of statistics to describe the management of H&NC patients. The 
database for head and neck oncology (DAHNO) published an audit based on 
patients identified with H&NC between January 2004 and November 2005 (British 
Association of Head and Neck Oncologists).  In this 18-month period, just over a 
quarter of all patients with H&NC were included.  Of this minority only two-thirds were 
discussed within the recommended format of a multi-disciplinary-team meeting.  This 
would suggest that domain five, from the outcomes domain framework, (described in 
table 2.2 page 47), treating and caring for people in a safe environment and 
protecting them from avoidable harm, is not assured by a quality process.  
Examination of this process reveals there is as yet no facility to describe in detail how 
the team might meet and discuss cases, to explore whether the decision-making is a 
collective, considered decision or merely a rudimentary rubber-stamping of patients 
treated in a centre.  In part this is why there is the recommendation within the 
specialty-specific guidelines, Improving Outcomes Guidelines (2004) that MDTs 
should discuss all of the presenting H&NC cases together in order to promote best 
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and current practice.  The intention is that each clinician can be supported and seen 
to be carrying out a treatment that has been sanctioned by colleagues, rather than 
becoming a lone operator who is not having their cases reviewed regularly.   
However, it is salutatory to note that even basic quality of discussion, stipulated in the 
guidelines, cannot be demonstrated to take place routinely.  The actual evidence to 
identify the effectiveness of an MDT discussion is scant.  Patkar et al (2011) in a 
review of the MDT commented that the empirical evidence to support the use of 
MDTs is weak. The major problem with trying to study the effect of such a practice is 
the extensive number of confounding variables, which make the establishment of 
causal links very difficult.  What they did conclude however is that it is important to 
recognise that the lack of good-quality evidence does not mean there is evidence to 
suggest the meetings are ineffectual for patient-care.  They were aware that the use 
of randomised controlled trials for such complex interventions were likely to be 
impossible, and concluded that it was both intuitive and obvious that MDT meetings 
improved information exchange.  They also urged regular communication-flow, which 
could only be seen as being supportive of the care of patients in a way that is 
accountable, transparent and reliable.  This is an essential governance role carried 
out by MDTs that is in part a legacy from Kennedy’s work that stipulated the need for 
joint and transparent decision-making following the Bristol cardiac-unit enquiry.  
This chapter has so far described the last decades’ shift by policy-makers and writers 
on health-care from the physical aspects towards the emotional ones too.  It would 
be a limiting concept to suggest that H&NC has no influence on the patients’ 
emotions.  It would also be too simplistic to suggest that patients do not draw upon 
previous life events in order to help them manage the current diagnosis. From these 
viewpoints alone there is value in exploring how patients recover from the disease 
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and treatment. NICE estimates that fifty percent of all patients experience anxiety, or 
depression at some point during their cancer assessment treatment and recovery 
(National Institue for Clinical Excellence, 2004).  If the subjective aspect is left out in 
an attempt to follow a quantitative protocol, the relevance of the results will remain, 
from the clinical perspective, poor representations of the patients. If the research 
depicts poorly the clinical caseload, the danger is that clinicians may fail to perceive a 
link between making clinical decisions and the research. This particular aspect is 
discussed in greater detail in chapter four through the works of Munro and Salander.  
 
ENSURING PEOPLE HAVE A POSITIVE EXPERIENCE OF CARE  
One such subjective aspect is distress, a significant element featured in holistic 
needs assessments, has been defined by the National Comprehensive Cancer 
Network (NCCN, 2012) as:  
‘A multi- factorial unpleasant emotional experience of a psychological, social, and 
spiritual nature that may interfere with the ability to cope effectively with cancer, its 
physical symptoms and its treatment’ (p2).   
 
Distress has been identified in as many as seventy percent of cancer patients 
(Holland and Bultz, 2007).  Bultz et al (2011) reviewed the Canadian perspective and 
has suggested that distress should be seen as the sixth vital sign because it should 
be monitored as routinely and overtly as the more traditional physiological signs of 
life.  They suggested that the ‘people part’ of cancer care is fundamental and has 
ethical, emotional and economical sense.  There would seem to be the need to use a 
formal tool as a way of identifying and grading distress, because there is no evidence 
to suggest clinicians recognise and grade it accurately.  This is perhaps even more 
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essential when it is recognised in the definition, that the very features of distress 
might prevent patients from being able to be expert patients as expected in the 
document of an NHS patient-led service (2005).  If clinicians are unable to identify 
this aspect it might impede patients’ abilities to make informed choices.   
There is limited evidence to suggest health-care professionals are able to recognise 
distress.  A study that directly reviewed clinicians’ ability to do this reported their 
performance as only “modest” (Mitchell et al., 2008).  Some studies have reported 
that certain styles of communication can help professionals detect distress more 
readily.  In a review of more than fifty articles published since 1980, accessed from a 
data base, to include the search terms of: physician-communication, non-verbal 
communication, doctor–patient communication, cues, detection of distress, Ryan et 
al (2005) concluded that active listening, open questions, emotional rather than 
factual terms and a patient-centred approach would be more able to identify distress. 
It is relevant at this point to state that health-care professionals, when assessed in 
the clinical setting, are not able to demonstrate their ability to judge, with any degree 
of accuracy, either the physical or emotional aspects of oncological disease.  It has 
also been reported that fewer than fifteen percent of cancer professionals use 
screening questionnaires, such as the distress thermometer in clinical practice, 
preferring instead to rely upon their clinical judgment.  Unfortunately, their abilities 
appear to be neither specific nor attuned enough to recognise the level of distress 
being experienced by the patients (Mitchell et al., 2008, Davis et al., 2006). This work 
has further support from an earlier paper which investigated the ability of oncologists 
to recognise appropriately which patients within a general oncology case-mix were 
distressed in an outpatient setting (Sollner et al., 2001).  The results suggested that 
even when distress had been screened as severe, it was only noted within a third of 
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the patients by the oncologists, and they tended to be least good at identifying the 
existence of distress in patients with head and neck and lung cancer.  Distress, from 
their medical perspective, was correlated much more with the advanced nature of the 
disease and the level of denial behaviours used by the patients. It might be 
concluded therefore that health-care professionals are likely to over-predict the 
physical aspects of the disease, based on the classification of the disease, from early 
to advanced and under-estimate the psychological impact of the disease and 
treatment.   It would seem imperative from such research that assumptions are not 
made on behalf of patients about what the personal impact has been on them and in 
particular that no assumption is made related to the staging of the disease from a 
pathological perspective because this is unlikely to be accurate.   
 
The situation is further complicated because patients may deny or avoid exploration 
of their emotional aspect from their experience so that they do not engage in the 
reality of the disease and avoid examining their fears (Madden, 2006). This specific 
facet has been demonstrated within the H&NC population in which results have 
suggested that patients are likely to under report their experiences because of fears 
related to how they might cope with the additional losses that H&NC has already 
imposed upon them (Moore et al., 2004).  There is evidence too, that the impact 
might be long-term.  Recent work, relating to cancer patients as a group, has 
suggested that whilst anxiety, pain and distress are transient during the first year of 
treatment, these features may remain in a third of patients a year post-diagnosis 
(Carlson et al., 2011).   From a UK perspective this prediction conjoined with 
Madden’s review of the UK cancer registries, suggests there will be a growing 
 60 
number of cancer patients who have not been able to express the psychological 
distress that they might be experiencing as cancer survivors.   
It would seem, therefore, that it is not enough to allow clinicians to gauge accurately 
the presence and degrees of distress without recourse to a specific framework 
through which they can review routinely and systematically the individual’s situation.   
The HNA, detailed earlier in this chapter, would conclude that the identification of 
such qualities is only part of the role; something has to be done beyond the 
identification.   Their management needs should move from a mere portrayal to 
action. It is for this reason that there has been the recommendation that health-care-
professionals should acknowledge emotional distress as a core-indicator of a 
patient’s health and well-being (Bultz and Johansen, 2011).  Yet the focus remains 
on the easier to measure bio-medical and clinical-process (Carlson and Bultz, 2003) 
despite the importance of going beyond the superficial-level of the disease and 
treatment so that the patient’s needs can be represented more holistically (Salander, 
2011b).   
 
The problem of identification is compounded by the knowledge that the research 
suggests patients place a low-priority on their desire for psychological support 
(Tuinman et al., 2008).  The research demonstrated of five-hundred patients with a 
diagnosis of cancer only ten percent wanted a referral to be made for psychological-
support.   For patients who were identified, as being distressed, eighty-two percent 
had no wish to be referred.  This would suggest that the patients are not able to 
contemplate referral onto other agencies. There is perhaps a misconception that 
distress is a negative reaction, rather than being accepted as part of a normal 
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process that patients might be expected to go through; to seek support implies it is 
an unnatural reaction and classifies it as morbidity (Bultz et al., 2011). 
ENHANCING QUALITY OF LIFE FOR PEOPLE WITH LONG-TERM CONDITIONS  
Quality of Life (QoL) has started to occupy a central-position in health-care generally 
and more specifically in H&NC care. The World Health Organisation defined this 
ubiquitous and somewhat over-used term as: 
 ‘A state of complete physical, mental and social well being not merely the 
absence of disease’.(WHO., 1997) 
 
In the context of disease, it is described in terms of health-related QoL (HRQoL) the 
subjective experience of the impact of health status on QoL for the patient (Curtis, 
1997;).  The single most difficult feature to overcome in the collection and 
representation of QoL information, is the inevitable impact of imposing an objective, 
numerical score on a subjective, phenomenological position (Rapley, 2003). 
Questionnaire design is a flawed science, and while rigorous psychometric principles 
are used in the development of QoL scales, the accuracy of their measurement and 
the validity of their focus may well be subject to debate (Sprangers and Schwartz, 
1999). They might, at first inspection, be thought to be patient-centred but many of 
the measures fail to capture this uniqueness to individuals, because the moment a 
standardised questionnaire is used, the domains thought relevant to the patient-
group have been pre-determined, becoming measures of health-status rather than an 
individual’s QoL (Carr and Higginson, 2001).   
Despite such a specific and undeniable limitation, the most common way of collecting 
QoL information is via a questionnaire. The number and diversity of questionnaires 
relating to QoL is vast, whether seen in general or disease-specific terms. QoL 
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questionnaires measure different aspects of a patient’s QoL.  Consensus has been 
reached, which recommends that a number of QoL components should be 
measured, irrespective of disease, and include symptom-status, (physical, emotional, 
role), and social-functioning (Moinpour, 1994).  Whilst a global, overall subjective 
measurement may give an indication of the impact, the more detailed components of 
the questionnaire enable better insight into the influence of the disease and treatment 
on the patient.  Coons et al (2000) reviewed seven of the most commonly used  
generic cancer HRQoL questionnaires and suggested that it is necessary for 
researchers to choose a questionnaire based on the characteristics that are most 
relevant to a particular HRQoL measurement. It has been recommended that the 
optimal combination of questionnaires used would include both a general and 
disease specific questionnaire, so that small, but significant changes to a patient’s 
health can be identified (O'Boyle, 1997). A review by Bottomley (2002) of HRQoL 
questionnaires used with cancer patients showed that there were three generic 
HRQoL tools that are most commonly used in the oncology field: the Medical 
Outcomes Study Short-Form Health Survey (SF-36), Sickness Impact Profile (SIP), 
and Quality of Well-Being (QWB) scale. The review suggested all of the 
questionnaires have inherent bias because: 
 The language and presentation of questions does not allow for patients to 
describe QoL in relation to the general population  
 The focus is on the degree of disease symptoms 
 
The latter point-of-view was made by Cummins et al (2004). The questionnaires do 
not recognise personal growth or secondary gain. Operationally, many of the 
instruments measure HRQoL, physical, social and emotional status that might be 
described generically as ‘performance’.  Such a model cannot be judged as patient-
 63 
centred.  They are, instead, a way of representing what health-professionals and 
society believe are the constituents to healthy lives (Carr and Higginson, 2001).   The 
overall scores however, make it difficult to distinguish these concepts so that the 
headline-score may subsume the impact of a particular difficulty.  The intricacies of 
these sub-scales may also alter over time, whilst the sum-total does not.  This would 
suggest that a method of weighting results would make them more meaningful. 
However, the use of weighting, by ranking item-importance, suggests that patients 
are able to judge which is more important to them (e.g. relationships with their family 
versus their ability to work, versus lack of control).   Similarly, it is hard to argue that 
symptoms or patient-care are of equal value, and much of that diversity will be 
because patients have different and personal values surrounding the situation.   
The result of not capturing an individual’s QoL is that the measures are unlikely to be 
responsive to change and even if they are, they do not measure what is important to 
the patient, with the likelihood that different scores might be obtained after the same 
intervention in the same population.  The implications of this are far-reaching and 
leave four fundamental questions with no satisfactory answers:   
1. How can the effectiveness of interventions be truly determined?  
2. Can the real quality of the service a patient has had be assured?  
3. Does much of the patient-response depend on the relationship built with the 
MDT?  
4. Are resources being used efficiently?   
 
All of these questions are set in the context of growing patient needs and 
expectations, whilst budgets diminish in real-terms, a point acknowledged within the 
document High Quality of Care for All (2008).  Chapter three expands these 
particular issues of QoL with reference to both the patient and health-care 
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professionals who care for them, by describing research carried out by the author 
that investigates the limitations of HRQoL questionnaires.   
ENHANCING QUALITY OF LIFE FOR PEOPLE WITH LONG-TERM CONDITIONS. 
-OUTCOME MEASURES SPECIFIC TO HEAD AND NECK CANCER VARIABLES 
THAT IMPACT ON QUALITY OF LIFE SCORES 
HRQoL data, when it is patient-derived, may be a medium through which clinicians, 
patients, policy-makers and researchers are informed about the effect disease and 
treatment can have on patients. It might be that such patient perspectives can offset 
the temporal target-driven health-care and system description that is controlled by 
clinicians and policy makers. The National Cancer Survivorship Initiative (Department 
of Health et al., 2010) an organisation that is a partnership between the NHS, 
charities and the Department of Health, has published recommendations that they 
envisaged could improve care and the support of cancer survivors.  They suggested 
that the quality of the survival, as well as the more easily measured survival statistics 
or treatment target measures, should be within domain one, preventing people from 
dying prematurely, the NHS Outcomes framework (Dept of Health.,2010).    They 
described specifically a greater focus on recovery and health and well being after 
cancer treatment; a shift from description towards information provision and 
personalised care-planning.  The intention is that patients have their management 
based on individual needs, with the appropriate clinical assessment, support and 
treatment.  This would mean a change in practice from a single model of clinical 
follow-up to one of tailored-support that enables early recognition of, and preparation 
for, the consequences of treatment as well as early recognition of signs and 
symptoms of further disease.  They also described a move towards measuring 
experience and outcomes for cancer survivors through the routine use of Patient 
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Reported Outcome Measures (PROMs) in aftercare services.  Such 
recommendations may be achieved by using QoL measures.  Despite the 
aforementioned short-falls of such measures, they are derived directly from patients.  
From a H&NC specific point of view, although many studies report on survival and 
recurrence-free survival (Kovacs et al., 2002) other studies report on the variables 
that might impact on QoL.  Gurney et al (2008) reported that predictors of worse QoL 
for this patient-group included advanced stage, the presence of a gastrostomy-tube 
and dependence on it and the presence of a complication, or recurrence. More 
recently there has been research that might suggest that QoL assessments may act 
as a way of screening at-risk patients, such that patients with a poor measure on 
particular parts of a QoL questionnaire were more likely to be at risk of recurrence 
(Karvonen-Gutierrez et al., 2008).  In the same year Ronis et al (2008) reported that 
smoking behaviours, depression, gastrostomy placement and treatment modality all 
impacted on QoL factors with physical domains tending to worsen and emotional 
domains improve.  They recommended that health-professionals should support 
patients with accurate information about the effect the treatment is likely to have on 
them.  The same research group (Duffy et al., 2008) also published information on 
patients at a year post-treatment and suggested that health-behaviours after 
treatment (drinking, smoking), and the symptoms of lack of sleep and depression are 
interrelated.  They impact on QoL and should therefore be treated together. 
Functional information has been published on patients undergoing multi-modality 
treatment (Skoner et al., 2003).  Although the patient-populations were small, (less 
than twenty), some of the significant information clinically can be reported upon, such 
as number of days in hospital, number of days taken for removal of tracheostomy 
and number of days to achieve oral intake.  Researchers have also reported on 
 66 
wound complication (Teknos et al., 2001) or donor-site flap-morbidity from a patient 
perspective (de Witt et al., 2007).  Even when investigating the literature with 
reference to a very specific outcome, such as the use and complications of           
free-tissue-flaps, there is a need for consensus surrounding the results collected.  
The specific variability can be illustrated by examining the research-papers that 
discuss the outcome measures used when detailing radial forearm free-flaps (RFFF).  
Some of the research has focused on the survival of the flap (Santamaria et al., 
2000), others the function, (Chen et al., 2005). Such an example is a very narrow 
part of the whole treatment process; if the definition of outcome is broadened to 
include the factors that impact upon speech and swallowing, there is even less work 
published (Zuydam et al., 2005, Pauloski et al., 2004, Pauloski et al., 1998, 
Colangelo et al., 1996). The variables remain obvious and many. Patient populations 
are not the same, the treatment regimes are many, and the access to full specialist-
rehabilitation-teams has many permutations.  It remains difficult to reach conclusions, 
because of the hidden, or unknown variables that might be influencing scores, it is 
difficult to compare results or understand with certainty why they may differ.  What 
may be concluded from such studies are generalities, which may include:  
 The relationship between the structures involved  
 The size of the lesion to be treated and the resulting functional impairment  
 The impact of combined modality treatment 
 
Anecdotally, however, there are still patients who might appear to be at odds with 
such research outcomes.  Those with small tumours and single treatment modality, 
might be unable to carry out their routine activities, return to work and seek support 
from either formal or informal sources, whilst patients who have had combined 
treatment for larger disease return to near pre-morbid function.   
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Health-care professionals are likely to be inaccurate, just as they have been 
demonstrated to be, with the identification and degree of distress.  They have been 
found to over-estimate the physical symptoms, under estimate the subjective impact 
(Maher and Jefferis, 1990) and not account for tumour size (Reid et al., 2009).   
 
 
QUALITY OF LIFE AND CO-MORBIDITIES 
It seems logical that patients who have co-morbidities at the time of their treatment 
might be different from those patients who do not.  However, the relationship 
between co-morbidity and HRQoL has produced conflicting results.  Post-treatment, 
Pourel et al (2002) found no significant association between co-morbidity and 
HRQoL.  However, Terrell et al (2004) reported that patients with two or more co-
morbid conditions had reduced QoL scores relating to the physical domains, and 
increased evidence of pain post-treatment.  Pre-treatment, similar conflicting results 
have been reported, in that pre-treatment co-morbidities have been reported as 
impacting on HRQoL (Piccirillo and Vlahiotis, 2006), whilst an earlier study by Gourin 
et al (2005), reported no such relationship.  The disparity in results might be a 
reflection of the heterogeneity of the patient groups, the varied assessments used to 
grade co-morbidity and the time-interval at which the data was collected.  It might 
also be that because the domains being measured are pre-determined they cannot 
be said to be measuring an individual’s QoL (Carr and Higginson, 2001). 
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REPEATED USE OF QUALITY OF LIFE MEASURES 
Over time, the scores within categories, or sub-categories for HRQoL, might vary 
without an apparent change to the overall score, or the possibility that if scores do 
change they are often in relation to the patient’s emotional response to a life-
changing event, and not as a consequence of a shift in physical symptoms.  It is 
therefore very possible that scores are more a reflection of people’s adjustment to 
their change of circumstances rather than a measure of their physical or emotional 
state.    This notion has been demonstrated by a study by Logemann et al (2001) in 
which the impact of dry mouth on H&NC patients’ function and perception of their 
swallow was investigated post-radiotherapy.  Logemann et al concluded that dry 
mouth did impact on sensory and comfort issues of swallowing but not on the actual 
function of the swallow.  Subjects’ functional abilities to swallow were correlated with 
their perceived lack of oral secretions rather than the actual saliva they produced.  
This would suggest that the patients are moderating, or adjusting to the experience 
and that, whilst objective measures are important, there is value in collecting the 
diverse, subjective aspects because this will influence patients’ score to physical 
aspects of the disease or treatment.   
 
 
QUALITY OF LIFE AND SURVIVAL-DATA 
In the context of accepting that outcomes have been measured in terms of survival 
and temporal and process targets it is little wonder QoL measures are not used in the 
clinical setting. Until recently it would be implicit that there would be little point in 
collecting QoL information unless it could act as a prospective, prognostic measure. 
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There has been no true link established between QoL scores and survival for H&NC 
patients.  A review of the literature concluded that the evidence was neither strong 
nor proven (Mehanna et al., 2008).  Such failure to answer research questions 
definitively has meant that the outcome is viewed as vague, complex and not 
particularly useful.   A review of the QoL literature relating to H&NC and survival by 
Montazeri (2009) identified only eight papers that investigated a possible link 
between QoL and survival, the ultimate measure of outcome.  Whilst four of the 
papers were not conclusive, a further four did show a clear relationship in this area 
and are presented in table 2.3. 
Table 2.3 Relationship between Quality of life Domains and Survival  
Primary author and date 
of study 
Quality of life 
Questionnaire used 
Quality of life domain 
associated with survival 
(de Graeff et al., 2001) 
 
EORTC QLQ-C30 + QLQ-
H&N35 + CES-D 
 
Cognitive functioning was 
predictor of survival while 
physical functioning; mood 
and global QOL were not. 
Fang et al., 2004 EORTC QLQ-C30 + 
EORTC QLQ-H&N35 
Pre-treatment fatigue 
Nordgren et al. 2006  
 
EORTC QLQ-C30 Physical functioning was 
significant predictor of 
survival 
Karvonen-Gutierrez et al., 
2008  
 
SF-36, HNQOL 
 
The SF-36 physical 
component summary 
score and three domains 
of the HNQOL (pain, 
eating and speech) were 
associated with survival. 
 
 
Montazeri concluded that in order to really identify other variables, future studies 
should use more methodological and statistical rigor.  This recommendation is a 
recurring conclusion and perpetuates the concept that quantitative research is an 
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adequate way of investigating the clinical complexity evident within the specialty 
H&NC.  Such an approach holds with the belief that if homogeneity can be achieved 
between patient groups, eventually statistically significant variables can be identified.   
Perhaps this is an unrealistic goal with the instruments available and explains why 
different studies might appear to contradict one another.  It is, therefore, possible that 
the actual variables impacting on outcome as measured by QoL remain both 
multiple, illusive and uncertain.   
 
 
CONCLUSION 
This chapter has detailed, through reference to key-policy documents for England 
and Wales since 2000, how other aspects might compliment survival and temporal 
outcome measures.  There has been no attempt to critique these policies but there 
has been the intention to describe the key papers that have influenced health care 
providers working with patients who have cancer.  It has also been demonstrated that 
bio-clinical data, whilst more amenable to measurement and easier to summarise, 
may conceal from researchers and clinicians a plethora of useful data.   The system 
looks for physical measures and does not routinely, or in a structured way, review 
distress.  Policy documents continue to recommend a more holistic approach that 
examines the patients’ experience as well as the evidence-base and safety of 
procedure.   However, clinical practice is as likely to rely on natural intuition, which 
has been demonstrated to be poor, when assessing patients who do not divulge their 
emotions to their health- care teams.  Patient experience of H&NC can continue to be 
described by tumour detail, survival and QoL scores, but this ignores important 
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aspects of the whole and does not allow patient-data derived directly from them to be 
represented.  A detailed review of the topic shows that many aspects of both patient 
and disease characteristics may influence the outcome of treatment.  The modifiers 
of outcome are interactive and should be included rather than controlled.  Chapter 
four will develop this aspect further.   
 
The care that patients receive and the experience surrounding an episode of care will 
impact on their judgment of care. However, there remains the significant challenge of 
how best to represent this and then influence clinical practice.  It is essential to 
assure leading commentators, such as Kennedy, that patient care is not fragmented 
or atomised, and that the patient is not seen only in terms of a currency.  
Patients will differ in their reaction to the diagnosis and the treatment, but it would 
appear unlikely that many patients will contemplate being open and honest about 
their feelings because of their limited physical resources as a consequence of the 
treatment.  It would seem, therefore, that there are two influences that might 
recommend more qualitative methodologies for the ongoing investigation of H&NC 
patients:  
1. The lack of clear and consistent QoL results because of an inability to truly 
represent patients at an individual level  
2. A political and professional expectation, which encourages a meaningful 
description of care at an individual level, which can enable patient views to be 
intertwined with those who treat them.  
 
There have been objective and well-constructed criticisms of health-care systems, 
which it is hoped will galvanise researchers and clinicians alike to work on 
understanding the real outcome for patients. There is evidence from the patient 
experience surveys conducted in England that there is a failure of clinical staff to 
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provide information to patients at critical points in their treatment and that health-care 
professionals persist with a culture that is not truly patient-centred (Dept of Health 
2010a).  The intention of this chapter has been to review in more detail the cognate 
aspects of outcome measure scales and particularly QoL scales.  It is evident that 
they do not cover the whole scope of the experience.   This means opportunities to 
engage H&NC patients with their own care and treatment is frequently missed.  
There is the perpetuation of a paternalistic style.  Much work is still to be done. 
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CHAPTER 3 
THE OUTCOME QUALITY OF LIFE WITH PARTICULAR REFERENCE 
TO HEAD AND NECK CANCER 
INTRODUCTION 
Chapter two has described some of the limitations surrounding QoL data. Despite 
these draw backs, in the last twenty-five years there has been an exponential growth 
in the number of papers that use QoL measures with H&NC patients because they 
are seen as a way of describing patients at either the pre or post treatment stage 
(Rogers et al., 2007). There is evidence that might help formulate reasonably 
accurate predictions about how patients’ tumour size and site will impact on their 
physical and psychosocial functioning. Yet policy documents and complex modern 
treatments may pre occupy teams to such a degree that acknowledgement and 
inclusion of the patients’ function and reaction post-treatment is overlooked at the 
expense of measuring aspects that are more quantifiable and more easily 
represented. ‘Overlooked’ in this context is not only left out but also poorly 
understood.  
The complexities in the specialism of H&NC are all pervasive. Chapters one and two 
have described these intricacies and also the policy documents in health since 2000 
with particular reference to cancer that have sought to make the care of patients 
more individual. The multiplicity of disease factors means there is no absolute 
baseline therefore the clinician and or researcher have to prepare for complex 
results, which may or may not corroborate with previous findings from other research 
groups. It would appear that patients with similar symptoms, or that have undergone 
similar treatments may present with different QoL scores and that this is a result of 
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the ability of the individual to adapt or mediate the symptoms that are highly 
significant (Llewellyn et al., 2005, Scharloo et al., 2005). 
This chapter presents two published pieces of work by the author that investigates 
two specific issues in relation to QoL: 
1. How useful are QoL questionnaires at measuring the patient experience of 
the disease?  
2. Are clinicians, if presented with the parameters associated with QoL, 
accurate in their assessment of the particular QoL issues for patients?   
 
The first question investigates the limitations of QoL data, and suggests that 
they are not able to cover the scope of an individual’s health-experience.  The 
second, carries out research involving the multi-disciplinary team at the author’s 
cancer centre. It demonstrates the limited understanding health care workers have of 
the possible symptoms H&NC patients may have with reference to the extent and 
range of symptoms they might experience.  Both are presented in their entirety with 
the same content as published within a book as a chapter (Reid et al., 2012a) and a 
peer review journal (Reid et al., 2009).  Appendix 3.1 reproduces the three QoL 
measures referenced in the first study.  
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This section of the thesis has been published as: 
HEALTH RELATED QUALITY OF LIFE QUESTIONNAIRES: 
ARE THEY FIT FOR PURPOSE? 
(Reid et al., 2012b) 
 
INTRODUCTION  
Patients frequently ask two poignant questions during their management: ‘How will I 
be after my treatment’ and ‘Am I cured?’ Focused or absolute answers are generally 
frustratingly absent and the multidisciplinary team are likely to be guarded in their 
response because at presentation the site of the tumour and the stage of the disease 
will influence treatment possibilities and outcome. Outcome from the varying 
treatment modalities have been reported in terms of survival interval and more 
recently the patients’ quality of life (QoL). The latter outcome is a multifaceted and 
dynamic concept which the World Health Organisation defined as a: 
 ‘Broad ranging concept affected in a complex way by a person’s physical health, 
psychological state, level of independence and their relationships to salient features 
of their environment’ 
 (WHOQOL group, 1993).   
More specifically, such data in the context of disease is described in terms of health-
related QOL (HRQoL), the subjective experience of the impact of health status on 
QoL for the patient (Curtis, 1997;) it can, in relation to H&NC patients be described 
as a patient’s physical, emotional and social function at the pre and post-treatment 
stage(Hammerlid et al., 2001, Hammerlid and Taft, 2001).  
The number of studies that routinely report on HRQoL has increased substantially 
over the last twenty years. In the literature it has been recommended that HRQoL 
tools should not only be used within the research arena but also within the clinical-
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setting (Velikova et al 2010).  However, the recommendation has not been put into 
practice and its use within the clinical setting remains limited.   This is despite 
patients reporting them both as a useful way of structuring their thoughts during 
outpatient appointments as well as a way of building a rapport with the teams 
involved in their care (Mehanna and Morton, 2006a, Velikova et al., 2010).  
Researchers have investigated why clinicians do not use QoL measures routinely 
within the clinical environment (Mehanna and Morton, 2006b, Kanatas et al., 2009). 
The results have suggested that clinicians do not view the findings as relevant to the 
clinical setting and that the logistical burden in the resultant collection and analysis of 
the data is too great. The volume of QoL questionnaires to choose from, further 
complicates the situation.  In a review of the head and neck cancer (H&NC) literature 
Kanatas and Rogers (2008) identified five broad categories of patient completed QoL 
questionnaires and as many as thirteen disease-specific questionnaires.  Their 
conclusion was similar to a previous review by Ringash and Bezjak (2001) in which it 
was acknowledged that choice of questionnaire should be governed by the research 
questions being considered and the resources available.  
The use of QoL data acknowledges that the patient aspect should be represented 
and that this information should be collected from the patient rather than from other 
sources such as health care professionals or carers. The former are likely to over 
estimate the physical symptoms (Reid et al., 2009) the latter under estimate the 
emotional aspects of the disease (Sollner et al., 2001). Complexity exists in all 
aspects of the field from the choice of questionnaire available to the possible 
influences on the results. Many and diverse variables would appear to impact on QoL 
scores and these include psycho-social factors: tumour characteristics,(Hammerlid et 
al., 2001) physical symptoms, (Campbell et al., 2004) and treatments  
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undergone,(Department of Health, 2011, Ronis et al., 2008) as well as psycho-social 
aspects of patients(Llewellyn et al., 2005, Howren et al., 2010).  
The multi-dimensional and subjective nature of QoL makes it difficult to fit into the 
bio-medical model throughout the treatment management process. The link between 
QoL scores and survival for this group of patients has been noted to be neither 
strong nor proven (Mehanna et al., 2008)  Over time the scores within categories or 
sub-categories might vary without an apparent change to the overall score, or the 
possibility that if scores do change they are often in relation to the patent’s emotional 
response to a life-changing event and not as a consequence of a shift in physical 
symptoms.  It is, therefore, very possible that scores are more a reflection of people’s 
adjustment to their change of circumstances rather than a measure of their physical 
or emotional state.    This notion has been demonstrated by a study by Logemann et 
al (2001) in which the impact of dry mouth on H&NC patients’ function and perception 
of their swallow was investigated post radiotherapy.  Logemann et al concluded that 
dry mouth did impact on sensory and comfort issues of swallowing but not on the 
actual function of the swallow.  This would suggest that the patients are moderating 
or adjusting to the experience and that whilst objective measures are important there 
is value in collecting the diverse subjective aspects because this will influence 
patients’ score to physical aspects of the disease or treatment.  A systematic review 
of the HRQoL, for H&NC patients diagnosed and treated with reference to 
psychosocial variables Llewellyn et al (Llewellyn et al., 2005) suggested that 
personality, depressive symptoms, social support, satisfaction with consultation and 
information, consumption of alcohol and tobacco all influenced HRQoL scores.   In 
the same year a study carried out by Scharloo et al (2005) described how illness 
perceptions by patients’ attention to symptoms, believing in a greater likelihood of 
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recurrence, engaging in self-blame, and a strong emotional reaction to the illness- all 
contributed to lower QoL scores.  There are, therefore, indications that the impact of 
the disease and treatment is moderated by subjective patient characteristics.   
 
A review of QoL within the field of H&NC by Montazeri (2009) identified eight papers 
that reviewed QoL and survival.  Whilst four of the papers were not conclusive in their 
findings about the effect of QoL on survival a further four did show a clear 
relationship in areas such as cognitive function, (de Graeff et al., 2001) pain, appetite 
and eating scores (Karvonen-Gutierrez et al., 2008) and pre-treatment fatigue 
(Karvonen-Gutierrez et al., 2008, Fang et al., 2004) were reported as being linked to 
survival.   The conclusion of the review paper was that in order to really identify other 
variables more methodological and statistical rigor should be used in future studies.  
This recommendation is a recurring conclusion and perpetuates the concept that 
quantitative research is an adequate way of investigating the clinical complexity 
evident within the specialty H&NC.  Such an approach holds with the belief that if 
homogeneity can be achieved between patient groups eventually the methodology 
will enable significant variables to be identified statistically.   Perhaps this is currently 
an unrealistic goal with the QoL instruments available and explains why different 
research findings might appear to contradict one another.  It is, therefore, possible 
that the actual variables that truly impact on outcome as measured by QoL remain 
both multiple, illusive and therefore uncertain.   
 
It would be a limiting concept to suggest that H&NC impacts on the physical aspects 
of a patient with no influence on the emotional aspect.  It would also be too simplistic 
to suggest that patients do not draw upon previous life events in order to help them 
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manage the current diagnosis. From these two premises there is value in exploring 
the experience of H&NC at an individual level.  The National Institute for Clinical 
Excellence estimates that 50% of all patients experience anxiety or depression at 
some point during their cancer assessment treatment and recovery (National Institue 
for Clinical Excellence, 2004).  If the subjective aspect is left out in an attempt to 
follow a quantitative approach to study design, the relevance of the results will 
remain, from the clinical perspective, poor representations of the patients.  This will 
mean that clinicians fail to perceive a link between making clinical decisions and the 
research because it poorly depicts their caseload.   
Being able to describe in a more representative way the disease and treatment is the 
preliminary stage of patient management.  A United Kingdom government report has 
set out the outcomes which it would like to see developed and used within cancer 
care in England (Department of Health, 2011)  The Department of Health cited 
research by Maddams within this document, which predicted that by 2030 there will 
be more than three million people who will have been treated for cancer and 
survived, of which a third will be of a working age.  The report emphasised the 
holistic nature of the patient experience, acknowledging the financial and emotional 
aspect as well as the more frequently cited physical aspects.  It is a real intention of 
the government’s health care system that patients should achieve as much 
independence as possible from both the health care system as well as their own 
support network. Specific aims are set out within the report, one of which is that there 
should be a decrease in the proportion of people who report unmet physical and 
psychological needs post-cancer treatment.  This is a significant challenge when 
considered in the context of a 2010 report that detailed patient experience and 
reported fewer cancer patients than in previous reports had understood the 
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information they were given even at the point of diagnosis (Department of Health, 
2010a).  Specifically within Britain therefore, despite more adherences to time-
targets, a cultural shift needs to be achieved from a process-driven system towards a 
more personalised one. Part of this process has seen the development of Holistic 
Needs Assessment (HNA) for people with cancer (National Cancer Action Team, 
2011). The publication suggested that if the holistic needs of patients were identified 
patients would be more likely to be engaged with their care, and identify the possible 
resources or services available during later stages of their treatment.  Another 
government publication published in the same year, Improving Outcomes-A strategy 
for Cancer Care (Department of Health, 2011) has also recommended outcomes 
derived directly from patients should form the basis of outcome measures. It would 
seem therefore that there are two influences that might recommend more qualitative 
methodologies for the ongoing care of H&NC patients (i) the lack of clear and 
consistent QoL results (ii) a political expectation, which encourages the description of 
care at an individual level.  It is within this context that the current study was devised.  
The purpose of this was to establish whether H&NC QoL measures adequately 
reflect a) the literature on patient experience b) the reported experience of H&NC 
patients undergoing curative treatment. 
 
METHODS 
RESEARCH DESIGN 
A qualitative methodology was used in order to identify the themes associated with 
the experience of H&NC.  Three different sources of information were systematically 
explored using a previously described method of analysing information (Attride-
Stirling, 2001).  The sources were: 
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1) The three most commonly used HRQoL questionnaires in the H&NC 
literature.  These had been identified by previous research carried out by 
Rogers et al (Rogers et al., 2007) who had reviewed a five year period 
(2000-2005) and reported on the range and most frequently used 
questionnaires.  These are reproduced in appendix 3.1  
2) A review of the literature that describes the H&NC patient’s experience of 
the condition, its treatment and sequelae 
 3) Semi-structured interviews recorded and transcribed from six H&NC 
patients.  The interview questions were informed by the themes developed 
from the literature, in source 2 
 
For each of the three sources the themes were derived using a thematic analysis 
protocol as described by Attride-Stirling (2001).  The application of thematic networks 
is a way of organising qualitative data in a systematic way.   It involves reviewing the 
material collected and establishing a network of themes, which are hierarchically 
developed from basic through organising to global themes.  The process allows for 
the researcher to classify all the material into the basic themes, which can then be 
categorised to higher levels. The themes were generated independently for the 
HRQoL questionnaires; but the literature review was used as a way of forming the 
semi-structured interview structure.  This meant the process was sequential and 
relied upon the literature generating the initial interview structure.   In effect the third 
source was dependent on the themes described in the second. Following 
categorisation, basic themes that evolved from each source were grouped, re-read 
and re-framed.  The intention was to identify underlying patterns that might not be 
apparent on reading each in isolation.  Finally, a review process took place in order 
to decide which organising themes were discrete or broad enough, to represent a 
group of ideas.  The themes that were identified were organised in relation to one 
another such that they could be classified as either super-ordinate, or sub-ordinate to 
one another.  Using the Attride-Stirling (2001) thematic analysis this meant that the 
themes were classified as basic, organising or global thematic networks. 
Independent assessment was provided to confirm the validity of the themes. 
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Diagrams, which represent and summarise visually the global themes between each 
of the three sources are presented within the section marked findings.  
 
 
DATA GATHERING 
SOURCE 1:THEMATIC ANALYSIS OF HRQOL QUESTIONNAIRES 
At the time of reviewing the H&NC QoL literature (2008) a paper by Rogers et al 
(2007) acted as a source of information.  The paper had reviewed the literature 
relating to H&NC and QoL presenting the range and frequency of QoL questionnaires 
used in the literature over a five year period, The review had identified the three most 
commonly used ones as:  
 The University of Washington (Hassan and Weymuller, 1993);  
 The EORTC C30 and H&N C35 (Bjordal et al., 1994, Bjordal and Kaasa, 
1992); which are used in conjunction to one another  
 The Functional Assessment of Cancer Treatment –Head and Neck Subscale 
FACT (List et al., 1990).   
These questionnaires are presented as Appendix 3.1.  Thematic analysis using the 
method described by Attride-Stirling (2001) was carried out on these questionnaires.  
The areas represented by each questionnaire require patients to describe in the past 
week which statement is most representative of their current situation.  The 
University of Washington (UoW) reviews: pain, appearance, activity, recreation, 
swallowing, chewing, speech, shoulder function, taste, saliva, mood and anxiety.  
Patients also represent these aspects of their health or function by one of five 
statements, which grade their abilities from ‘no’ to ‘severe change’ in function. 
Patients also have to identify three domains that are most affected, rate their health 
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to prior to the cancer diagnosis, during the past week and their overall quality of life 
during the past week from outstanding through to very poor.   The Functional 
Assessment of Cancer Treatment –Head and Neck Subscale (FACT H&N) has a five 
point scale ranging from a description of “not at all” to “very much” examining specific 
areas and which include: seven questions re physical well being, seven questions 
regarding social well being six questions regarding emotional well being and seven 
questions regarding functional well being one of these questions asks the patient to 
rate their current satisfaction with their QoL.  There are also twelve H&NC specific 
questions that investigate eating, communication, appearance, smoking, and drinking 
behaviours and pain.   The EORTC reviews via a four-point likert scale with 
descriptors ranging from “very much” to “not at all” the presence of the quality a 
range of issues.  The general questionnaire EORTC C30 is composed of 30 multi-
item scales and single items assessing areas of functioning (physical, role, 
emotional, cognitive, and social), as well as general symptoms -fatigue, pain, emesis, 
dyspnoea, insomnia, appetite loss, constipation, and diarrhoea. The patients are also 
asked to rate on a seven-point scale their attitude to their own health and quality of 
life status over the past week. The disease specific module EORTC H&N35 consists 
of 35 questions including seven symptom scales: pain, swallowing, senses, speech, 
social eating, social contact, and sexuality. There are 11 additional, single items 
covering problems with teeth, mouth-opening, dry mouth, sticky saliva, cough, feeling 
ill, weight loss, weight gain, use of nutritional supplements, feeding tubes, and 
painkillers. The patient can complete all three questionnaires independently.  
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SOURCE 2: THEMATIC REVIEW OF THE LITERATURE  
A literature search was carried out in July 2009 using MEDLINE, EMBASE, the 
Science Citation Index (ISI), the Cumulative Index to Nursing and Allied Health 
Literature (CINAHL), the PsycINFO, the Allied and Complementary Medicine (AMED) 
and Global Health databases to review the literature surrounding H&NC patients’ 
experience and or coping with the disease. The search terms used were ‘head and 
neck cancer’ and ‘experience’; and ‘head and neck cancer’ and ‘coping’.  There was 
also a manual review of topic areas specific to experience and H&NC.   The 
references are presented in Table 3.1 Reading the literature associated with the 
experience of H&NC and care generated the questions for the semi-structured 
interviews.  A summary of the literature conclusions which then generated the 
questions for the semi-structured interviews are presented in Appendix 3.2.
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Table 3.1 Papers Reviewed as a Result of The Literature Review 
Aarstad AK, Aarstad HJ, Bru E, Olofsson J 
Psychological coping style versus disease extent, tumour treatment and quality of life in successfully treated head and neck 
squamous cell carcinoma patients.Clinical Otolaryngology, December 2005, vol./is. 30/6(530-8), 1749-4478 
 
Aarstad AK, Aarstad HJ, Olofsson J  
Personality and choice of coping predict quality of life in head and neck cancer patients during follow-up. 
Acta Oncologica, 2008, vol./is. 47/5(879-90), 1651-226X 
 
Baker, C., 1992. 
Factors associated with rehabilitation in head and neck cancer. Cancer Nursing. 15(6), pp. 395-400. 
 
Bjordal K, Freng A, Thorvik J, Kaasa S 
Patient self-reported and clinician-rated quality of life in head and neck cancer patients: a cross-sectional study.  
European Journal of Cancer. Part B, Oral Oncology, July 1995, vol./is. 31B/4(235-41),  
Cady J 
Nutritional support during radiotherapy for head and neck cancer: the role of prophylactic feeding tube placement. 
Clinical Journal of Oncology Nursing, December 2007, vol./is. 11/6(875-80),  
 
Chaturvedi SK, Shenoy A, Prasad KM, Senthilnathan SM, Premlatha BS 
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SOURCE 3: THEMATIC ANALYSIS OF PATIENTS’ PERSPECTIVES 
 A purposive sample of six H&NC patients was recruited for the study from a UK 
cancer centre.  The bio-clinical details and treatment undergone for each participant 
are presented in Table 3.1 and Table 3.2.  
TABLE 3.2 BIO-SOCIAL STATISTICS OF PARTICIPANTS n=6 
n Sex Age Smoker *Alcohol Job Tumour 
site 
**Pathology 
1 f 68  none Secretary Mandibular 
alveolus 
PT4N0 
2 m 45  ≤ 21 Craftsman Floor of  
mouth 
PT2NO 
3 m 68 ex ≤7 Health wk Laryngeal PT1N0 
4 m 62  ≤ 21 Hairdresser Laryngeal PT4N1 
5 m 66  ≤ 21 Accountant Laryngeal PT4N2b 
6 f 82 ex ≤7 Linguist Buccal PT4N1 
 
*number of units of alcohol consumed in a week   
**pathological classification UICC 6th edition 
TABLE 3.3 TREATMENT AND COMPLICATIONS FOR PARTICIPANTS 
n Surgey Neck 
dissection 
RT chemo Complications 
1 Scapula flap failed 
Pec major 
Uni lateral  x Flap failure 
salvage 
surgery pec 
major 
2 Radial fore arm flap Bilateral x x Paralysed 
tongue due to 
neuro praxis 
3 Laser Excision None x x None 
4 Pharyngolaryngolaryngectomy 
free flap (ALT) 
Tracheal oesophageal 
puncture 
Bilateral x  Infected skin 
donor site 
5 Pharyngolaryngolaryngectomy 
Tracheal oesophageal 
puncture 
Bilateral x  Trachy at time 
of biopsy 
6 Fibula flap Unilateral  x None 
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The participants were eligible if it was a year since the definitive treatment date of a 
squamous cell carcinoma, were judged to be cognitively intact and able to speak 
English. Thirty questions acted as the structure of the interview and are reproduced 
in Table 3.4. A year post-treatment was judged an appropriate time interval so that 
participants would have recovered from the acute phase of treatment and not be 
overwhelmed by some of the pervasive physical symptoms that have been well 
documented (Rogers, 2010).   Each interview was digitally recorded and 
independently transcribed before being analysed by the primary researcher.  The 
length of interview ranged from 40-70 minutes.   
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TABLE 3.4 QUESTIONS USED TO GENERATE INTERVIEWS OF THE H&NC 
PATIENTS 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Pre diagnosis 
What made you go to the doctor in the first place?  
Did you suspect you had cancer when you first went to your doctor?  
If so, what made you suspect this? 
At the time of diagnosis 
How do you feel about the care you’ve been given?  
How do you feel about all the people that you have had to meet directly so your 
care could take place?                         
How did having a diagnosis of H&NC impact on your life before you were 
treated?  
How do you feel about the information you’ve been given? 
Can you explain the effect the amount of information had on you? 
What has been the best thing about the information? 
Can you explain how the information written or verbal impacted on your ability 
to cope with the situation?  
Who did you feel the key people were? 
What helped you to cope with the pre treatment phase?   
Post-treatment 
What are your main concerns now? 
Has the H&NC affected the way you see yourself? 
What was the lowest point for you over the past year? 
Has anything been particularly difficult to cope with? 
Are there particular symptoms that you continue to experience? 
How comfortable have you felt when discussing your situation with the team 
and why? 
What has been the most difficult time or thing to deal with? 
Are you still smoking or drinking -why?  
Is there anything particular that the team can do to help you cope? 
What enables you to cope with all that has happened? 
How do you feel about being reviewed in outpatients? 
Do you think that the team managing you have any idea how the treatment and 
disease has impacted on you?   
Do you feel the team understands your problems and concerns? 
Is there anything you wish you could tell the team that would make a difference 
to your care or others?  
What have been your feelings about undergoing the treatment?   
Since the treatment how do you think the disease and the treatment has 
impacted upon you psychologically?  
What were the expectations you had of the disease and treatment and how did 
the reality compare? 
How has your disease and treatment impacted on those around you at home 
and socially?   
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FINDINGS FROM QUESTIONNAIRES, LITERATURE AND SEMI-STRUCTURED 
INTERVIEWS 
The Attride-Stirling (2001) thematic analysis was used to analyse the data from all 
three sources. A network of themes, which are hierarchically developed from basic 
through organising to global themes, is constructed.  The process allows for the 
researcher to classify all the material into the basic themes, which structured into 
more overarching terms by the organising and finally global themes.  The data and 
the way it was coded is presented for each source in appendix 3.3 
 
Six global themes were evident; day to day physical comfort; emotional well being; 
place in society; own mortality; quality of care; and reality. Figure 3.1 presents the 
global themes diagrammatically.  Not all of the global themes were represented by all 
of the sources.  Day to day physical comfort, emotional well being, place in society 
and reality were evident from all three sources; quality of care from the 
questionnaires and the semi-structured interviews and reality from the semi-structure 
interviews.  
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Figure 3.1 Six global themes evident from a review of all sources:  
QoL questionnaires, literature review; semi-structured interviews.    
 
 
The global themes that were evident from all three sources however differ in the 
detail covered.  The questionnaires were at a basic theme level and remained at the 
identification and quantification of symptoms function and role.  The literature and 
semi-structured interviews revealed a wider range of physical and emotional 
symptoms and demonstrated increased subtleties.  This meant that there was more 
explanation into how participants coped with physical and emotional symptoms, as 
well as place in society.   
Participant 1: “We have an away day in October.  I said I don’t think I can go because 
I think it would bother me.  They said “oh no we would ask for something special for 
you at mealtimes” I said “no I don’t want to eat around a table with people, if I could 
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just bring my drinks and be somewhere separate where no one would bother me or 
say “come and eat with us” then I’ll come”  
 
Participant 2: “People don’t know how much you rely on your tongue.  There are a lot 
of things I can’t do.  I can’t touch the top of my lip.  If I get a piece of meat stuck in the 
back of my tooth, before I’d use my tongue….. But now I can’t.  I have to use the 
toothbrush to get it out….. There’s no point in getting irritated  because I can’t change 
it.  I might do it one day but I just get on with it.” 
 
Participant 3: You try not to let it get to you, how bad you are and the pain you’re 
in(pointing at anterior lateral thigh donor site)  so you cope with it more because if 
you’re not showing it you can cope.” 
 
All three of the above semi-structured interview excerpts describe symptoms and 
function - eating in public, reduced tongue mobility and the ongoing issue of pain- but 
also describe what strategies the participants use to over come them.  
Whilst as a basic theme identification of primary risk behaviours such as tobacco and 
alcohol use were evident within one of the three questionnaires-the FACT (I smoke 
Cigarettes; I drink alcohol); the semi-structured interviews were able to develop the 
theme into a personal appraisal of such behaviours being renewed.  
Participant 2:“I was diagnosed on the Wednesday, I went outside and lit up; I had half 
a cigarette and went home, had a cup of tea and a sandwich and smoked half a 
cigarette.  About five o’clock, I lit up another cigarette up and had half.  I finished the 
other half about eight o’clock and I said when I go to bed tonight I’ll have a cigarette 
in the morning.  I woke up and never touched one. 
 I used to smoke thirty or forty per day. I don’t know how I just stopped and I’d been 
trying to pack up for ten years as my New Year resolution”   
 
Participant: 3 More than ever, I still crave a cigarette I’ve actually banned it from the 
house now.  If it’s raining I’ll let them smoke in the kitchen with the door closed and 
the windows open but it’s not for me”  
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Figure 3.2 Thematic Network Day-to-Day Physical Comfort  
 
 
Figure 3.3 Thematic Network Emotional Well Being 
Within the global theme place in society the HRQoL questionnaires revealed the 
basic theme of personal roles identified at work, -“my work is fulfilling” and within 
social and family circles “ I get emotional support from my family”, “ I feel close to my 
partner” (FACT H&N).  Within the interviews the global theme was expressed more in 
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terms of the alienation from society and the purpose of some roles that participants 
had.  Participants were very specific and actively chose who would or would not 
know about the diagnosis and the treatment, a way of maintaining a particular role 
but which within the FACT might still be labelled as having family support and so 
overlook certain choices made to protect other members of the family.   
Participant 1:“I couldn’t tell my brother and sister, or my children.  One of my sons 
had a first child on the way and he was born three days after I left the hospital so I 
couldn’t possibly worry him.  ……..My younger son had had a terrible accident when 
he was ten months old, he poured a kettle over himself, so knowing that I had mouth 
cancer, I didn’t even want him to come and see me, I thought it would bring it all back 
to him, so I shut them out of life whilst I was in the hospital.” 
 
The semi-structured interviews also revealed the detail of explicit secondary gain that 
predominantly focussed around enhanced relationships.  This included the 
adjustment of values and priorities such that more time was spent with family 
members. Situations were also reappraised in the context of health and survival.   
Participant 3: “I allow a lot of trivialities to go out the window, which I wouldn’t have 
done before……..domestic situations at home, I’ll break something it would have 
bothered me before, and I would have fixed it quickly but it can wait. I’ll get it done 
when I feel like it when it’s convenient………. I can’t wait to see my grandkids.  It 
makes you more appreciative of your family.” 
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Figure 3.4 Thematic Network Place in Society 
 
The final common theme between all three sources “Own Mortality” was again 
explored to different depths by each source.  Within the HRQoL questionnaires it was 
evident with the FACT questionnaire “I worry about dying” In the literature it was 
explored through the theme of disease recurrence- a substantial part of the H&NC 
survivor literature (Llewellyn et al., 2008, Humphris et al., 2003)and an acceptance 
that death is a possibility (Chaturvedi et al., 1996).  Fear of recurrence within the 
semi-structured interviews was openly expressed.  
Participant 5 “Now and then I worry it might come back”  
Participant 1 “Now and then the worry comes over you. I don’t worry if it will come 
back; I wonder if I would have the courage to meet new people with that diagnosis 
again, I’m ok where I am.” 
 
There was acknowledgement that participants had actively prepared for the 
possibility of dying soon after treatment.  Five of the six participants had made 
personal preparations in the event of not recovering enough to adequately deal with 
personal effects.    
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Participant 1: “All day for a couple of weeks I didn’t think I would survive the 
operation and I knew the house would have to be cleared so I just spent day after 
day clearing books.  One day I had eight bags for the charity shop” 
 
Two participants within the global theme of mortality expressed regret at having the 
treatment.  There was a sense of reappraisal in the context of having the treatment 
and an admission that the current existence was hard to reconcile because of the 
change in function.   
Participant 3: “I wish to God now that I had not had it done and I would have just 
carried on for twelve months with a bottle in one hand, well not for twelve months I 
most probably would have had three.  I’m not used to being ill for longer than a 
couple of weeks.” 
 
One of the participants commented on the difference for them between the 
questionnaires and an interview discussion.  
Participant 4 :  “if you do the normal surveys when you’ve come round and asked me 
questions, I tick and cross the response but I don’t think I give out that much 
information,………… but some people like me when you start talking never stop and 
then you find out so much in twenty minutes, -all in one go.”  
 
 
Figure 3.5 Thematic Network Own Mortality  
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FINDINGS FROM LITERATURE AND INTERVIEWS 
The literature and interviews added a further global theme: quality of care.   
The quality of care theme was able to illustrate patient vulnerabilities and 
assumptions that might be present during the treatment process. There was a sense 
from participants interviewed that it was not possible to really appreciate how long it 
would take to begin to recover from the treatment. The semi-structured interviews 
gave evidence of the difficulty participants had in the assimilation of written and 
verbal information, and more specifically the implications of not understanding 
information. One participant explicitly described how it was difficult to appreciate what 
the real meaning was of a neck dissection until it had happened, relating it then to 
physical changes.  
Participant 2: “The surgeon was saying what he was going to do, he said he would 
cut me from here to here and he would take my glands out.  I understood but I 
suppose I didn’t understand the extent of what the operation involved.  Does that 
make sense? They are alien words; when you say you are going to make a line from 
here to here and take away glands I don’t really know what that means.  I didn’t know 
the glands were as big as they were.  It was obvious what was happening but I didn’t 
understand what it would mean.” 
 
Another described how despite needing three operations within the space of three 
weeks it was not possible to be prepared any more comprehensively because of it 
being so difficult to predict the course of recovery. Research has concluded that the 
timeliness, individuality and amount of written and verbal information given to 
patients are vital if trying to reduce evident mismatch between patient expectations 
and experiences (Llewellyn et al., 2008, Llewellyn et al., 2006). 
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Figure 3.6 Thematic Network Quality of Care 
 
A substantial organising theme was the relationship with the team.  Examples were 
given within the literature of individual and patient orientated care and although the 
teams judged this as time consuming,(McLane et al., 2003) it was seen to have value 
and focus to the team and patient interactions.  H&NC patients undergoing treatment 
have been described as resilient and resistant to offers of help (Wells, 1998), an 
issue echoed within the semi-structured interviews when a participant described not 
wanting to bother busy ward staff unless there was a real need.  For example it might 
also be that there is some difficulty in patient compliance and adherence to treatment 
programmes that needs to be identified and addressed (Edmonds and MaGuire, 
2007).   Specific to the semi-structured interviews there was evidence of institution 
organisation difficulties.   These included logistical and practical issues relating to 
appointments. Both the literature and semi-structured interviews disclosed 
information relating to the humane judgments in patient care.  There was evidence to 
suggest that it was expected that there would be good advanced communication 
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skills used, which would result in a consistent and understood message from the 
teams (Moore et al., 2004, Llewellyn et al., 2006). Specifically the semi-structured 
interviews highlighted the utter trust, vulnerability and belief in key members of the 
clinical team that the participants had.   
Participant 1 “Well you couldn’t be in better hands anywhere in the world, from first 
meeting my surgeon I had no fear and trusted him.  I always felt better when I left the 
appointment he was just so down to earth and gave me so much confidence” 
 
Participant 2 “And the surgeon’s reputation is important, because you’re thinking if 
you are going to do this to me, and you are telling me its going to work, I have to 
believe you are the best to do it, because if I don’t then you are completely 
lost…They don’t make you feel like a number.  If I’ve got a problem I can raise it with 
somebody.  It’s not as though you go to the bottom of the pile and have to repeat it all 
the next time you visit they remember the conversation and what was on your mind 
at the last appointment.” 
 
 
FINDINGS FROM THE SEMI-STRUCTURED INTERVIEWS 
The semi-structured interviews revealed a specific global theme, reality that reflects 
some of the stoical aspects of the participants in dealing with the situation.  In this 
context participants described unremitting symptoms, the acceptance of being 
reactive rather than in control, the need for an inner strength and the stark choices 
that had been faced during the assessment and treatment phase of their disease.  
Participants did not perceive choice at the time of treatment because in reality little 
choice existed in deciding whether to have treatment.   
Participant 5: You’ve got no option, it’s that or nothing, so you have to have it done 
you don’t have to think about it at all-there is no choice.”  
 
 The perceived choice by others was not in reality available to the participants.  This 
aspect of stark choices linked to the basic theme of alienation that participants felt in 
the global theme “place in society”.  The inner strength that became an organising 
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theme was made up of examples of physical and emotional loneliness and a sense 
of if the participants did not deal with the issues then no one else would.   
Participant 3 “I just worried that I’m not going to feel much better and I’m finding it 
difficult to cope” 
 
Participant 5 “The days pass and you go to sleep and you relax and you don’t think 
about it even with the tube in your neck (tracheostomy) you have to learn to switch 
off and let the nurses do the worrying” 
 
There was also evidence of unremitting symptoms, both physical and emotional that 
were continually present and difficult to ignore.   This in part explained the reactive 
state that participants expressed in which they were not able to take control of certain 
symptoms.  There was a sense of needing to wait to heal; knowing that to be too 
active would lead to frustration, fatigue and deterioration in function.  
Participant 6: “For me it is a very ongoing thing and also to the point where you can 
have what are called one of my ‘good days’ and you think this is great only to feel the 
next two days are horrid and you think I’m back to where I was.  I count my good 
days and enjoy and do what I can …. You have to let time pass, you can’t hurry (the 
recovery) and you have to let it go at it’s own pace.” 
 
Figure 3.7 Thematic Network:Reality  
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The evident stoicism and depiction that participants presented that they were 
emotionally coping hid the reality of the gruelling impact that participants dealt with.   
Participant 4  “Once you let your defences down that’s when you start to crumble, so 
it’s as though I’m standing on the outside of the building, but I’ve crumbled inside, 
………there are times in the last few weeks I’ve felt ‘oh hell what’s the point, I’m not 
bothered but I don’t let on” 
 
From the semi-structured interviews it was possible to represent the global themes 
from statements made by the patients such that statements could be categorised 
under the global themes and perhaps give some real salience to the experience of 
the disease and treatment of H&NC.  Figure 3.8 present the phrases that have as 
their sources the semi-structured interviews and which represent the six global 
themes.   
Figure 3.8
45 REPRESENTATIVE STATEMENTS OF THE EXPERIENCE OF H&NC 
      1.  Physical symptoms: day-to-day comfort (8) 
1. I recovered much slower physically than I expected  
2. I am still in pain  
3. It’s hard to remember things you’re told  
4. I felt physically very isolated  
5. When I talk it doesn’t feel like me anymore  
6. I always think that people are staring at me  
7. Any symptom I get I always think the cancer might be back  
8. Day-to-day existence is physically exhausting 
2. Emotional well-being  (10) 
1. I worried a lot how others would cope  
2. When I was told I had the cancer I knew I had to face it.  
3. I wish I’d never been treated  
4. My appearance was much better than I expected  
5. I am much more irritable than I used to be  
6. I cannot do things on the spur of the moment.  
7. It really affected my confidence  
8. It’s amazing how much you can adjust to all the physical changes  
9. Life will never be the same again  
10. I never appreciated how long it would take to get better 
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3. Place In Society (7) 
1. I felt very alone 
2. I didn’t want people to know what had happened to me  
3. Everyone around me was so upset  
4. I still don’t think anyone can really understand what has happened to 
me  
5. I cannot have a good argument now  
6. I never think of myself as ill  
7. I do things but on my terms 
4. Own mortality (7) 
1. Being cured of the cancer is still the most important thing  
2. It’s just as well you don’t know what’s going to happen or you would 
never cope  
3. It’s very hard to think about your own possible death  
4. You never think it could happen to you  
5. Once I knew they could do something about it that’s all I needed to 
know  
6. You just become really grateful for different things  
7. Life is hard you just have to get on with it 
5. Quality of care (8) 
1. I didn’t understand what was meant by the treatment until I experienced 
it  
2. I felt very vulnerable when I was in hospital  
3. Little things like the car park or appointments being cancelled really 
irritate me  
4. I never felt like a number I was always treated as an individual  
5. I was most frightened when I came out of hospital  
6. I wanted the team always to be honest with me  
7. I never read the written information I was given.  
8. No two patients are the same 
6. Reality (5) 
1. You should never have to face this sort of thing on your own  
2. If you didn’t want to die there was no choice but to have the treatment  
3. It’s so hard waiting to heal 
4. I have to be careful to not upset people  
5. I’ll talk about things that I wouldn’t have done before my diagnosis 
 
 
 
 106 
DISCUSSION 
Three sources of information relating to the experience of H&NC have been 
thematically analysed using a previously described approach  
(Attride-Stirling 2001).  HRQoL questionnaires focus on symptoms and function, 
which mean they remain at the level of basic themes. They do not allow the 
influences or the connections between scores to be understood so that patient 
adjustment and reappraisal when undergoing treatment is poorly represented. 
Whilst there might be changes identified by HRQoL questionnaires when they are 
repeated, there is limited explanation as to how the patient might have achieved this 
or the relevance of the symptom or change in function for the patient.  This 
perspective is verified further in the context of the literature which has suggested 
that H&NC patients will under-report symptoms, due in part to a sense of 
hopelessness and loss of meaning to life following treatment for the disease (Moore 
et al., 2004).  It might be, therefore, that the use of HRQoL questionnaires under-
represents patients’ real experience both in terms of intensity and scope.   
This investigation of the experience of H&NC enables one to conclude that there 
are perhaps complex and interactive patient characteristics that will impact on the 
H&NC patients’ QoL scores. The semi-structured interviews identify in participants a 
reappraisal of values, numerous coping strategies, and adaptation.  It might 
therefore be that HRQoL questionnaires are measuring other effects, that modify 
patients’ scores which are not directly related to the treatment and disease and 
which might, if better understood, give insight to the patient, carers and health care 
team which might secure a more successful management of the patient.  A specific 
example of this can be seen within health behaviours.  If a patient is still smoking or 
drinking alcohol the behaviour should not only be identified but have a patient 
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specific commentary so that the health care professional might become more 
informed of the context for the continuing behaviour.  If this could happen cessation 
programmes if appropriate might be more successful. Assessment of the existence 
of risky behaviours is only evident within one of the three most regularly used 
HRQoL questionnaires the FACT.  It would seem therefore discussion of health 
behaviours is poorly represented within HRQoL questionnaires.  
The current study demonstrates that the focus of HRQoL questionnaires is narrow 
and that it is important to build a context in which the HRQoL variables are a part 
rather than the whole.  Whilst physical, emotional symptoms and personal 
relationships are a substantial part of a patient’s description of their well being they 
are not the complete picture.  In order to achieve this, patients’ needs and possible 
current limitations, quality of care and the reality of the situation for them as 
individuals should be discussed.  If this aspect of the whole person can be better 
understood then personalised care can be described and care plans created which 
meets UK government policy (National Cancer Action Team, 2011).  It might also be 
that the process of semi-structured discussion allows a patient to review their 
concerns and have them recognised as important aspects of their care. Through 
this method of investigation the health care team might begin to truly understand, in 
the context of the patient’s own previous life-experiences why they might have 
reacted in a particular way during their treatment and recovery.  Such 
understanding and reflection might allow patients to recognise at an earlier stage 
their needs, which might avert a crisis; a further intention of the Holistic Needs 
Assessment set out by the National Cancer Action Team (2011).  It might also 
mean that patients are able to discuss and understand dissatisfactions in life without 
having feelings labelled as either anxiety or depression.   
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It has been suggested by Salander (2011b) that the added burden of the cancer 
diagnosis and treatment prompts patients to seek support in order to lessen the 
total psychological burden.  He went on to suggest that whilst patients need medical 
input to cure them of the cancer they are capable of lessening some of the emotions 
associated with the situation.  As part of this process they may respond well to the 
opportunity to reappraise their life. Within a treatment paradigm patient data should 
not only act as a descriptor but also as a way of formulating a treatment plan.  If this 
could be achieved, studies would move beyond recognising the presence of the 
impact, towards aiming to describe more specifically how treatment has affected 
patients. Discussion via semi-structured interview enables much more explanation 
of the patient’s situation and allows for the true context of the symptom or feeling to 
be described.  This approach is more holistic and might allow for the medical team 
to make judgements with the patients, which relate to their tolerance of the situation. 
This method of enquiry is less likely to be open to misinterpretation and might add 
more satisfactorily detail so that care-plans might be formulated.  It might be that 
HRQoL questionnaires can act as a screen of needs assessment for some of the 
more obvious physical and emotional impacts of the disease and treatment, but 
they should not take the place of detailed discussion between the team and patient, 
and in no way can they be said to be representative of the whole experience.  
 
 
 
CONCLUSION 
Outcome should be represented in more meaningful terms than length of survival or 
clinical process targets.  HRQoL measures might identify some of the more 
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superficial aspects of outcome but a more rounded understanding of the covert 
aspects may positively support both the patient and their carers through such life-
changing experiences.  HRQoL questionnaires cannot be said to adequately reflect 
either the available literature on patient experience or the reported experiences of 
H&NC patients themselves.  Review of all three sources would suggest that when 
used HRQoL questionnaires are used there is a narrow, symptoms biased 
collection of information. The questionnaires cannot capture the wealth of the data 
that is potentially available or offer an explanation to some of the measures that are 
taken.  
Health care teams, patients and their families should understand the impact of 
H&NC and its management from a holistic perspective so that the care can be 
achieved successfully for each individual. HRQoL measures by necessity have a 
narrow focus on symptom and function and these can be mistakenly seen as 
representing a patient’s QoL rather than as some of the constituent parts.   Within a 
clinical setting it would seem valuable to routinely invite patients who have 
undergone treatment to discuss, in a semi-structured way, the individual impact of 
the disease and the treatment.  The purpose of this would be to facilitate a deeper 
understanding through explanation of the individual experience and to enable 
specialist teams to support patients more appropriately in outpatient settings.   If this 
were to happen it would enable teams to move away from the quantifying process, 
in which a change in score has limited real meaning, towards more a detailed 
explanation. Moving towards a more holistic needs assessment should enable 
patients to explain what has happened to them and to appreciate a more complete 
picture of the impact. If this could be achieved one might expect that a patient is 
less dependent on others for their well-being and that they could seek help earlier.  
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There should be a recognition that patients’ minds are intrinsically linked to their 
physical status and are not well represented because they are hard to describe in a 
meaningful way.  
This study only examined the experience of six H&NC patients’ experience of their 
treatment within a UK cancer centre.  The statements gathered from them can be 
used in a more formal way to investigate the experiences of other H&NC patients.  
A future study will use the list of statements generated from the six identified 
themes with other H&NC patients and invite them to rank them according to how 
like or unlike their experience of the disease the statements are.  The current study 
has therefore acted as a way of creating a set of statements from three sources, 
and is part of the a method called Q Methodology, which has been described as a 
way of looking for patterns in the way people think (Webler et al., 2009a).  There is 
perhaps a role for more qualitative methodologies to be used alongside quantitative 
methods in order to discover what factors affect people who survive the disease, 
which to date has been poorly identified.  This may allow a structured approach that 
is replicable with more groups of patients and this might be said to be an influential 
method of gathering key factors that are important for patients at an individual level.   
The ultimate goal will remain to collect information that can inform the management 
of patients who live with the consequences of a life changing event so that they can 
live as independently as possible from health care systems and carers.   
 This section of the thesis has been published as: 
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EFFECT OF ORAL TUMOUR SIZE ON QUALITY OF LIFE JUDGEMENTS BY 
HEALTH CARE PROFESSIONALS WORKING WITH HEAD AND NECK 
CANCER PATIENTS: A PILOT STUDY. 
 
(Reid et al., 2009) 
ABSTRACT 
AIM To investigate whether information about the size of oral tumour influences the 
multi-disciplinary team’s judgements about the quality of life (QOL) of Head and 
Neck Cancer (H&NC) patients.  
METHOD Using a between-group design, two groups of Health Care Professionals 
(HCPs) rated a hypothetical patient on 20 outcome variables. Patient description 
was identical for both groups, except for tumour size.  
RESULTS Comparisons of ratings for variables revealed only 3 significant 
differences between the groups’ predictions and no consistency within conditions, 
suggesting that the participants held few common assumptions about the impact of 
tumour size on a range of patient experiences.  
CONCLUSION The lack of agreement amongst the HCPs in the study suggests 
that where humane judgements are used in treatment decisions for H&NC patients, 
then these may be random and inconsistent. Consequently, patients should have a 
direct input into treatment decisions, using formalised QoL data.  
 
Key words: 
Head and Neck Cancer, Decision Making, Quality of Life. 
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INTRODUCTION 
Randomised Control Trials (RCT) are the gold standard of medical research, 
because they enable the prediction of outcomes for given interventions.  However 
RCT methodology may be less relevant to some patient groups because of what 
has been termed ‘diffuse technology’ (Ferguson et al., 2001) - an acknowledgement 
that some treatments are not easy to prescribe in experimental terms. One example 
of this is the management of Head and Neck Cancer (H&NC) patients. The 
complexity and heterogeneity of their condition, and the impact of both the disease 
and treatment, mean that RCT investigations of cognate interventions may be 
neither appropriate, nor possible to conduct satisfactorily.  H&NC patients’ 
treatments, therefore, may be best managed not through rigid adherence to clinical 
protocol, but instead, through incorporating into clinical decision-making, a wide 
range of patient centred factors.  
This position is supported by the research on clinical judgement. The bedrock of 
treatment decision making, is defined as the fusion of technical judgement, 
(encompassing the scientific and evidence based information) and humane 
judgement, (relying on the Health Care Professional’s interpretation and insight into 
the patient and symptoms) (Downie and Macnauhgton, 2000). It is clear from this 
definition that clinicians need to use, and interpret, a constellation of objective, 
empirical data, as well subjective, experiential and interpersonal data. Traditionally, 
the technical aspect of clinical judgement has relied on research that for H&NC 
patients has focussed almost solely on survival and loco-regional recurrence rates 
as the outcome measures (Norris et al., 1993, Bernier et al., 2004). However, this 
takes little account of the comprehensive impact H&NC and its treatment may have 
on the quality of all aspects of the patient’s life, which, given the complex and 
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diverse nature of the condition, should be central to the humane judgements made 
about treatment options. Acknowledgment of this has more recently resulted in an 
exponential growth in the research relating to Quality of Life (QoL) in relation to 
H&NC (Rogers et al., 2007).  The typically poor prognosis, the wide variation in 
reported problems and the highly individual response to the condition and its 
management mean that treatment decisions must be predicated on both technical 
and humane aspects of clinical judgement. However, if humane judgements are 
being used in the management of this patient group, it is important to establish 
whether the health care professionals (HCPs) involved in treatment decisions, share 
an understanding of the physical and psycho-social implications of the condition for 
the patient. Without a common understanding of what is relevant and why, clinical 
judgements may be ill-conceived and randomly applied, rather than informed and 
systematic (Brown et al., 2001). HCPs therefore need to be aware of, and 
responsive to, a range of subtle and often immeasurable psycho-social cues and 
patient concerns, and be able to interpret this information in a way that enhances 
treatment decisions. Although this clearly challenges the evidence based health-
care culture, it may, nonetheless, be highly relevant in the management of a 
condition that, because of its diversity does not readily lend itself to randomised 
control scrutiny. 
Research evidence suggests that the site and size of the tumour in H&NC may 
enable some reasonably reliable predictions to be made about a range of 
outcomes, which would mean that the research can inform technical judgement, 
and aid clinical decision-making. For example, the site of the tumour has been 
reported to influence the type and severity of swallowing difficulties pre-
treatment;(Stenson et al., 2000) and site and the stage of tumour has been 
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demonstrated to have the strongest impact on Health Related Quality of Life, 
(HRQOL) (Hammerlid et al., 2001).  Similarly, at pre-treatment, a relationship 
between tumour-burden, speech and swallowing for oral and oral-pharyngeal 
cancer patients has been demonstrated, concluding that the percentage of oral 
tongue affected significantly reduced articulation and swallowing efficiency 
(Colangelo et al., 2000). From this objective clinical evidence it may be possible to 
formulate reasonably accurate predictions about how patients will report their 
condition and how it impacts on their functioning and QoL.  To this end, reported 
psychosocial/QOL information may be highly relevant to the management of the 
individual patient’s condition (Funk et al., 2004).  The crucial role of the multi-
disciplinary teams (MDTs) in improving both treatment decisions and the 
coordination of cancer care, means that their interpretation of the totality of the 
patient’s condition will be pivotal (Tattersall, 2006).  Consequently, the way in which 
MDTs use patient data to interpret the patient’s condition and to make humane 
judgements may be worthy of investigation. 
Therefore, the aim of this study was to investigate whether the MDT is influenced 
pre-treatment by the size of the tumour when making judgements that relate to QOL 
issues. The research question was: 
Do HCPs use their knowledge of the patient’s condition (tumour size) consistently, 
to inform their humane judgements about the patient’s QOL? 
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METHOD 
STUDY DESIGN 
An experimental between-subject design to compare the responses of two separate 
groups of HCPs was used. The aim was to establish whether tumour size 
(independent variable - IV) affected the HCPs’ assumptions about the patient’s QOL 
and other psycho-social issues (Dependent variable - DV). The study used a variant 
of Asch’s Central Trait Theory, with tumour-size operating as a central trait (Asch). 
Asch’s original study demonstrated that by interchanging one adjective from two 
otherwise identical descriptive lists, participants would form a different impression of 
a person. His findings were interpreted as suggesting that past experiences become 
organised as outstanding frames of reference and therefore affect current 
judgements. The theory also suggested that in making a judgement about a person, 
the participant will eliminate any incompatible perspectives, since rarely are 
attitudes half-formed or absent. Evidence for Central Trait Theory exists within 
healthcare (Darbyshire, 1986). Based on this research, this pilot study used the key 
descriptors of tumour size to see whether manipulation of this variable impacted on 
HCPs’ assumptions about other aspects of the patient’s condition. 
 
SAMPLE 
A convenience sample of HCPs were invited to participate. All worked in a MDT, 
within a large H&NC centre, which is involved with the management of patients with 
an oral tumour. Subjects were selected if they were known to have regularly worked 
with H&NC patients. Seventy-nine subjects were approached from a range of 
professional backgrounds – see Table 3.4.  
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MATERIALS 
The materials consisted of a questionnaire specifically designed for the purpose. 
The questionnaire was split into three parts. The first part focused on basic 
biographical details of the respondent. The second part provided a description of a 
fictitious H&NC patient, giving clinical and social information that would be typical of 
a patient presenting to the unit. The information about the fictitious patient was in 
the style and content routinely used within the MDT weekly meetings and in 
language used on the unit to describe patients, both in discussion and in written 
reports sent out to referring agents. It was the researchers’ deliberate intention not 
to be gender-specific with the hypothetical patient, and for the patient to be 
assigned a job that might be seen as one that would require a degree of 
communication on a daily basis. A carcinoma of the tongue was chosen as the site 
so that the location of the tumour was clear and unambiguous. The description of 
the patient was identical for each group, with the exception of tumour size. To 
ensure clarity and lack of ambiguity in the respondents’ understanding of the 
presenting clinical problem, the labels T2 (larger than 2cms but smaller than 4cms) 
or T4 (larger than 4cms and invading adjacent structures) were used, one for each 
condition.  
The third part of the questionnaire required the participants to rate 20 statements 
relating to a range of clinical and psycho-social outcomes that the patient described 
in part 2 may typically experience. These outcomes were derived from a thematic 
analysis of the cognate research, including work involving the European 
Organisation for Research and Treatment of Cancer (EORTC) Quality of Life 
Questionnaire C30 (Aaronson et al., 1993) which, and the EORTC Head and Neck 
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specific questionnaire (Bjordal et al., 1994); both are validated and intended for use 
with H&NC patients (Bjordal et al., 2000, Sherman et al., 2000). 
The 20 domains that were subsequently distilled from the research included 
tension, energy, sleep, appetite, memory, depression, limitations on work, oral pain, 
choking, worry, oral communication, sexual enjoyment, swallowing diet, social 
eating, saliva consistency, use of supplements, sore mouth, dry mouth. The 
participants were required to score the 20 statements on a 10cms visual analogue 
scale (VAS) which has been demonstrated to have good reliability and validity as a 
measure of subjective experiences (McCormack et al., 1988). 
 
PROCEDURE 
PILOT 
The study was piloted on 3 people to see if the form and the procedure had any 
specific problems, which had not been identified by the investigators. No difficulties 
were identified. 
 
MAIN STUDY 
Questionnaires were distributed by hand, to each participant. They were asked to 
complete the form on their own and without discussion with anyone else.  (The 
questionnaire is presented in Appendix 3.4). Of the 79 participants, 39 were 
randomly given questionnaires that contained the variable T2 and the remaining, 40 
participants were given the questionnaire with the variable T4. In all other respects 
the questionnaire and procedure were identical. 
The allocation to condition followed a stratified random sampling to ensure that 
there was equal distribution of the questionnaire between professional groups. This 
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procedure involved making a pre-requisite number of envelopes with the HCP role 
and then randomly allocating slips of paper to each envelope marked T2 or T4. The 
envelopes were then shuffled and distributed to the appropriate type of HCP. All the 
questionnaires were completed anonymously. The data gathered were inputted into 
SPSS for windows version 14, and analysed using techniques of descriptive and 
inferential statistics. 
 
ETHICAL CONSIDERATIONS 
The study is part of a much larger study approved by the ethics committee of South 
Birmingham.  Participants were able to discuss with the investigator any queries 
they had relating to the questionnaire before completing it and were able to 
withdraw without giving any reason. 
 
RESULTS AND ANALYSIS 
Seventy-two out of the seventy-nine participants completed the questionnaire 
according to the instructions, of which thirty-six completed the T2 version and thirty-
six completed the T4 version of the questionnaire. 
Table 3.4 reports on the details of the participants with reference to their profession, 
and years working with H&NC patients. 
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TABLE 3.5 BIO-DETAILS OF CONVENIENCE SAMPLE HCPS TAKING PART IN 
THE STUDY  
 
Profession   T2 group    T4 group 
Nurse 17 18 
Senior Nurse   3   3 
Junior Doctor   7   7 
Consultant surgeon   4   3 
Consultant Other   2   2 
Therapist   3   3 
Number of years  
working with h&nc           
  
Less than 5 years 18 17 
More than 5 years   6   5 
More than 10 years 10 14 
 
PRE-ANALYSIS CHECK OF THE QUESTIONNAIRE’S INTERNAL RELIABILITY 
To test the internal reliability of the questionnaire, respondents’ answers on those 
variables that were either clinically or psychologically similar were analysed using a 
Pearson’s product-moment correlation.  Correlations coefficients were calculated 
between social eating and difficulty eating solids; tension and worry; and HRQOL 
and QOL. All showed significant positive correlations at <0.005 level (1- tailed), 
thereby suggesting that the instrument has some internal reliability. 
To test the main hypothesis, independent t-tests were used to compare the 
responses from the T2 and T4 groups on each of the 20 variables in section 3 of the 
questionnaire. Independent t-tests were used here because the focus of interest 
was the difference in ratings provided by the two separate groups (T2 and T4); the 
rating data was obtained from Visual Analogue Scales and could therefore be 
treated as interval/ratio measures. The comparison of two different Subject groups 
and the use of interval/ratio data therefore required analysis by the parametric 
independent t-test. The results are presented in Table 3.5.  
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TABLE 3.6 INDEPENDENT SAMPLES T-TEST COMPARING RESPONSES OF  
PARTICIPANTS ACCORDING TO SIZE OF TUMOUR T2 VS T4 
 
Symptom 
dependent variable                                   t-test Df Sig. (1-tailed) 
T2 mean 
score  
 
T4 mean score 
Tense 1.805 68 0.0375* 7.8676 7.4222 
Lack of energy .425 68 0.336 6.3794 6.2083 
Lack of sleep .750 66 0.228 7.5152 7.3029 
Poor appetite 1.341 68 0.092 7.0735 6.5639 
Poor memory -.279 68 0.3905 6.0176 6.1222 
Depressed -.510 68 0.306 6.594 6.825 
Work ltd .507 68 0.307 6.038 5.800 
Pain -.629 67 0.2655 5.1206 5.5333 
Choked -1.356 67 0.09 4.674 5.536 
Worry .213 67 0.416 7.597 7.776 
 Difficulty on ‘Phone -.189 66 0.4255 5.376 5.789 
Sex -1.215 67 0.1145 6.276 7.017 
Swallowing diet -1.703 67 0.0465* 5.726 6.625 
Saliva -.960 67 0.17 4.724 5.300 
Social eating -1.983 67 0.026* 5.529 6.472 
Supplements .194 67 0.4235 4.721 4.756 
Sore -.208 67 0.4175 6.403 6.675 
Dry -.659 67 0.256 4.182 4.642 
HRQOL .698 67 0.2435 3.509 3.331 
GQOL 1.184 67 0.12 3.012 2.736 
*Significant at ≤0.05 level 
The effect sizes for the significant results are as follows: tension = 0.041 (small – 
moderate effect) the ability to swallow diet = 0.04 (small to moderate effect) and 
social eating = 0.053 (small to moderate effect) (Cohen, 1988).  These three 
domains were acknowledged by the HCPs to be significantly more difficult for the 
T4 group than for the T2 group. The remaining 17 factors showed no significant 
differences between the groups.  
To establish whether there was agreement within each group, Kendall Coefficients 
of Concordance were calculated. This statistical test permits assessment of the 
level of agreement between judges. Here, the judges were the participants in either 
the T2 or T4 group and the items to be judged were the 20 variables. The Kendall 
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Coefficient of Concordance provided a measure of the extent to which the judges in 
each group agreed with regard to their assessment of how far each variable applied 
to their allocated hypothetical patient.  The results for each group are presented 
separately. 
 
T4 GROUP 
Using a Kendall’s coefficient of concordance on the data (S=337553.71 
W=0.39167,n=36 N=20; X2 = 26.791 df=19 ) the results were not found to be 
significant. This means that there is a no significant agreement among HCPs as to 
which of the symptoms is most likely to be present in the patient described with a T4 
tumour.  
T2 GROUP 
Using a Kendall’s coefficient of concordance on the data (S=262729.80 W=0.3858, 
n=32 N=20; X2 =23.457 df=19 the results were not found to be significant. This 
means that there is no significant agreement among HCPs as which of the 
symptoms is most likely to be present in the patient described with a T2 tumour. 
These results suggest that there is no agreement within either group regarding the 
psycho-social and physical concomitants of tumour size.
 
 
DISCUSSION 
In so far as the participants were able to complete the task, it would seem that 
HCPs do associate an oral tumour with a wide range of emotional, cognitive and 
physical difficulties. However, these associations were not consistent within tumour 
size. Moreover, there were no significant differences between the groups regarding 
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their assumptions about 17 of the 20 associated patient problems. It can be 
concluded that for this group of experienced HCPs, tumour size has not been 
demonstrated to be a reliable central trait.  Only three variables produced any 
significant differences, viz: that eating socially, swallowing diet and tension were 
considered to be worse for the T4 (larger tumour) condition. Overall, these results 
do not accord with the available research that suggests there is a consistent 
relationship between tumour size and a range of symptoms (Stenson et al., 2000, 
Hammerlid et al., 2001, Colangelo et al., 2000).  It is also worth noting that there 
was no consistency either between professional group or number of years’ clinical 
experience with H&NC. There are several possible explanations for these results. 
Firstly, it is conceivable that tumour size is not pivotal for the HCPs in the prediction 
of symptoms, and that other factors (such as a range of psycho-social factors and 
the nature of the patient) may be more influential in determining the impact of the 
disease on QOL. Secondly, and related to this, tumour size may be more variable in 
its clinical manifestations than the available research literature would suggest.  The 
inherent heterogeneity of H&NC patients means that the implications of tumour size 
would be confounded by a range of individual variations in psychological or medical 
response, and in the personal/social circumstances of the patient. Thirdly, the lack 
of consistency among the HCPs studied may be a genuine reflection of their 
attempt not to stereotype, but rather to treat patients on an individual basis. Finally, 
the HCPs samples may simply be unaware of the research evidence relating to the 
impact of tumour-size. 
Taking the first two, inter-related explanations, it is conceivable that HCPs consider 
H&NC to be so inconsistent, subjective and unpredictable, that there is little real 
clinical use in relying on just the clinical evidence about the tumour size to make 
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predictions about the impact of the disease. Certainly, anecdotal evidence from 
within the unit suggests that within a six-month period it is unlikely that there will be 
even two patients who present with similar objective clinical criteria (age, gender, 
site, size, pathology). Such variability will not only mean that consistent clinical 
pictures are scarce, but also means that HCPs may not be able to build up a critical 
mass of experience on which to base their technical and humane judgement. 
Exposure to such diversity may also spawn a philosophy, much in favour with the 
trend towards patient-centred care, that each case should be managed individually, 
rather than imposing a condition driven protocol irrespective of the patient’s real 
needs and problems.   The uniqueness of the presenting problem would then 
preclude the generation of stereotyped assumptions on which to base treatment-
decisions. While this may be laudable in its objective, the lack of consensus within 
the groups about the clinical and QOL implications for the hypothetical patient may 
mean that where treatment decisions are influenced by the humane judgements of 
the HCPs, arbitrary management may result. Such a situation would compromise 
target driven outcomes.  
The final possible explanation suggests that the HCPs may simply not be aware of 
the relevant research.  While oncology research has, over the last 20 years, started 
to acknowledge QOL information as an important outcome that needs to be 
incorporated in treatment decisions, and one which needs time and experience to 
assimilate, synthesise and subsequently integrated (Frost and Sloan, 2002), it is 
nonetheless conceivable that the HCPs simply lack knowledge of the cognate 
literature. This contention is reinforced by the fact that there is a concerning under-
use of QOL questionnaires in clinical practice nationally (Kanatas and Rogers, 
2004), despite the number of available instruments and the demonstrable value of 
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the information they provide.  As the unit participating in the current study does not 
routinely collect QOL data, the contextual research may simply be unknown. Allied 
to this is the lack of research that investigates patients’ pre-treatment QOL 
symptoms – the focus of the current study (Stenson et al., 2000, Hammerlid et al., 
2001, Scharloo et al., 2005).   This may explain in part the typical focus on the 
measurable end points such as length of time to treat, length of stay, morbidity, and 
disease free survival. A recent paper suggested that a government pre-occupation 
with health care reforms means that the practical and mundane tasks necessary to 
improve quality and outcome of complex services will always be secondary 
(Haward, 2006). 
In absolute terms, the respondents in both conditions tended to attribute high 
degrees of worry, anxiety and allied problems to the hypothetical patient, 
irrespective of the severity of the presenting tumour. This statement may be 
supported by a review of HCPs’ perceptions of caring for cancer patients generally 
(Lampic and Sjoden, 2000), which suggested that HCPs tended to ascribe high 
levels of anxiety and distress to all patients with a cancer diagnosis, and to 
overestimate patient distress and under-estimate QOL. In practice this may mean 
that patients are receiving care from HCPs who have a more negative interpretation 
of their disease than the patients themselves.  The interpersonal dynamics of the 
HCP/patient relationship may act as a conduit for these negative suppositions, 
which in turn, may adversely impact on the patient’s psychological state pre-
treatment.  Clearly, it would be desirable for the emotional interaction of the carer 
and patient to be realistically represented rather than assumptions being made by 
HCPs based on their previous experiences of managing patients.   
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CONCLUSION 
This study has demonstrated, for a small convenience sample at least, that there is 
very little shared understanding of the physical and psycho-social implications of 
different oral tumour-sizes, despite the available evidence. While there may be 
many reasons for this, such variation in views may adversely impact on the humane 
judgements used to inform the management of this complex and diverse disease. In 
consequence, it might be expected that such lack of agreement as to what is 
relevant may result in inconsistent decision-making unless the patient is more 
actively involved in the process, especially via the systematic routine use of 
psychometrically sound QOL measures as a means by which the patient-voice and 
experience can be incorporated into care-plans 
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     CHAPTER 4 
 
THE ROUTE TO A METHODOLOGY -THE DECISION PROCESS 
DESCRIBED WHEN CHOOSING Q METHODOLOGY AND A 
DESCRIPTION OF THE METHOD 
 
INTRODUCTION 
The research route has helped the author to describe in detail the experience of the 
disease and treatment for H&NC, which would not have been possible via the 
clinical route alone.  This chapter provides a narrative to some of the author’s 
decisions made when exploring how to investigate the experience of H&NC.  It 
describes the stages that have accompanied the process of deciding on the best 
method for the study.  In answering the research questions posed in the introduction 
to the study, the chapter refers to some of the writers who influenced the author in 
choosing the methodology.  The last section of this chapter details the main 
features of Q methodology, which was chosen for this research. 
 
USING REFLECTION TOWARDS A RESEARCH QUESTION  
The author has worked with H&NC patients since 1991.  This is several years 
before the publication of two influential national reports that described how it was 
envisaged cancer patients might be treated in general and in disease-specific terms 
(The Expert Advisory Group on Cancer to the Chief Medical Officers of England and 
Wales, 1995, National Institutue for Clinical Excellence, 2004).  The clinical 
introduction occurred after a maxillofacial consultant asked for help with the 
management of a H&NC patient’s swallowing during his post-operative recovery.  
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Oral surgery was not a typical clinical area of practice for speech therapists in the 
early 1990’s.  They were trained in the theory and practical application of patients 
with neurological disorders but any treatment of H&NC patients would have been 
restricted to patients who had undergone a laryngectomy.  The focus of intervention 
with this patient group was on the production of oesophageal speech.   It was not 
recognised that these patients might have swallowing difficulties or that there was 
the possibility of further surgery in which the patient is given a small surgical hole.  
This latter  surgical intervention connects the oesophagus and trachea allowing lung 
air to drive a vibratory source and produce a sound from the oesophagus, by a 
valve being fitted. The author advised on the management of the patient’s swallow 
and continued to work with this patient group as the surgeon operated on  more 
patients.  There were several factors that meant the clinical skills within the 
emerging MDT would flourish: 
 The personal support and enthusiasm of the surgeon towards MDT working  
 The mutual recognition by the team of how patients’ function could be 
enhanced by involving different members of the team 
 The inquisitiveness of the team to work with a patient-group who had been 
given free-flap reconstructive surgery to replace diseased tissue within the 
head and neck region  
 Clinical practice, developing in an organic, exploratory fashion, rather than 
from a business-case model   
 
At an individual level the author, with a typical neurological background, applied 
these learnt principles to patients who had undergone reconstructive surgery.   
There was a sense that the evidenced based practice techniques, learnt from the 
neurological specialism, could be transferred by practice-based-learning to this 
patient group.  There was, for the author, a reassurance in working with the patient-
group that many of the principles from the neurological background could be 
translated so that the perceived gap in expertise was not as large as it might have 
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been supposed.  There were very few resources available to increase the 
theoretical knowledge for the management of H&NC patients.   Most examples of 
learning involved shadowing and discussion with profession-specific self-appointed 
experts.  In 1997 Manchester Metropolitan University had established a module 
designed to increase therapists’ expert management of H&NC patients. The lecture 
notes detailed reviews of papers relating to swallowing, which might be considered 
in the clinical environment. It is of note that very few of the speakers on the course 
acknowledged the use in their clinical practice of Quality of Life (QoL) 
questionnaires.  Instead they discussed possible treatments and judged them by the 
mortality rates, numbers of days in hospital and physiological measures of 
swallows.   
A year later the author attended a national conference on QoL measures in H&NC.  
A recognised expert in the field gathered interested clinicians to discuss this aspect 
of the patient-group.  Research relating to the validation of key-questionnaires, the 
European Organisation for the Rehabilitation and Treatment of Cancer (EORTC) 
and the University of Washington (UoW), (Aaronson et al., 1993, Hassan and 
Weymuller, 1993) had been completed within the last four years.  It is of note that 
the addition of the domains mood and anxiety, were not included in the UoW 
questionnaire until 2002 (Rogers et al., 2002).  The conference recommended that 
QoL questionnaires should be used within clinical settings and suggested that this 
was starting. The attendance at the conference had an effect not experienced 
previously by the author.  It had always been the author’s experience that 
conferences informed thinking, distilled ideas and developed knowledge.  The exact 
opposite occurred.  The author had a real sense of inadequacy around the 
information relating to QoL questionnaires and an apprehension, as well as a 
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realisation, that it still felt impossible to include such detail in day-to-day clinical 
practice.  The field of QoL was complex and the author reflected uncomfortably, but 
without more specific understanding, on how difficult local uptake of a 
questionnaires use would be.  These emotions generated unease, panic and a 
feeling of uselessness.   Temporal measures, as unsatisfactory as they seemed, 
would not be complemented by QoL patient-specific detail in the clinical 
environment in which the author worked.   The practical issues surrounding their 
administration and interpretation were factors that were unlikely to be overcome.  
This aspect was established more formally when members of the UK national 
surgical group were canvassed (Kanatas and Rogers, 2004).  Their inclusion 
became even more of a remote possibility when the recommendations from the 
Calman-Hine report (The Expert Advisory Group on Cancer to the Chief Medical 
Officers of England and Wales, 1995) were realised. It expected temporal targets to 
be achieved, and ensured that trusts would strive to record the number of patients 
treated annually in order to achieve or maintain cancer centre status (Williams et al., 
2010). At this stage of health service development such pressure was appropriate, 
but it meant that QoL data would remain of secondary importance. 
Over the next five-years the disquiet for the author remained.  These feelings 
stemmed from an acknowledgement that what was measured was not changing the 
most basic-level of care.  It did not explore the human aspect of the experience.  
The 'not fit for purpose' aspect of these questionnaires is detailed in chapter three 
and articulates what the author had felt for  more than ten years before this study. 
The author had a sense that the day-to-day clinical experience of patients was not 
well-represented within the literature.  It also seemed as though what was 
represented were poor reflections of what really mattered to patients.  Demanding 
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clinical issues and organisational reconfiguration blunted the negative emotions 
generated by the conference.  The latter aspect entailed the merger of two health-
authorities.  At a local level this meant a district hospital and teaching hospital, 
situated less than two miles apart from another, amalgamated.  The consequence 
of such managerial changes was that the number of consultants in the H&NC unit 
increased and there was the establishment of more joint speciality working.  The 
number of shared cases increased, as did the complexity of the surgery undertaken.  
Surgeons stopped operating as single teams, which facilitated more  complex 
surgical procedures, without increasing the overall operating time.  One of the 
consequences of such collaboration for the author’s unit was that in 2004 there was 
a patient who underwent a total glossectomy -an operation advised rarely  because 
of the predicted morbidity.  The patient, TG, had a profound effect on the author’s 
thinking.  In team discussion post-operatively his surgeon admitted he would be 
surprised if the patient talked or swallowed again. The team questioned the benefit 
of the procedure for the patient and predicted that TG would: 
  Not be able to communicate orally,  
 Have a permanent tracheostomy, 
 Not able to eat or drink, so be tube-fed because of the risk of aspiration-
pneumonia 
 
There was a belief that TG was alive but at what cost?  These worries were, in 
reality unfounded.  The patient, despite sustaining a myocardial-infarct peri-
operatively, was discharged in less than three weeks.  The speed of discharge was 
enhanced by better than expected function.  The patient could drink fluids, had no 
tracheostomy and could communicate face-to-face orally, with a slight but evident 
pre-morbid black-country accent. The patient continued in outpatients to surpass 
the team’s expectations.  He talked on the ‘phone, would drink socially, did not  
develop chest infections and returned to his favourite past-time of woodturning. He 
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reported he was pleased with what he could do, free from pain, and observed that 
he felt the team had never expected him to be functioning so well, -an insightful, 
accurate comment.  Three factors struck the author and acted as a catalyst to 
investigate more completely the TG phenomenon:  
 Why were the team so poor at predicting how he would function? 
 Had TG shown a normal or prodigious reaction to the situation?  
 Were there special features that enabled TG to be predisposed to do this 
well?  
 
Discussion between the author and the surgeon suggested the possibility that the 
tumour, although advanced at presentation, had grown slowly and insidiously.  It 
appeared that TG had adapted his swallow and used other complex, dynamic 
structures to overcome the tumour-derived symptoms.  He had made adaptations 
so that, although the tumour had rendered his tongue immobile the flap, that 
replaced it, had not replaced a tongue that was functioning fully.  This situation 
enabled the author to ask two original research questions: 
 
 If patients were given exercises pre-surgery would they recover more quickly 
and beyond current expectation?   
 Does pre-treatment intervention build a relationship with the patient that 
helps facilitate better and more targeted recovery?  
 
It was as a desire to answer these specific issues that the author started to enquire 
about opportunities for post-graduate study.   There started to be, through the 
clinical example of TG, the real questions that should be asked, but could not be 
answered by QoL measures.   
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EARLY STAGES OF RESEARCH 
Initial discussion with the author’s first academic tutor started to identify some of the 
complexity that had remained peripheral aspects of knowledge to the author.  It 
enabled the author to understand that a randomised controlled trial (RCT), a 
methodology believed by the author to be the ultimate study method, would be 
impossible to undertake as a way of researching the aforementioned questions.  
Chapters one and two have explored and evidenced the situation relating to H&NC.  
Presentation, causes of disease, outcomes used, the extreme heterogeneity of the 
circumstances revealed to the author a plethora of hitherto poorly acknowledged 
variables.  The original research question had been formulated around the hierarchy 
of evidence for interventions based on Sackett’s framework (Sackett et al., 2000) 
presented in table 4.1.  It had intended to achieve an RCT examining the value of 
pre-treatment intervention exercises.  If patients carry out pre treatment tailored 
exercises, can length of stay be shortened? 
 
TABLE 4.1 LEVELS OF EVIDENCE FOR INTERVENTIONS (Sackett et al., 2000) 
Level Type of study 
1a Systematic reviews of randomized controlled trials (RCTs)  
1b Individual RCTs with narrow confidence interval 
2a Systematic reviews of cohort studies. Identification of two 
groups (cohorts) of patients, one receives the exposure of 
interest, and one does not, review the cohorts prospectively for 
the outcome of interest 
2b Individual cohort studies and low-quality RCTs  
3a Systematic reviews of case-control studies identifying patients 
who have the outcome of interest and control patients without 
the same outcome, and looking back to see if they had the 
exposure of interest 
3b Case-controlled studies 
4 Case series and poor-quality cohort and case control studies 
5 Expert opinion 
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The author had had unease around how to fit the clinical experience of H&NC 
cancer patients within the Sackett framework, but these feelings started to subside.  
This was because there was a realisation that the ‘gold standard’ of methodologies 
was not suited for the question being asked -there were too many uncontrolled 
variables, which would interact over protracted time-intervals. The possible 
variables are listed below: 
Age, gender, occupation, attendance at pre-treatment clinic, social 
circumstances, smoking, drinking, presence of a specific virus-type (human 
papilomatus and epstein barr virus), possible co-morbidity, method of being fed 
(oral vs tube), site and classification of tumour, nodal status, treatment 
recommended (surgery +/- chemo-radio-therapy), peri-treatment complications, 
length of stay, patients’ traits (optimism, mood, engagement, locus of control), 
quality of life domains, such as from the EORTC (function, symptom, global QoL 
score), as well as individual domains (pain, swallow, teeth, mouth-opening, dry-
mouth, saliva, senses, cough, speech, feeling ill, social- contact, social-eating, pain, 
supplements and weight-status).   
All of the variables could be measured at baseline and at an agreed post-treatment 
interval but this could not account for participant compliance, motivation 
understanding of the situation and patient-team relationship. These aspects would 
remain difficult to test, vague in their description and yet critical to the outcomes that 
might be generated. There were also further, vital quality questions:  
 Would the exercises be specific enough to target specific muscle groups?  
 How would the research be able to verify that a patient was managing to 
strengthen that particular group of muscles rather than using compensatory 
movement from other adjacent soft tissue, or using a different strategy, such 
as an airway protection?     
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 What effect would the relationship between the patient and the team have?  
Could it be that attunement by certain patients to members of the team or 
vice versa would influence compliance? 
 Would trust, or belief in the team influence outcome? 
 
The original questions, from the clinical experience of TG for the author, although 
easy to ask, and alluring in terms of value of intervention, would not be answered by 
using a quantitative methodology.  There was also the personal aspect to the 
situation.  There was no guarantee that patients would either carry out the 
exercises, or carry them out in a standardised way.  The ultimate situation was 
accepted; too little was known about the patient-group to carry out a quantitative 
study.  More detailed information was needed to understand the patient-group and 
what really affected them.   There was for the author relief, rather than the previous 
sense of inadequacy. It now seemed possible to advance academic study with 
reference to this patient group without an RCT paradigm.     
 
Discussion between the author and supervisor started to focus on the poor 
understanding of QoL domains.  It became more apparent that the measures used 
were perhaps limited in their value. The author had never before considered this as 
a possibility.  It became clearer that the QoL measures debated at conferences and 
which had generated numerous papers, measured pre-determined domains that 
might be of limited interest, or meaning to patients.  There was no flexibility in their 
use so that individual needs, beyond the scope of the questionnaires, could not be 
identified.    It seemed as though if the right questions could not be asked there 
could not possibly be answers that might be relevant clinically.  Chapters two and 
three have illustrated that QoL measures have been used increasingly to 
supplement objective clinical or biological measures of disease.   Despite their 
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increased prevalence, such measures have been shown by researchers to be 
limiting.  A study by Bowling (1995) investigated the difference between prompt 
cards and free-responses, in order to  investigate patients’ QoL.  It showed that 
there were discrepancies between the two stimuli and concluded that standardised 
measures might not capture QoL. Instead they investigate pre-determined aspects 
of presumed QoL and predispose the answers by the questions asked.   Such a 
position is at odds with health care plans to create and maintain the role of expert 
patient.  It has echoes also with the sentiments that Porter (2003,p151) expressed 
and which had become a powerful motivator for the author: 
‘The hospital was no longer primarily denounced, however, as a gateway to 
death but as soulless, anonymous, wasteful and inefficient medical factory, 
performing medicine as medicine demanded it, not as the patient needed it.’ 
 
   Carr and Higginson, (2001) also had similar conclusions to Bowling.  They 
concluded that newer, individualised approaches, rather than standardised QoL 
measures, should be investigated so that patients can define their QoL in relation to 
their goals and expectations.  This would enable the goals and expectations to 
become more appropriate to patients in the clinical setting.   
They described the limitations of QoL measures by stating that: 
 Quality of life is an individual construct and measures should be sensitive to 
that facet; 
 Many measures are not patient centred because they are not generated 
directly from patients and as a consequence the patients’ choice is 
constrained to a finite set, which may not be representative for them. (Carr 
and Higginson, 2001) 
 
They also concluded that such a limitation is fundamental because the measures 
don’t gauge what makes up QoL for all patients and so the accuracy and usefulness 
of the measure is reduced.  They suggested that it is possible to measure QoL in 
patient centred ways by using individualised measures but that further research is 
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necessary.  The natural extension of not implementing Carr and Higginson’s 
recommendations is that patients’ health, at an individual and collective-level, is 
being expressed in terms understood by health professionals or society. The danger 
is that they have little resemblance to what matters to patients, because it cannot be 
measured easily or directly.  It would seem that Kennedy’s (2003) assertion, 
detailed in chapter two, that health remains the domain of health care professionals 
rather than patients, is accurate and that more worryingly Porter’s (2003, p151) 
description of hospitals as inefficient medical-factories is perpetuated.  
RESEARCH IN THE CLINICAL ENVIRONMENT 
To try and counterbalance such challenging commentaries research has to be as 
inclusive as possible of the real clinical situation.  Any investigation that explores the 
experience of a disease and its treatment should be set in the context of modern 
health care.  It cannot be sanitised; all of the evident features should remain rather 
than be controlled.  Munro,( 2005b), an oncologist and academic, has described his 
frustrations around epidemiological research, which seem to have parallels with the 
current situation. He suggested in a commentary,  ‘Why do we know so much but 
do so little?’ that there are tensions between epidemiological and clinical research.  
He observed that epidemiological and clinical researchers are diametrically 
opposed.  The former uses large numbers of patients, with inclusion criteria and 
controls for an explicitly identified group of variables that are being tested.  The 
latter uses too few patients, selected with too much clinical detail, from an inherently 
biased group. In his view the result is that epidemiological conclusions can be 
viewed as ‘robust but vague’ and clinical ones as ‘precise but flimsy’. This makes it 
difficult for either party to see the merit in the other’s results.   Munro (2005) has 
developed this issue further within a commentary  in order to illustrate the 
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complexities that are very real in clinical practice (Figure 4.1). This is because 
humans are complex and remain so as patients, both in terms of possible co-
morbidities and their reaction to their current illness.    
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FIGURE 4.1 MODEL OF HOW SOCIO-DEMOGRAPHIC FACTORS (INPUTS) 
CAN BE MEDIATED TO BECOME POOR OUTCOMES (OUTPUTS) (Munro 
2005,P915) 
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Munro was able to be more specific with his description of function.  
Epidemiologists focused on the inputs and outputs whilst clinicians focused on 
the mediating factors and output.  He made the point that there is no linear 
relationship with input to output and these will vary from patient to patient.  It is 
also reasonable to suggest that some of the input factors may vary over time, 
as well as be influenced by long-term, yet fluctuating states, such as stress and 
depression.  Such a situation is not going to be investigated satisfactorily using 
a method that hopes to isolate variables and manipulate them.   
He provides a clinical example from within oncology that emphasises the 
problem further (2005, p193) 
“Increased risks associated with treatment” which may be affected by two 
possible variables:  
 Low income,patients have no access to private transport to the treatment 
centre;  
 Poor literacy, patients fail to understand the importance of some of the 
possible side effects.  
 
The situation is further complicated because patients might fail to appreciate the 
real implications of symptoms as a consequence of denial, fear, or no 
motivation to read written information.  Such a patient may become at greater 
risk of an infection due to neutropenia (a possible side-effect of the 
chemotherapy treatment, low white cell count making the patient susceptible to 
infection) whilst having their treatment.  In its most serious presentation this 
would mean that unless the health care team can treat the acute infection the 
patient’s recommended treatment cannot be completed.  They have in effect 
failed to tolerate the optimal, advised treatment regime based on factors beyond 
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those of the disease classification. Such detail, almost without exception, will be 
overlooked by the epidemiological approach.  The result in clinical terms would 
be, no matter how effective, it is unsuccessful if the patient is unable to comply 
with the treatment.  More meaningfully, the consequence is a missed 
opportunity to obtain a better understanding of how patients might best be 
enabled to receive their advised treatment. Munro argues powerfully that it is 
not sufficient to understand and describe factors; instead there should be a 
responsive change in the clinical practice that enables the real impact of 
patients’ poor resources to be identified and quantified.  These patients should 
not be excluded from the final study results because they do not complete the 
treatment.  They might represent a significant aspect of the clinical reality.   
Through such scrutiny, he suggests that clinicians should develop an 
awareness to both the problems experienced by patients as well as the possible 
inequalities of healthcare; once identified they should be acted upon.  He 
recommends that there should be a way of mediating the robustness of 
epidemiological studies with the perceived vagueness of clinical studies.  
Reflecting upon this in the context of the holistic needs assessment discussed 
in chapter two, health-policy has begun to be influenced by indifferent or poor 
outcome.  It has started to try and describe the well being of patients rather than 
remaining with the more absolute outcomes of survival or QoL measures.  
Munro does not align himself to the hierarchy of evidence framework that 
Sackett et al (2000) presented. Instead, he suggests that RCTs have had their 
value and we are on the edge of change.  There is the possibility that other 
methodologies, more suited to be health-care, can be utilised.  From a historical 
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perspective he has suggested that RCTs can no longer be used to address 
clinical issues.  He proposes instead that studies should seek to encapsulate a 
world of personalised medicine in which variables are included rather than 
disregarded.  Such a situation requires meticulous observation of a patient, and 
the accumulation of data to establish the optimal management.  He asserted 
that this would move research away from the accruing of more subjects in 
clinical trials, where enough numbers would mean that eventually a significant-
factor could be established.  He has recommended that clinical-medicine has to 
be rooted to the individual human, allowing the power of science to be 
represented in a humane way in clinical practice.   This end-point might be seen 
as the purpose and reasoning for mixed methodology and allows for clinical 
judgement and decision-making. 
 
Whilst Munro (2005) discusses his thoughts within the epidemiological and 
clinical research paradigms, the same framework could be applied to 
quantitative and qualitative research. Deductive researchers perceive the 
subjective aspects of qualitative work as being so vague as to have little if any 
specific-value for large patient-groups. The reality is, however, that patients, 
many of whom by social circumstance and or diagnosis are vulnerable and will 
depend upon their clinicians’ expertise in delivering the optimal treatment.   
Clinicians are having to apply aspects of both the technical and humane 
judgement in order to reach a clinical decision (Downie and Macnaughton, 
2000) a point fully discussed in the introduction of the pilot-study paper in 
chapter three.   The treatment that they have may possess only a passing 
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resemblance to the theoretical models devised as ways to explain complex 
phenomena.  The result is a situation where, for the sake of best methodology, 
the individuality that might be so valuable to explore is left out in order that 
statistical rigor can be satisfied.  Can such a circumstance really be seen to 
represent evidenced based medicine or are there so many exceptions and 
addendums to be included, that the research is still in danger of being a 
personal -reflection of a clinician?  In Sackett’s terms (2000) this would mean 
poor methodological rigor.   Clinicians are likely to remain wary about how to 
generalise the research published into their clinical practice, whilst researchers 
will be equally frustrated by what they perceive as poor research design and the 
vague results generated by studies that are poorly constructed.   
What Munro (2005) discussed has resonance with the current study.   
Deductive research is a dominant methodology within H&NC.  Many research 
papers that investigate H&NC use an experimental design.  The studies, 
whether reviews, pooled data, or directly generated data, conclude, all too 
frequently, with the recommendation that there should be better-designed 
studies or that further research is needed in order to substantiate preliminary 
findings (Ramroth et al., 2011, Rudolph et al., 2011).  Such conclusions are 
made in order to rally researchers and clinicians alike, the implication being that 
the methodology chosen is correct and just needs more statistical validation.  
The sense is that if only the methodology could have more refinement, a 
succinct, meaningful correlation will be discovered. This may be too naïve a 
stance, or one that in vain chooses to reduce patient-complexity to variables 
that are controlled superficially. The conclusion that should be reached is that 
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the scrutinised topic is never likely to be answered satisfactorily through such 
investigations because of the numerous variables or protracted treatment times 
that are inherent, and are, as yet, either invisible or  understood only vaguely.  
This is not to suggest that the sense of the complexity is wholly overlooked, 
rather that there is an acceptance within reductionist studies that the variables 
are complex.  The paper by Rudolph et al (2011) concluded that they have 
awareness that the life-style, genetics and nutritional factors remain uncertain 
when survival factors are being considered.  The covert message of such a 
conclusion is perpetuated, that despite the complexity of the topic, the aim of 
further research should be to isolate and control the variables, rather than to 
acknowledge that perhaps the methodology chosen is unlikely to achieve an 
answer that is meaningful.  
 
The struggle for both clinicians and researchers is to work through how close to 
the real clinical situation the study has been, and whether the chosen 
reductionist methodology has any merits.  Salander (2011b) suggests, in similar 
ways to Munro (2005), that within the field of psycho-oncology there is the need 
to use quasi-experimental design instead of  experimental methodology.  It 
would seem possible that within the field of H&NC there is a requirement to use 
more of an observational, inquisitive and exploratory approach.  It should not be 
that  patients’ own subjective-view is of little interest because of what Salender 
termed “methodological narrow-mindedness” (Salander, 2011a).  He stated, just 
as Munro (2005) had concluded, that RCTs should not be seen as the only 
method of enquiry when studying patients with cancer.  He recognised that 
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patients will have multiple motives and desires (which also may change during 
treatment).  The conclusion he made was that RCTs should be complemented 
with other research designs, quasi-experimental, interview studies, to ensure 
that we not only get to know if but also how something was helpful. 
The deductive approach, which includes quantitative methods is well suited to 
certain experimental situations, but becomes more questionable in multi-
factorial, complex and protracted interventions.  Answering the 'how' aspect of a 
research question might need a different approach.  Brown et al (2003) stated 
that the quantitative methodology has been acknowledged as the only truly 
acceptable way of generating research of sufficient quality to inform clinical 
practice. However, they described some of the limitations, such as results being 
presented in a numerical format, which might have very little meaning to the 
topic under investigation.  The ramifications they suggested were that it selects 
both the questions asked and the way answers are represented.  This would 
mean that if a possible effect cannot be isolated and manipulated, the topic 
couldn’t be explored. From Brown et al’s (2003) perspective this means that:  
 “The search for improved care doesn’t begin and end with the 
randomised controlled trial but instead there can be a recognition of the 
limitations of this approach and the value of alternatives.” (P86).  
 
It had now become possible for the author to understand and state that the 
aspect of care being scrutinised by the current thesis, could be addressed by 
a qualitative method.  Patients have to continue their existence beyond their 
questionnaire filling and there might therefore be real meaning and benefit from 
capturing observational data.  If this could happen there might be a greater 
understanding of the real impact of H&NC. Perhaps descriptors do not need to 
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be reduced to an overall survival statistic.  Such representations limit data to 
numerical outcomes - QoL scores pre, peri and post-treatment.  Academic 
clinicians such as Munro (2005) and Salender (2011b) have described the 
limitations of the RCT methodology in the clinical setting.   
Whilst this might be so, it is possible that in a specialty where temporal-data is 
so dominant it is not likely that qualitative, descriptive approaches will be 
encouraged.   Yet it is not possible, or appropriate, to test a hypothesis because 
too little is truly understood about the topic.  The variables identified from  
patients, their disease, proposed treatment and individual organisations need to 
be observed through a longer lens.  
 
 
CONSIDERING OTHER METHODS THAT ARE NOT QUANTITATIVE   
In reviewing other possible methods it was appropriate for the author to 
consider the use of qualitative methods.  There are some attributes of 
qualitative analysis that might be better at investigating the experience of 
H&NC. Cousin (2009) described the purpose of the method for research:  
 Get at complex meaning from research text or visual data,  
 Interpret human behaviour and experiences beyond their surface 
appearances  
 Provide vivid illuminative and substantive evidence of those behaviours 
and experiences 
 Build theory inductively from qualitative data sources.   
 
The result, she suggests, is that the texts explore the information and are able 
to generate “rich depictions of research settings” (P31). It would have been 
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possible to consider one of several qualitative approaches when exploring the 
experience of H&NC, presented in table 4.2. 
 
TABLE 4.2 QUALITATIVE RESEARCH APPROACHES 
Type of research Brief description 
Grounded Theory 
Unearths the social processes in the subject 
investigated  
Ethnography 
Explores a culture, or understanding of a 
human behaviour 
Phenomenology 
Unearths the meaning of a situation for an 
individual  
Discourse Analysis 
Scrutiny of language in a context of total 
communication situation so that all aspects of 
the communication are included.   
 
In reviewing these different qualitative techniques Grounded theory, or a 
phenomenological approach, would both have been possible methods for the 
current study.  However, there has always been a sense that the author needed 
to have a level of objectiveness influencing the results, because of having such 
a close identification with the topic.  The author has worked within an acute 
medical setting for more than twenty years.  This aspect of the research 
situation, although in many ways useful at the interpretation-stage of data, could 
bring bias if the method relies extensively on interpretation of the results by the 
author.  To counteract this possibility it would seem reasonable that there 
should be some statistical rigor that supports qualitative data in order to 
understand objectively what the true meaning for H&NC patients is.  It is also of 
note that the surgical, oncology arena expects results to be presented in terms 
of statistical significance.  Any data derived from the patient-group is likely to be 
more easily interpreted and accepted if there is a statistical method through 
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which data can be described.  A mixed methodology, which uses both statistics 
and descriptions, could compliment the gaps that might be levelled at either 
methodology if it was used on its own.  Cresswell and Plano-Clark (2007) have 
described a mixed-methodology  as one that includes both qualitative and 
quantitative aspects of research.  They commented that its use would suggest 
that the researcher has judged that the topic being investigated is best explored 
by integrating elements from both methodologies to enhance the results.  The 
results will include both statistical and verbal descriptions. 
It is to be hoped that at this stage in the thesis the reader can be drawn to a 
point from which two premises can be stated with insight into the rationale:   
(i) There is not enough known about the experience of H&NC to use a 
deductive approach;  
(ii) Discovery, rather than testing reasoning, is a suitable stage of enquiry 
for the exploration of a patient’s experience of H&NC and its 
treatment. 
 
It is therefore suitable to introduce the methodology chosen for the study by 
defining and describing it in detail.  The methodology chosen was Q 
methodology. 
 
 
A DESCRIPTION OF Q-METHODOLOGY 
Q-Methodology is an exploratory technique, viewed as a way of bringing a 
sense of coherence to research questions that have many complex and 
answers that are contested socially (Watts and Stenner, 2005). It has also been 
described as a way of analysing text in order to find underlying subjective 
meanings (Webler et al., 2009a). Q intends to look for holistic patterns that 
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researchers can classify as viewpoints, perspectives, or narratives (Lazard, 
2003). The methodology is able to study, in a systematic fashion, subjective 
experiences and is regarded as combining  the richness of qualitative protocols 
with the rigors of quantitative ones (Akhtar-Danesh et al., 2008). 
 
SPECIFIC Q-METHODOLOGY TERMS. 
Q-methodology has a specific vocabulary used to describe the stages of the 
method. The total process involves distinct and step-wise stages. Table 4.3 
describes the terms and presents them in the order that they are carried out.  
 
TABLE 4.3 Q-METHODOLOGY TERMS, STAGES AND DEFINITIONS 
Q methodology 
term 
Q 
methodology 
stage 
Definition 
Identify and 
create the 
concourse 
1&2 Contains all the relevant aspects of 
the topic from numerous sources 
and is created from a large list of 
statements 
Development of 
Q sample 
3 A reduction of the concourse 
statements, which will have clear 
meaning and not be repetitious 
Q sort 
P set 
4 Participants rank the statements 
Group of participants who complete 
the Q sort 
Analysis 5 Computer programme and interview 
transcription analysis help to form 
the significant factors 
 
The first two stages are the development and establishment of the concourse - 
a group of single pieces of thoughts or descriptions, which can be represented 
by unambiguous phrases.  Stage 3 refines the phrases to the final Q sample, 
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whilst Stage 4 entails these phrases being sorted by a group of participants into 
a forced distribution curve, represented by a grid.  
FIGURE 4.2 Q-METHODOLOGY GRID – STATEMENTS ARE SORTED 
ONTO AN ALLOCATED SPACE ON THE GRID. 
 
The completed grid is discussed in order so that the placement of the 
statements in relation to one another can have the subjective and specific 
perspective for each participant. The fifth and final stage involves each Q-set 
being analysed; more recently researchers have completed this stage by using 
a purpose-built software programme, PQ Method (Schmolck, 2002).  The 
distinct viewpoints are created and become known as factors, which are seen 
as representative of a view.  The researcher, with knowledge of the field under 
investigation and the specific factor distributions, reviews the Q sets for the 
meanings that they might represent.  No particular statement is as important as 
the complete Q-set statements, although they are constituent-parts are 
interpreted in the context of all of the others (Webler et al., 2009a).   
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THE MAIN DIFFERENCES BETWEEN R-METHOD AND Q-METHOD 
The Q-method analyses text-based statements in order to determine underlying 
patterns or meaning (Webler et al., 2009a).  As part of the process individuals 
are clustered, based on how they describe themselves, so that a pre-
determined set of statements is investigated for correlations.  There is debate 
as to how Q- methodology might be classified, which means that either 
proponent of more conventional methodologies can marginalise it. Lazard 
(2003) appears somewhat irritated by this attitude and suggested that Q-
methodology has a shared-focus on both subjectivity, and hypothetico-
deductivism. 
In chapter two the main outcome descriptors used in H&NC have been 
described.  In quantitative research, respondents are subjects and questions or 
measures are the variables.  Patterns are therefore sought across a range of 
variables or from a single one for each participant.  A hypothesis is cited and 
tested, for example:  ‘all patients who have oral tongue cancer have more pain 
than tumours at other sites’. Traditional factor analysis would explore a group of 
H&NC patients by describing them through a number of pre-determined tests, 
measures, or questionnaires.  These would aim to classify pain and subject it to 
factor analysis. Q Methodology inverts the factor analysis so that a specific 
number of pre-determined statements (tests) are ranked by a number of 
selected individuals (Watts, 2012).  It is the statements rather than the 
participants that are tested.  In the context of Q- methodology the hypothesis 
set regarding pain would be regarded as too specific. The premise that pain, 
rather than other symptoms or attitudes, should be singled out, as the specific 
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factor to be tested would be challenged.  Instead it is proposed that the 
participants need to be given the opportunity to express what they consider to 
be the key-issues rather than what others assume.  Q methodology therefore 
would not presuppose that pain is the dominant feature and would collect many 
of the antecedents or values a patient might have that influence ongoing acute-
on-chronic oral pain.  Table 4.4 depicts the differences between the two 
methods. This would seem to be an attempt at describing individualised patient 
aspects of the disease aspiring to Carr and Higginson’s (2001) aspirations and 
the health documents described in chapter two that seek to discover outcomes 
beyond patient safety and quality of care.   
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Table 4.4  
THE MAIN METHODOLOGICAL DIFFERENCES BETWEEN THE 
REDUCTIONIST R METHOD APPROACH AND Q METHOD BASED ON 
WORK BY WEBLER ET AL (2009a).  
 
Descriptor  R Method Q Method 
 
Hypothesis   State a prediction relating  
to the result that needs  
testing 
Do not predict what meaning 
might be uncovered as a result 
of the study 
Variable  Survey question Q sort done by a Q participant 
who represent different 
aspects of the topic  
Subject  Respondent Q statement 
Population 
 
 
 
All possible respondents / 
participants 
Concourse (all possible Q 
statements) 
Goal  Find patterns in how 
respondents answered  
different questions 
 
Find patterns in where Q 
statements appear in different 
Q sorts knowing that the 
pattern will not be unique to 
one person 
  
 
  
Factor 
Analysis 
 
 
Normal Inverted, participants 
not the tests that load onto the 
factors 
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Example using each type of methodology:  
R methodology question: 
Do people with tongue cancer report more pain than other head and 
neck sites?  
Results presented as: 
Percentage of population with tongue cancer who perceive their pain to 
be worse than other cancer sites of the head and neck. 
 
Q methodology question:  
What is the experience of pain for patients with H&NC? 
Results presented as:  
A finite and distinct set of factors will be created which define key-themes  
for patients that describe how they have experienced pain over the course of 
their disease and treatment. These are only meaningful in the context of the 
other statements.  An exemplifying Q-sort represents each factor.  The results 
produced are described as factors, which are a range of reports that can be 
formulated from the individual sorts of participants. A specific trait, gender, age, 
or type of treatment undergone, will not form the basis of the results revealed 
but there will be a grouping of participants based on their opinions. This is a 
fundamental aspect of Q; the researcher is not looking for specific attributes of 
participants but for their shared opinion.   
Subjectivity, in Q-methodology terms, represents a person’s communication of 
their point of view.  It is the person’s internal frame of reference that becomes 
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expressed by the ordering of the statements.  The result of the Q Sort is the 
representation of human perception from a personal perspective (Brown, 1993).   
Such an aspiration is very much sought after in the current context of health 
care; the views and experiences of patients are seen as central to health care 
provision. Carr and Higginson (2001) have recommended the individual nature 
of this experience a point discussed earlier in this chapter, which might be seen 
to be satisfied by the use of this method.   Patients may have a mechanism 
through which they can describe, in personal ways, the real meaning of a topic.  
This methodology seeks to keep the sorts as an entity and does not aim to 
reduce or segment them.  It will remain multi-faceted and will never be 
summarised in numerical terms without the support of text, generated from the 
individual participants.  The text is able to add clarity to the specific statements, 
and can act as a way of illustrating a point of view. It might be described, 
therefore, as both a qualitative and quantitative methodology.  Hence it is 
portrayed as mixed-methodology.   
The quantitative aspect of the methodology establishes, through inverted factor- 
analysis, the patterns from a subjective perspective held by the participants. It is 
the configuration of a finite list of statements presented to participants that are 
correlated and factor analysed (Brown, 1993).  The factor analysis moves from 
correlation between variables or tests towards correlation between people. The 
procedure is an inverted factor-analysis; it is the participants rather than test 
results that load onto the emerging factors.  Brown (1993), has detailed the 
differences that Stephenson saw between the two methods in his historical 
perspective of the methodology:  
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“Stephenson referred to R methodology as "a selected population of “n” 
individuals each of whom has been measured in “m” tests" (note the passive 
verb has been measured), and Q methodology referred to "a population of “n” 
different tests (or essays, pictures, traits or other measurable material)”, each of 
which is measured or scaled by “m” individuals".   
 
Through the method, Stephenson has created holistic data (Watts, 2012).    The 
individual creates actively this data.  However, there is a finite number of distinct 
viewpoints on any specific topic.  The Q sample, (the statements used to 
explore the topic) contain a wide range of opinions, the resulting Q-sorts will 
disclose the perspectives (Brown, 1980). A large and representative sample is 
not needed, because it is perspectives, not the participants that are being 
analysed (Brown, 1993, Stainton-Rogers, 1995, Webler et al., 2009b, Webler et 
al., 2009a). 
 
 
WHAT THE RESULTS LOOK LIKE AND HOW THEY CAN BE USED 
The beginning of the analysis will translate each of the statements that have 
been sorted by the participants into a numerical value.  In this specific study the 
extreme opinions have a score of +5 or -5.  The numbers work back towards 
the middle so that a zero-point represents ambivalence.   Each participant’s sort 
is inter-correlated with all of the others in the study.  A correlation-matrix -a 
series of “m” variables is presented variable-by-variable in a grid, which can be 
reviewed by the participant when the sort has been completed (Watts, 2012).  
For a specific study, participants will have an opportunity to sort statements, 
which might mean that they sort in very similar ways. These correlation-
matrices are then subjected to factor analysis, which are data arrays that are 
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highly correlated to one another.  There are now, from a results perspective, 
factors that are an indication of how like a particular factor a participant is.  If the 
participant has a factor score of 0.8 they would be judged to have a high and 
representative array of the factor.  This would suggest because a score of 1.0 is 
an exact replica of the factor, that the subject is expressing eighty percent of the 
factor discovered.  The participant becomes an examplar of the factor.   
Weighted-average scores for each statement within each factor are also 
obtained.   For each statement there is an understanding as to where the 
statement for this factor would fit.  A composite opinion of the topic investigated 
is represented by each of the factors that have been discovered.  This means 
that each statement has a typical number relating to the forced-distribution 
matrix.  The qualitative part of the study compliments the factor revealed.  This 
part consists of a narrative being written for each, which uses as its source the 
quotations from the participants who load most closely onto that factor.  The 
commentaries, therefore, are a way of substantiating the Q sorts with phrases 
that are powerful. 
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THE PURPOSE AND VALUE OF THE APPROACH TO HEALTH-CARE AND 
RESEARCH BY USING Q METHODOLOGY 
The purpose of Q-methodology is to describe views via a population of 
viewpoints and not describe a population of people (Risdon et al., 2003).  It is 
likely to be at the inception of a topic being investigated that it is used because 
it is a way of establishing what hypotheses could be posed at a later stage.  The 
intention of this more preliminary method is to define perspectives, before 
conducting a survey to measure the frequency of occurrence of those 
perspectives in a population (Webler et al., 2009a).  It makes the assumption 
that not enough is understood about the topic to isolate particular variables. 
This method in the current thinking of health care delivery, might satisfy the 
need to accommodate what matters to patients as noted by the King’s Fund and 
King’s College report (2012).  It would mean that professionals are able to 
accommodate, and even change practice, based on patients’ perspectives.  Q 
methodology does not try and estimate population statistics, it intends to sample 
the range and diversity of views expressed and will at no point represent the 
number of participants who express these claims in a percentage value (Cross, 
2005).  This in effect means that participants who might have a marginal view or 
one that is not expressed because of statistical cut-off points is acknowledged 
as a perspective from the investigation.  The value of the methodology is to 
uncover and represent opinion clusters; it does not intend to make generalised 
statements beyond the participant group.  There is however an intention to 
discover opinions and clusters within the sample (Webler et al., 2009a).  Q 
methodology has been used within social-sciences and more recently has been 
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applied to different aspects of health which are multi-factorial and are 
systematically studying viewpoints:  
 patients’ understanding of irritable bowel (Stenner et al., 2000)  
 Chronic pain (Risdon et al., 2003) 
 Patients’ viewpoints about health and rehabilitation (Ockander and 
Timpka, 2005) 
 Post-natal symptoms (Herron-Marx et al., 2007)  
 Adolescent experience of fatigue during chemotherapy (Lai et al., 2007)  
 Attitudes of H&NC patients to alternative methods of feeding and in 
particular gastrostomy (Merrick, 2012)   
 
The technique offsets many of the methodological problems faced by patients 
when attempting to reflect upon their own personal experiences because the 
technique requires the participants to consider individually a range of 
statements within the context of one another so that a large range of views and 
experiences are represented by a small group of participants.  
The validity of a Q study is established by reviewing the literature on a topic and 
domain experts reviewing the statements.  A pilot-study to verify that the 
statements are clear and do not have repeated redundant themes should be 
carried-out. 
 
Reliability of the methodology has been established by examining the test re-
test on specific individuals. It has been suggested by Webler et al (2009), that Q 
methodology is not a good medium through which to represent very dynamic 
processes because the intention would be that it represents a viewpoint that 
could be further qualified with each group of participants that present with each 
specific factor array.  The topic under investigation that is depicted by the 
statements becomes the subject of a factor analysis.   Q allows significance to 
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be associated with the meanings that are discovered (Webler et al., 2009a). 
There are a finite number of perspectives, but the likelihood of these being 
produced by chance rather than thought and opinion about the topic is 
infinitesimally small (Brown, 1993).   
 
 
ADVANTAGES OF Q METHODOLOGY 
Q sorting does require greater involvement by participants than standard 
questionnaire completion, but it can be broken down into stages so that the 
whole process does not seem overwhelming.  It may be seen as a process that 
engages the participant in thinking through the topic; it requires them to link 
each statement in some way to others around them and so is not subject to 
impulsive poor reasoning skills that questionnaires are vulnerable to.  
Participants have to consider their responses more carefully and the intention is 
that this brings out their true feelings.  The statements that represent the Q sort 
will have been generated, at least in part, from relevant literature but as the 
participant sorts the cards they bring to the Q-set their specific interpretation.    
It is also envisaged that the participant will understand the Q-set because it 
represents their personal view of the situation.  The onus is on the researcher to 
check-back that the Q set is representative of the participant’s particular view.  
Webler et al (2009) suggested that an advantage of the Q has over other forms 
of discourse analysis is that the participants’ responses can be compared 
directly in a consistent manner.  All the participants are reading and reacting to 
the same set of Q statements. This is not the case in other kinds of qualitative 
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discourse analysis.  Other forms of discourse analysis depend on the 
communication skills of the subjects, which for this patient-population is likely to 
be compromised.  This means that patients who are less likely to be 
approached because of their reduced oral communication skills are not going to 
be represented.  It is viewed as aspirational to maintain a holistic approach to 
investigations.   The dual quality of both quantitative and qualitative results is 
also important in the field of H&NC. Clinicians relate to definitive results, which 
will be expressed with statistical rigor.  The presentation of results in such a way 
ensures that the technique is more acceptable in epistemological terms to the 
clinicians it might seek to influence.  
Q method allows participants’ response to be compared in a consistent manner 
because each participant is exposed to the same Q set; there is some control 
and thoroughness of the topics covered within the Q set. Another advantage is 
that unlike surveys and questionnaires in which the investigator imposes the 
responses, Q determines the categories that are operant (Stainton-Rogers, 
1995).  The objective of Q methodology is to describe different perspectives, not 
to achieve a high volume of participants who load onto each of the factors.    It 
is therefore the representation of the different views that is important not the 
proportion of participants who adhere to the factor. This means that the number 
of participants in the study can be small (Stainton-Rogers, 1995).  It is 
recommended that the sample size should remain small deliberately, because it 
should not be that the quantity of participants prevents the detail from the Q 
sorts and the interviews from being recognised (Webler et al., 2009a). 
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DISADVANTAGES OF Q-METHODOLOGY 
There are several disadvantages to the methodology.  These are mainly rooted 
in the time intensive nature of the process and the vague description of how a Q 
sample might be created.  These two aspects are interrelated, because it is the 
formation of the Q sample that is likely to take the greater amount of time.  It is 
critical that this part of the method can create a Q set that has been sourced 
from a range of information about the topic under investigation.  Watts and 
Stenner ( 2012) suggested that the ultimate Q set will be representative and 
seamless in its coverage in order to create a balanced Q set.  It is not implied 
that balanced means the Q-set is represented equally by positive and negative 
statements.  It must not be value laden towards one aspect of the topic only.  If 
this were the case it would cease to be representative. A participant, on 
completion of a Q set, should have a sense that that they have not been 
restricted in their response so that a whole aspect of the topic has been left 
unrepresented. If this were the case the participants will not have been able to 
express their viewpoint. It would be expected, however, that this shortfall would 
be highlighted within the interview after the Q set at the pilot stage of the 
research.  It would at this point, be possible to review the statements in order to 
achieve a more representative Q set.  
The method used to generate the Q sample has not been well described and is 
open to individual’s preference. Its development is open to interpretation, which 
might make it difficult for researchers to replicate a study.  To counteract the 
criticism of vague process, Attride-Stirling’s method of categorising text for a Q 
sort (Attride-Stirling, 2001) has been used in this study. The time spent on 
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creating the concourse should mean that it is representative of the study topic. 
There should be meticulous and thoughtful sampling in order to achieve a Q 
sample that will allow the participants to represent a complete account of the 
topic under discussion. There is a danger that bias is present from the 
concourse, but it has been suggested that this can be reduced if the Q set 
includes direct quotes from the participants used to construct the concourse 
(Robbins and Krueger, 2000).   The statements also need to be as transparent 
as possible so that they are not vague in their meaning for participants (Webler 
et al., 2009a). 
The selection of the Q sample statements is not the only possible area of bias.  
The other possible arena into which bias can be introduced is the data analysis 
field because the factor solution and commentary are value judgements, made 
by the researcher.  This difficulty can be to some extent negated because the 
results are transparent and can be reviewed by the participant and readers of 
the area of research explored (Webler et al., 2009a).    
There is a question over the reliability of responses because this presupposes 
that attitudes or experiences are likely to remain the same over a year.   There 
is no expectation by researchers who use Q- methodology that the respondent 
should express the same view on separate occasions.  It is thought however, 
that the study scenario should be one that would be described as having 
stability, and not one that is likely to alter radically over-time.  There has been 
no longitudinal use of the methodology and it is seen as a way of capturing data 
at one point in time from an individual (Brown, 1993) rather than at several 
predetermined intervals.   
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SUMMARY 
This chapter has described the author’s first clinical encounters with the H&NC 
patient population.  It has also described how through powerful, clinical 
examples the accepted ways of describing the possible outcomes were 
perceived as poor representations of the patients.  The lack of clarity and 
relevance to the clinical situation motivated the author to seek further 
investigation of the topic through a formal research route.  This was brought into 
more focus after it was realised that QoL questionnaires would not be brought 
routinely into the author’s clinical setting.  It had also been the author’s 
expectation that a quantitative study would be used to investigate the 
experience. However, reflection and learning about possible methodologies 
were able to guide the author towards a mixed-methodology, and in particular 
Q-methodology.  The methodology has been explained in broad-terms and its 
potential use within the health care context.  There is a particular appeal within 
the context of health policy because of its stance on remaining holistic rather 
than becoming too focussed or fragmented.  The next chapter will describe 
more specifically the methods and results for the current study and it will seek to 
explore the experience of head and neck cancer patients from diagnosis 
through treatment.   
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CHAPTER 5 
A Q METHODOLOGY STUDY TO EXPLORE THE EXPERIENCE 
OF PATIENTS DIAGNOSED AND TREATED FOR HEAD AND 
NECK CANCER 
 INTRODUCTION  
This chapter describes the specific method and results used to investigate the 
experience of H&NC using Q methodology.  Q-has five steps in its process: 
Step 1: Establish and identify the concourse  
Step 2: Create a Q sample- a reduced number of statements from the   
concourse, which remains representative of the concourse  
Step 3: Rank the statements via a likert-scale on a forced-distribution-
grid and engage the participants in a semi-structured interview to 
discuss the placement of the statements in order to help interpret 
the placement of the statements   
Step 4: Analyse the Q Sort data, which will produce a number of discrete 
factors (viewpoints) through the use of a computer programme 
Step 5: Interpretation of the factors by reviewing the statements’ 
placements and using the participants’ semi-structured interviews 
understand the rationale for the placement of the statements 
 
Step1 Identify and create the concourse, which has been described in chapter 
three (pages 83-10) following an approach devised by Attride-Stirling (2001).  
The concourse to represent the experience of H&NC was created by the 
triangulation of representative information from three sources, which were: 
 The three most commonly used Quality of Life (QoL) questionnaires in 
the research literature  
 A literature review of the topic Experience and H&NC  
 Six semi-structured patient interviews   
 
The hierarchy of themes, devised by Attride-Stirling (2001), entails the 
development from basic, to organising to global themes.  The figures in chapter 
3 (3.1-3.6 pages 87-98 ) are diagrammatic representations of the concourse 
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established and depict the hierarchy of the six global themes which are listed 
as: 
1. Day to day physical comfort 
2. Emotional well being 
3. Place in society 
4. Own mortality 
5. Quality of care 
6. Reality 
 
The concourse created has used a range of different sources in order to be 
representative of the subject (Brown, 1993). This chapter describes, steps two 
to five of the Q methodology study that investigated the experience of H&NC 
from diagnosis up to a year post treatment. 
 
 
METHOD  
STEP 2 CREATION OF THE Q SAMPLE 
An analysis of the six participant interviews conducted at the stage of the 
development of the concourse generated more than 120 statements, which 
could be judged as representative of the concourse relating to the experience of 
H&NC.  These statements are verbatim from participants and could each be 
categorised under the six global themes.  They were reduced to a final list of 45 
by reviewing how representative and salient they were of the themes and the 
issues within them (Watts, 2012). The statements chosen were reviewed by 
another member of the research team (DF) for clarity, and thoroughness for the 
topic.     From global theme three 'place in society', the comment,“I have to 
accept I can’t have a good row, it’s easier just to stay quiet” became “I cannot 
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have a good argument now”.  One statement is able to represent an idea as a 
stand alone entity. The Q-methodology literature suggests that there should be 
an attempt to be as inclusive as possible about the topic, but the specific 
balance of the statements is not particularly important, because each participant 
will derive this at the time of the Q sort (Brown, 1993). The aim of a Q set is to 
be as inclusive as possible across themes from original sources to the research 
question, and be broadly representative of the issues (Watts and Stenner, 
2012).  In this study therefore the three sources used had been the quality of life 
questionnaires, the literature review and the semi structured interviews.  These 
had created the six global themes that would now be represented through the Q 
set. There is a sense that the Q set does not limit the participants in their views 
and should not have repetitions of ideas.  The number of items generated will 
be large initially these are then refined and reduced as the statements are 
reviewed for having a single perspective and not having technical or specific 
jargon.  The author, with input from another member of the supervisory team  
(DF) was able to develop a Q set that was broad, unambiguous with no 
omissions as well as ensuring that there was no duplication of aspects within 
themes. The reduction of the statements is shown for the global theme Reality 
in Appendix 5.1.  The number of statements chosen was not arbitrary and refers 
to work carried out by Webler et al (2009), in which a ratio of statements to 
minimum number of participants for the study, is calculated.    
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This paper recommends a ratio of statements to participants of three to one: 
 30 statements need to be used  for 10 participants 
 36 statements need to be used  for 12 participants 
 42 statements need to be used  for 14 participants 
 45 statements need to be used  for 15 participants 
 
The statements presented below were judged representative of the six themes 
and form the Q sample for the study.  
FIGURE 5.1  
45 REPRESENTATIVE STATEMENTS OF THE EXPERIENCE OF H&NC 
1.   Physical symptoms: day-to-day comfort (8) 
1. I recovered much slower physically than I expected  
2. I am still in pain  
3. It’s hard to remember things you’re told  
4. I felt physically very isolated  
5. When I talk it doesn’t feel like me anymore  
6. I always think that people are staring at me  
7. Any symptom I get I always think the cancer might be back  
8. Day-to-day existence is physically exhaustin 
     2.      Place In Society (7) 
1. I felt very alone 
2. I didn’t want people to know what had happened to me  
3. Everyone around me was so upset  
4. I still don’t think anyone can really understand what has happened 
to me  
5. I cannot have a good argument now  
6. I never think of myself as ill  
7. I do things but on my terms 
3.Own mortality (7) 
1. Being cured of the cancer is still the most important thing  
2. It’s just as well you don’t know what’s going to happen or you 
would never cope  
3. It’s very hard to think about your own possible death  
4. You never think it could happen to you  
5. Once I knew they could do something about it that’s all I needed 
to know  
6. You just become really grateful for different things  
7. Life is hard you just have to get on with it 
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4.Quality of care (8) 
1. I didn’t understand what was meant by the treatment until I 
experienced it  
2. I felt very vulnerable when I was in hospital  
3. Little things like the car park or appointments being cancelled 
really irritate me  
4. I never felt like a number I was always treated as an individual  
5. I was most frightened when I came out of hospital  
6. I wanted the team always to be honest with me  
7. I never read the written information I was given.  
8. No two patients are the same 
5.Reality (5) 
1. You should never have to face this sort of thing on your own  
2. If you didn’t want to die there was no choice but to have the 
treatment  
3. It’s so hard waiting to heal 
4. I have to be careful to not upset people  
5. I’ll talk about things that I wouldn’t have done before my diagnosis 
           6.Emotional well-being  (10) 
1. I worried a lot how others would cope  
2. When I was told I had the cancer I knew I had to face it.  
3. I wish I’d never been treated  
4. My appearance was much better than I expected  
5. I am much more irritable than I used to be  
6. I cannot do things on the spur of the moment.  
7. It really affected my confidence  
8. It’s amazing how much you can adjust to all the physical changes  
9. Life will never be the same again  
10. I never appreciated how long it would take to get better 
 
 
 
The statements were printed onto small flash cards that were laminated and 
assigned a number randomly so that each theme did not have sequential 
numbering.  This Q set is reproduced in Appendix 5.2.  The set was tested 
initially on two participants to assess the transparency of the statements and the 
ease of the actual process.  Both participants felt that the statements were easy 
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to understand and felt that they could be described as representing possible 
aspects of the experience.   
 
STEP 3 THE Q SORT 
SELECTION OF PARTICIPANTS FOR THE Q SORT 
Q-methodology, as described in chapter 4, is an inversion of R methodological 
research techniques.  The reality of this is that the 45 items in the Q set are the 
study sample and the participants are the variables.  The aim is to avoid a 
homogenous group of participants.  Brown (1980) suggested that the 
participants who carry out the Q sort should be “theoretical…..not accidental”.  
He suggests that there is real purpose in achieving a range of participants from 
different experiences.  In this specific study it would be an assumption rather 
than a fact, that there is a correlation between the disease size or treatment 
modality, which could predict the likely participant response.     Participants 
were therefore sought with a range of tumour sites and treatments, using a 
purposive sampling strategy.  A patient database from the cancer centre that 
the author works at, provided a list of patients who had been diagnosed and 
treated over a year period and might therefore be eligible to take part in the 
study.  The number of participants judged necessary was taken from a 
recommended formula of at least one participant for every three statements 
(Webler et al., 2009a) (described on page 162 of this chapter).  This would 
suggest that there should be at least fifteen participants when 45 statements 
are used. 
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INCLUSION CRITERIA 
The criteria for participation in the study were:  
 Aged over 18 
 Able to understand and speak English  
 Completed treatment with curative intent at a UK cancer centre for 
H&NC:  
 surgery only 
 surgery plus radiotherapy  
 surgery plus chemo-radiotherapy 
 chemo-radiotherapy  
 
EXCLUSION CRITERIA 
 Known to have a co-existing malignancy 
 Co-existing cognitive disorder 
 Treatment that was being used with known palliative intent 
 
At the time of the Q sort the participants were without any clinical sign of 
recurrent disease.   Twenty patients were approached when they were 
attending outpatient reviews, by the author.  Two declined to take part; eighteen 
participants completed the study. The bio-clinical information for the participants 
is presented as each factor is described. 
 
 
Q SORT PROCEDURE 
The participants completed the Q sort in two stages:  
(i) An initial, broad sort that separated the statement cards into one of three 
categories  
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(ii) A more detailed one when the statement cards were placed onto the 
forced distribution grid.  The format of the distribution grid has been 
discussed in the Chapter 4 and presented as figure 4.2 (page 145).  
 
In order to carry out the first sort, participants were instructed by the researcher 
to read through all of the statement cards initially so that they could establish 
the range of statements that were for consideration.  They were then asked to 
sort each of the statement cards into one of three distinct piles.  This statement 
is:  
 Most like I think 
 Least like I think  
 I am ambivalent about this in relation to my experience of head and neck 
cancer  
 
The participants kept the groups of statement cards separate, but in 
essence they had started to form a physical continuum.   The participant was 
next instructed to look at the forced distribution grid sheet on an A1 sized card 
with the -5 to +5 range. Two cards could be placed at +5 and represented their 
strongest agreement  with statements.  The same process continued until the 
participants had worked their way back to the position of +1.  They then were 
asked to turn their attention to the other extreme group –‘least like I think’, and 
to decide, in a similar way, what were the two statement cards that represented 
how they least thought.  These statements were placed at -5.   The process was 
repeated until the participants had the 'least like I think' dimension filled-up with 
the statement cards.  As they made progress towards the centre of the chart' 
the participants were told that there was more scope to have more statement 
cards in the central positions.  Each card had to have its own space, so that no 
blanks or doubling-up of allotted spaces could occur.  The participants were 
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also given the explanation that the height of the distribution placement did not 
matter, what mattered was the numbered position from +5 through to -5.  It was 
explained that in order to make a statement card 'most like I think' the card 
should be moved towards +5 and in the opposite direction for 'the least like I 
think'.  This meant that there were frequent discussions concerning those 
statements about which participants had ambivalent thoughts, before a decision 
was made as to where the statements might be placed.  The grid became a 
personal construction of a forced distribution curve.  Due to the almost 
infinitesimal permeations of the arrangements for the statement cards when two 
participants have a consistent patterned response; the participants are 
responding to the topic in a meaningful and similar, rather than random way 
(Webler et al., 2009a).  Once all the cards had been allocated to a place, each 
participant had time to review the position they had given to each statement.  
The array was recorded on a scoring grid that represents the layout of the 
distribution sheet.  A completed example of a scored Q sort for one of the 
participants is presented in Appendix 5.3. 
After the sort, participants were asked whether they felt that the statements 
reflected their experience of the disease and treatment and whether in their 
opinion there were any omissions. The participants were also asked if the zero 
mark really represented indifference, or whether this needed to be moved within 
the scale (Webler et al., 2009a).    The participants were now able to discuss 
with the author their rationale for placing certain statements at the extremes, or 
in the centre of the distribution grid, so that more detail surrounding the 
placement of the statements could be gathered.  This discussion was recorded 
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and later transcribed by the researcher.  One such semi-structured interview 
transcript is presented in Appendix 5.4.  Adding line and page number tabulates 
the transcript which enables the interviews to found within the results.  The text 
generated is helpful in the interpretation of the factors when they have been 
discovered statistically. It was decided by the author to carry out a face-to-face 
Q sorts.  Some of the patients would have been difficult to understand if there 
had not been the face-to-face cue, because of how their speech had been 
compromised by the disease and or treatment.  It also felt that for a Q sort that 
might provoke emotion, the researcher should be able to advise the participant 
of possible further support that could be accessed after the participation in the 
study.   
 
 
STEP 4 AND 5 ANALYSES OF THE RESULTS AND INTERPRETATION 
The completed Q sorts were analysed using a software programme that is 
available via the internet, the PQ method 2.1 programme (Schmolck, 2002).   It 
analyses the sorts so that participants who are presenting similar experiences 
are clustered together and form a factor.  The participants have rank ordered 
the statements which have been analysed statistically.  The product of this 
analysis creates the clusters or variables that are known as factors.    The 
analysis produces an ordering of the statements that become specific to one 
factor over another.  Statements in similar positions for all the factors are called 
the consensus statements because they are in the same place within each 
factor.   The factors are interpreted by reviewing them both in terms of the 
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consensus and contention statements.   The semi-structured interviews from 
the participants are able to elaborate and help the researcher interpret further 
the ranking of the statements by each participant.   Q Methodology has the 
option to use varimax rotation (an automatic way of generating variables which 
are called factors).    The use of varimax rotation is recommended for larger 
data sets so that the factors uncovered account for the maximum amount of 
study variance.  The intention is that it is possible to consider and recognise the 
importance of each factor relating to the topic under investigation (Watts and 
Stenner, 2012 P.125).  Eigen values, used in R methodology when factor 
analysis is carried out, are used to decide the variance extracted from each 
factor.  It has been recommended that only factors with an eiganvalue greater 
than 1 are analysed (Brown, 1996), but the coherence of the factor as well as 
the eigenvalue should be taken into account (Coogan and Herrington, 2011).   
Q methodology is holistic in its nature and therefore it has been suggested that 
the value has little meaning in the context of Q methodology because they are 
based on an arbitrary number of individuals (Brown 1980).  The other specific 
issue to recognise is that factor analysis will break-up the topic investigated into 
separate components and Q methodology relies on the participant being their 
own reference point.   Figure 5.2 represents the different and step-wise stages 
of the study; the results are presented in the subsequent section.
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    45 statements 
representative of the 
experience of H&NC 
form the Q- set 
     18 Participants 
complete a Q sort and 
discuss the placement of 
the statements 
 
        Create the Concourse from: 
 3 Quality of Life Questionnaires  
 Literature review of experience 
and H&NC 
 6 semi-structured interviews with 
H&NC 
6 Global Themes Elicited 
o Physical 
o Emotional 
o Place in Society 
o Own Mortality  
o Quality of Care 
o Reality 
 
 
 5 factors 
1. Meaning and attachment of  
illness 
2. Overwhelmed by the cancer 
 
3. Change and recovery 
 
4. Surviving or not 
 
5. Keep control-greater good of    
    others       
 
 
 
 
 
 
 
 
 
 Figure 5.2    
STAGES USED TO  
CREATE FIVE FACTORS 
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RESULTS 
Eighteen participants, twelve men and six women completed the Q sorts.  The 
age-range was 37-77 years all of their details with reference to the treatments 
they had are presented as table 5.1.pages 173-174 
This investigation of the experience of H&NC suggests that there are complex 
and interactive patient characteristics that will impact upon patients. The semi-
structured interviews, which contributed to the formation of the concourse, 
identified in participants a re-appraisal of values, numerous coping strategies, 
and adaptation to the disease.  The paper in chapter three 'HRQoL 
questionnaires are they fit for purpose?' (Reid et al; 2012) has demonstrated 
that there are aspects of the experience, which are represented poorly within 
HRQoL questionnaires. These are represented by the global themes, Quality of 
care and Reality. 
In its most basic form after the Q sorts had been completed there were 18 Q 
sort grids populated with statement cards, with a corresponding digital audio- 
recorded discussion by each participant associated with them.  The statement 
distributions were analysed using the P-Q method programme 2.1 (Schmolck, 
2002) and the comments generated from discussion of the placement of the 
statements were transcribed.  
The results are presented in three ways:   
 Factor matrix denoting defining sorts for each factor (Table 5.2 
Page 175) 
 Distinguishing statements with a significance value for each factor, 
(Figure 5.3 page 177-178)  
 Placement of statements for each factor, presented as a range 
from statements with most consensus through to most 
contention (Table 5.3 page 180-181) 
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The factor matrix Table 5.2 Page 175 of each Q sort demonstrates the 
individual’s concordance with each factor.  The level of agreement between the 
individual sorts gives insight into whether the participants share similar 
viewpoints.   A positive loading with a high score represents a typical example 
of the factor, conversely a negative loading shows that the participant rejects 
that particular factor. Each Q Sort has a score for each factor between one and 
zero and is a measure of the correlation that each sort has to each particular 
factor.  This means that Q-sort 1 is most correlated with factor one and possess 
a factor loading of 0.70, which is 70% of the positive factor one loading.     
The normalised factor scores produce the statements that most and least typify 
each of the factors; they are presented as Z scores and form part of the data 
presented in figure 5.3.   The statements need to be interpreted in the light of 
the other statements because it is the overall configuration that creates a more 
subtle meaning than a particular statement in isolation (Shemmings, 2006).  It is 
for this reason that more recently Watts and Stenner (Watts, 2012) have 
suggested that whilst the research has tended to focus on results for statements 
at the extremes of the grid, some of the central ones occupying the minus one, 
zero and plus one can also be enlightening because they might corroborate the 
reasoning behind the placement of some of the more extreme statements. 
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TABLE 5.1  BIO-DETAILS FOR ALL THE PARTICIPANTS 
Sort 
number 
Factor Gender 
 
Age 
at Q 
sort 
Employment Site 
 
T N Treatment modality Time of Q sort from 
last treatment 
(years:months) 
Total length 
of treatment 
(days) 
1 CS 1 M 55.10 IT manager Floor of mouth T3 N2 Surgery& 
Chemo,RT 
1.10 104 
2 SS 1 M 46.04 Unemployed 
metal worker 
Retro-molar 
Soft palate 
T4 N2b Surgery& RT 0.11 70 
6 MH 1 M 61.07 Salesman Tonsil T1 N3 Chemo,RT 1.03 103 
12MG 1 F 37.04 Accountant Buccal and 
mandible 
T4 N2b Surgery 
RT 
0.6 70 
13 KG 1 F 51.09 Catering business 
owner 
Tongue base T3 N1 Chemo RT 
& neck dissection 
.10 136 
14 RP 1 M 62.06 Retired policeman Tonsil T2 N2a Surgery & RT 1.0 48 
17 PW 1 M 64.06 Retired IT manager Larynx T3 N1 Chemo RT 
Surgery 
1.00 98 
9 AB 2 F 65.01 Retired health care 
worker 
Tongue base T4 N2c Chemo RT 
Plus neck dissection 
.04 167 
16 GHU 2 M 55.05 Dustman Tonsil T1 N1 Surgery 
RT 
.10 90 
4 GM 3 F 65.09 Retired care worker Tonsil T2 N2b Chemo RT 1.04 88 
5 EN 3 F 55.01 Office worker Tonsil T2 N1 Surgery 
Chemo,RT 
1.07 90 
18 JH 3 M 60.01 Salesman Oral Pharynx T3 N0 Surgery  RT 1.00 97 
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TABLE 5.1  BIO-DETAILS FOR ALL THE PARTICIPANTS 
 
 
 
 
 
 
Sort 
number 
Factor Gender 
 
Age 
at Q sort 
Employment Site 
 
T N Treatment modality Time of Q sort from 
last treatment 
(years:months) 
Total length of 
treatment 
(days) 
3 GG 4 M 77.06 Retired builder Oral tongue T1 N0 Surgery 1.0 0 
7 SN 4 M 61.07 Builder Larynx T3 N0 Surgery 1.0 0 
11 CA 4 F 58.07 Shop worker Larynx T2 N0 Surgery 1.01 0 
10 AS 5 M 40.02 Computer 
programmer 
Mandible T4 N0 Surgery 
RT 
.06 76 
15 KK 5 M 61.05 IT worker Floor of mouth T2 N1 Surgery 
RT 
.09 90 
9 BT none M 69.07 Retired driver Maxilla T4 N0 Surgery 1.0 0 
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Seventeen of the eighteen participants (94%) loaded onto one of the five 
factors.  No one person loaded onto two factors, an indication that the factors 
have a degree of independence from one another (Webler et al., 2009a).  The 
percentage variation accounted for by the five factors was 87 percent.  
 
TABLE 5.2 FACTOR MATRIX  
 
 
 
 
 
 
 
 
 
 
 
* = defining sort 
Each factor represents a group of individual points of view that are correlated 
highly with each other.  Any percentage of the study variance above 35-40 
percentage is considered a credible solution to the factors (Watts, 2012). 
 
 
 
Q  
       Sort 
Factor 
1 
Factor 
2 
Factor 
3 
Factor 
4 
Factor 
5 
1 0.7092*  0.3838  0.0809  0.3204  0.0659 
2 0.6743* -0.1689  0.4317  0.0005  0.2438 
3 0.1381  0.0304  0.2301 0.7660*  0.1605 
4 0.2145 -0.0843 0.6781*  0.1057  0.1255 
5 0.0544  0.3262 0.6743*  0.1653  0.0375 
6 0.8582* -0.0405  0.1736  0.2001 -0.0803 
7 0.1487 -0.2704  0.1121 0.6455* -0.0075 
9 0.0910 0.6103*  0.4766  0.1814  0.1956 
8 0.5984     0.0484     0.2089     0.6271     0.1521 
10 0.3482  0.1187 -0.0499  0.1236 0.7800* 
11 0.2600  0.1310 -0.0215 0.6691*  0.4597 
12 0.6518*  0.0597  0.0656  0.3881  0.2847 
13 0.6443* -0.0088  0.0949  0.2418  0.4051 
14 0.6396*  0.0948  0.4238  0.1839  0.3133 
15 0.0622 -0.0985  0.4527  0.3060 0.6992* 
16 0.0403 0.8471* -0.0881 -0.2151 -0.0313 
17 0.6058*  0.1180  0.4504 -0.1925  0.3164 
18 0.2288 -0.0639 0.6404*  0.1027 -0.0493 
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Five Factors were identified: 
1. Meaning and attachment to illness 
2. Overwhelmed by the cancer 
3. Change and recovery 
4. Surviving or not 
5. Keep control-greater good of others 
 
Figure 5.3 represents a summary of statistical data:  
 Distinguishing statements for each factor,  
 Eiganvalues   
 Z scores.  
 
The latter is a measure of how closely a statement is situated to the middle of a 
distribution.  Such that a Z score of -2.00 is 2 standard deviations from the mid- 
point of the distribution, and so would be to the left of the Q sort distribution grid.   
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Figure 5.3 DISTINGUISHING STATEMENTS FOR EACH FACTOR              
  
Factor            Number of respondents                          % variance       (Statement number) 
(eigenvalue)  loading to factor         Factor Name       accounted for         Statement                rank        z-score 
 
1          7       Meaning and  
(7.0796)                                   attachment of illness       39      26 It’s very hard to think about your             -3              -1.09** 
                    own possible death 
   
2                           2                Overwhelmed by the       10       41 Day-to-day existence is physically                 5               1.73**       
(1.7221)                                  cancer                                         exhausting 
         11 Little things like the car park or                      5               1.51**                  
              appointments being cancelled irritate me 
         37 I cannot do things on the spur                       3               1.38** 
              of the moment 
         38 I am much more irritable than     3               1.27** 
              I used to be  
         45 I am still in pain                                              1               0.35* 
         12 I wanted the team always to be honest        -2              -0.93** 
              with me 
         39 My appearance was much better than         -5              -1.84** 
               I expected 
         13 If you didn’t want to die there was no           -5              -2.07* 
               choice but to have treatment 
 
 
 
 
 * Indicates P<. 05    ** Indicates P<. 01 
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Figure 5.3 DISTINGUISHING STATEMENTS FOR EACH FACTOR             
 
Factor            Number of respondents                          % variance            Statement number 
(eigenvalue)   loading to factor          Factor Name       accounted for              Statement               rank z-score 
 
3       3                    Change and recovery      8                 1 I recovered much slower physically           4 2.00** 
(1.3900)         than I expected 
                24Once I knew they could do something       4  1.97* 
          about it that’s all I needed to know 
               13 If you didn’t want to die there was              1  0.03** 
          no choice but to have treatment 
               38 I am much more irritable than             -3 -1.40* 
          I used to be 
               29 I never think of myself as ill            -4 -1.46** 
               15 I’ll talk about things that I wouldn’t                     -4 -1.48** 
          have done before my diagnosis 
4     3      Surviving or not  24       42When I talk it doesn’t feel like me      2  1.05** 
(1.2857)         anymore 
               33 I never appreciated how long it would   -2      -0.90** 
          take to get better 
                 1 I recovered much slower physically    -2      -1.04** 
          than I expected 
                14It’s so hard waiting to heal     -3       -1.11** 
                45I am still in pain      -5 -2.31* 
5    2      Keep control - 
(0.9950)                greater good of others      6        22I felt very vulnerable when I was     4 1.43** 
                    in hospital 
               40 I worried a lot how others would cope      3 1.33** 
 
*   Indicates P<. 05    ** Indicates P<. 01 
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Eigan values of less than 1.00 are taken as the cut-off point for the retention of 
factors. Closer inspection of factor five revealed that there was a significant and 
different factor story with coherence that was being told by this group and 
therefore it was decided to leave this factor in. Five statements were statistically 
significant consensus statements and were towards the centre of the 
distribution. Table 5.3 displays the statement scores that are consensus 
statements between the factors.  
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TABLE 5.3 STATEMENTS FOR ALL FIVE FACTORS ARRANGED FROM CONSENSUS TO CONTENTION. 
 
T 
No Statement Factor  Range 
  1 2 3 4 5  
F&R34 Life will never be the same again 1 0 1 0 0 1 
R 16 I have to be careful to not upset people -1 -2 -2 -1 -2 1 
R   17 You should never have to face this sort of thing on your own 2 2 3 4 3 2 
R 23 I didn’t understand what was meant by the treatment until I had it 0 0 0 2 0 2 
F&R 19 No two patients are the same 1 1 -1 -1 0 2 
R 4 When I was told I had the cancer I knew I had to face it 3 2 2 4 4 2 
R 6 I didn’t want people to know what had happened to me -1 -3 -1 -1 -3 2 
R 36 I wish I’d never been treated -5 -3 -5 -5 -5 2 
F&R 10 You just become really grateful for different things 2 -1 0 0 0 3 
R 31 I cannot have a good argument now -2 -3 -3 -3 -5 3 
R 30 Everyone around me was so upset 0 -1 -1 1 2 3 
R 40 I worried a lot how others would cope 0 0 0 0 3** 3 
R 44 It’s hard to remember things you’re told -2 2 -2 1 -1 3 
R 5 It really affected my confidence -2 0 -1 2 1 3 
F&R 27 I do things but on my terms 1 -1 -2 -2 0 3 
R 32 I felt very alone -4 -2 0 -2 -1 3 
F&R 25 It’s just as well you don’t know what’s going to happen you -3 -1 -1 0 -3 3 
R 21 I never felt like a number I was always treated as an individual 4 5 2 3 1 4 
R 26 It’s very hard to think about your own possible death -3** 1 2 1 1 4 
R 20 I was most frightened when I came out of hospital -5 -4 -1 -1 -1 4 
F 28 Being cured of the cancer is still the most important thing 5 3 5 5 1 4 
R 7 No one can really understand what has happened to me 0 1 1 -3 -3 4 
F&R 9 Life is hard you just have to get on with it 1 -2 3 0 1 5 
F18 I never read the written information I was given 0 -2 1 0 -4 5 
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No Statement Factor Range 
R 43 I always think that people are staring at me -2 0 -5 -3 -1 5 
R 8 You never think it could happen to you 1 0 -2 3 2 5 
F35 It’s amazing how much you can adjust to all the physical changes 3 -1 2 -1 2 4 
F42 When I talk it doesn’t feel like me anymore 0 -3 0 2 -2 5 
F2 I felt physically very isolated -3 2 2 0 -2 5 
F&R 3 Any symptom I get I always think the cancer might be back -2 3 -1 3 0 5 
R 15 I’ll talk about things that I wouldn’t have done before my diagnosis -1 1 -4** -2 -2 5 
F14 It’s so hard waiting to heal 1 2 3 -3 2 6 
F45 I am still in pain -1 1* -3 -5 -2 6 
R 38 I am much more irritable than I used to be -1 -3** -3 0 -1 6 
F1 I recovered much slower physically than I expected 2 1 4** -2 1 6 
F11 Little things like the car park or appointments being cancelled really 
irritated me 
-3 4** -3 -1 -1 7 
F39 My appearance was much better than I expected 2 -5** 0 2 1 7 
R 29 I never think of myself as ill 3 0 -4** 1 2 7 
F 37 I cannot do things on the spur of the moment 0 3** -2 -4 -4 7 
R 24 Once I knew they could do something about it that’s all I needed to know 2 -2 4* 2 -3 7 
R 33 I never appreciated how long it would take to get better 3 4 5 -2 2 7 
R 12 I wanted the team always to be honest with me 4 -2** 3 5 5 7 
R 22 I felt very vulnerable when I was in hospital -4 -4 1 1 4** 8 
R 41 Day-to-day existence is physically exhausting -1 5** 0 -4 -2 9 
F&R13 If you didn’t want to die there was no choice but to have treatment 5 -5** 1** 3 5 10 
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These consensus statements suggest that participants do not feel as though the 
experience of disease and treatment had been catastrophic.  They were not 
secretive about the diagnosis that they had had, they believed that it was not 
the sort of thing to be faced alone, and they did not feel that they had to be 
careful not to upset people they knew.  Each factor will now be interpreted 
based on the sorts that loaded to the factor.  Q methodology convention 
identifies statements by their number and their position in the Q sort.  The 
statement number, followed by the position on the grid, is placed within a set of 
brackets.  This style of presenting the statement results will be used within this 
study.   
 
FACTOR 1: MEANING AND ATTACHMENT TO ILLNESS 
Seven subjects were associated significantly with this factor, five men, and two 
women.  This factor was identified as the one which seems pragmatic but will 
have interpreted the diagnosis and treatment in their own way.  They think that 
that being cured of cancer is the most important thing (28: +5) and strongly do 
not think that there was any choice but to have the treatment offered (13: +5). 
‘When I was diagnosed it just went bang in my head, but you have to get on 
with it’  
Sort number 1: 1.1-1.2.  (The figures for each text quoted is presented as the 
page number followed by the line number from the start to the end.) 
 
Their attitude was reiterated by them agreeing that once they knew treatment 
could be offered that was all they needed to know (24:+2) and further re-
enforced by an equally strong rejection of the idea of wishing they had never 
been treated (36:-5).
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There was one statement that was a defining statement for this factor presented 
in Table 5.4. It related to the group’s apparent rejection that it was hard to 
consider their mortality as a result of the diagnosis and treatment. The four 
other factors agreed slightly with the statement, whilst factor one subjects quite 
strongly did not.   
TABLE 5.4  DISTINGUISHING STATEMENT FOR FACTOR 1  
                                                                                                                
Factor 
Statement 1 2 3 4 5 
16 Its very hard to think of your own 
possible death  
-3** 1 2 1 1 
**=P<.01 
 
They appreciated that they had to face the fact they had cancer (8+3) but were 
ambivalent towards the concept that others truly understood what had 
happened to them (23:0).  One of the participants who completed their Q sort 
reflected, during their review of the statements, that from their perspective they 
had heard about acquaintances having cancer and how they would not really 
understand the true implications of it.  They had been polite, but the impact of 
other people’s diagnosis that they had experienced previously had been 
somewhat superficial.   
‘I think everybody in general cannot take on board other people’s symptoms 
and its only really if they are close to you.  You hear it so many times; so and so 
has cancer or whatever, and you say “oh dear I’m sorry” but you never really 
have any real understanding of those words……’  
Sort number 13: 1.19-2,5   
 
They wanted strongly that the team caring for them would be honest with them 
(12:+4),  
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‘I wouldn’t have wanted someone to give me false hope …….you need to put it 
(the disease) in perspective in your own mind ….gives you an understanding of 
where you are on the spectrum’   
Sort number 13:  5.21-5.25  
 
They had no feeling of being treated by the team in an anonymous way (21: 
+4).  Their positive experience of the process was further illustrated by their 
belief that they did not feel vulnerable whilst in hospital (22: -3) and strongly 
refuted feeling frightened when they left hospital (20: -5). These participants did 
not feel alone (32: -4) or think they were physically isolated (2: -4). The Meaning 
and Attachment to Illness group did not particularly have a strong view that 
patients were the same (14;+1); had an indifferent response to a change in self  
(42:0), or worrying how others would cope (40:0), or that the people around 
them were not upset (30:0). They did however, have a different emphasis on 
what mattered to them (10:+2).  They thought but did not find themselves 
talking about topics they would previously have avoided as a consequence of a 
life threatening diagnosis (15; -1).  They did not agree to a vulnerability of being 
likely to attribute a symptom they had as a possible recurrence (3: -1).  This 
vague thought was substantiated by the view that they did not think specifically 
about their own mortality as a consequence of the H&NC diagnosis (26: -3). 
 
‘Possible death? Well I’ve been in the Royal engineers and a special constable 
…..in the army we were fired on once …I thought I’d been shot I was screaming 
on the floor and the medic came and said “you’re fine don’t worry get up it’s OK” 
and I said “I can feel a warm liquid on my leg” and he said ” yeah that’s your 
water bottle that saved you”.   The bullet had scudded the water bottle not me 
so my number still wasn’t up no bullet with my name on it….’  
Sort number 4:  1.26-2,25.   
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The experience was however by no means easy for anyone.  They had a poor 
appreciation for how long it would take to heal (7;+3) and they took much longer 
to heal than they expected (1:+2)  They knew they did things on their own terms 
(14;+2) and thought that no one should ever have to face the experience of 
H&NC and its treatment on their own (17;+2).  
 
 
FACTOR 2: OVERWHELMED BY THE CANCER  
Two subjects were significantly associated with this factor.  These participants 
felt isolated physically (2:+2) and they thought it  hard waiting to heal (14:+2).  
Despite their particular thoughts related to poor physical recovery they are 
ambivalent about describing themselves as ill (29:0).  They thought strongly that 
they were treated as an individual by the medical team caring for them (21;+5) 
but did not want the team to be completely honest with them  (12:-2).  They 
found it hard to remember what was said to them (44:+2), which is why they 
were more likely to rely on the written information provided (18: -2).  This aspect 
is reinforced by the view that they don’t think that once a treatment plan has 
been devised, that’s all they needed to know (24:-1).  For them there are many 
more details that have to be understood.   
They did not think that anyone should have to deal with the experience on their 
own (17:+2), but personal isolation is exacerbated, because they think no one 
can understand what has happened to them (7:+1). They did not feel vulnerable 
in hospital (22:- 4), or frightened out of hospital (20:-4), but were strongly  
irritated by health processes (11:+4) and would acknowledge that they are 
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generally more irritable (38:+3).   They never appreciated how long it took to get 
better (33:+4) and cannot do things on the spur of the moment (37:+3).  They 
strongly did not think that they had adjusted well physically, (35:-1) but like all 
the other factors had no difficulties with people knowing what had happened to 
them (6:-4).   
They disagree strongly that there was no choice but to have treatment (13:-5)  
‘I can’t understand not being treated, on a bad day I can. I feel guilty though- I 
don’t think about it a lot- but to have no treatment.  Being cured of cancer and 
when I was told the cancer was there I had to face it- means there is no choice 
so I have to get on with it.  The two paths are different alive or dead’  
Sort number 9:  3.7- 3.13 
 
The participants who loaded to this factor seemed very limited by the physical 
aspects of their disease and treatment.  They felt their existence was physically 
exhausting (41:+5), which would in part explain why they could not do things 
spontaneously and were in pain, this was more than any of the other groups  
(45:+1).    The real hopelessness is expressed in the interview with participant 
16.  
‘Unless you’ve been through it that battle of emotions they just can’t appreciate 
the ups and downs.  I just feel very vulnerable- I’ve given up work……..no one 
can understand what’s happened to me ….I don’t think anyone, unless you 
experience it what it actually does to you mentally or physically’  
Sort number 16: 2.33-2.38  
 
This was also the group who had not had their expectations met with reference 
to their physical appearance (39:-5).  It is of note that neither of the participants 
had needed extensive surgery to their oral cavity.  Whilst one had had a neck 
dissection, they both had been treated primarily by chemo-radiotherapy.  This 
treatment is routinely described as organ preserving, and might be thought to 
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be less mutilating than surgery.  This was despite them still identifying with what 
they sounded like when they talked (42:-2). 
 
There were eight statements that were defining from a statistical significance 
perspective, which are represented in Table 5.6.  All of these significant 
statements build a picture of being overwhelmed by the disease.  They were the 
group who wanted the team to recognise their weakness and to temper their 
honesty at times.  They trusted the teams to decide how much more information 
they could cope with.   
 
TABLE 5.5 
DISTINGUISHING STATEMENTS FOR FACTOR 2 *=P<0.05 **=P<.01       
                                                                                                 Factor                                                                                                               
Statement 1 2 3 4 5 
Day to day existence is physically  
exhausting 
-1 5** 0 -4 -2 
Little things like the car park  
and appointments being changed annoy me 
-3 4** -3 -1 -1 
I cannot do things on the spur of the moment 0 3** -2 -4 -4 
I am much more irritable -1 3** -3 0 -1 
I am still in pain -1 1* -3 -5 -2 
I wanted the team always to be honest with 
me 
 
4 -2** 3 5 5 
My appearance was much better than I  
thought 
2 -5** 0 2 -1 
If you didn’t want to die there was no choice  
but to have treatment 
5 -5** 1 3 5 
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FACTOR 3: CHANGE AND RECOVERY  
Three subjects were associated significantly with this factor- two females one 
male.   Factor three participants strongly think that being cured of cancer is still 
the most important thing (33:+5) and refute strongly that they wish they had 
never been treated (36:-5).  When they knew something could be done that was 
all that mattered (24:+4), and they knew that to have treatment was the only 
option (13:+1).  This was in great contrast to factor two, overwhelmed by the 
cancer, who had scored the same statements as -2 and -5 respectively. 
 
They did not find the treatment easy, but seemed to take the view that 
realistically they just had to get on with it no matter how bad it was.  They 
seemed to have the end point in their sights   
‘That horrible mask…. I got through it with will power I had to have the treatment 
to have the treatment I knew I had to wear the mask and that’s that.’  
Sort number  4: 4.33-5.3 
 
They disagree strongly that people stare at them (43:-5) and they are 
ambivalent about the effect the treatment and disease has had on their 
appearance (39:0).  This group strongly think of themselves as ill (29:-4).  They 
also think they recovered much more slowly than they expected (1:+4) but have 
got to a point where they are not really in pain (45:-3).  
 ‘The last time I was in hospital was 18th October and I thought there was a 
possibility of going back to work before Easter.  Even then … I thought once I’m 
off that tube (Nasogatric tube) I’ll be up and away and off I’ll go; and the first 
meeting I had about going back to work was the April the following year.’  
Sort number 6: 1.34-1.40 
 
They did not think that the treatment had meant that they talked about things 
they would not have done previously (15:-4).  They found it hard waiting to heal 
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(14:+3) but were surprised at how well they were able to physically adjust     
(35:+2).  They experienced vulnerability in hospital (22:+1) but were not 
frightened when they were discharged (20:-1).   They felt physically isolated (2: 
+2) and agreed that they never read the written information they were given 
(18;+1). 
‘I never read the info.  I guess I didn’t want to know …….my wife read up on it I 
just did not want to know, it was as if the detail didn’t bother me I wanted to 
know a little bit but when they give you a book that thick on neck dissection that 
was of no interest’  
Sort number 18: 1.1-1.7   
 
This placement of the statement compliments and helps to explain statement 24 
‘once I knew they could do something that’s all I needed to know’ (24:+4).  
 It seems their resources were focused on the reality and the present, and that 
they were unable to cope wth any more information apart from what they dealt 
with currently.  They were also ambivalent about understanding the treatment 
until they had experienced it (23;0), but expressed this with more detail to 
suggest they were not prepared for the changes they experienced. 
‘No, nothing like the reality the long term effects are not particularly explained 
the fact I am numb from the top of my ear, puffy round the neck that was never 
really explained……’ 
Sort number 18: 1.10-1.14  
 
They thought they were treated as an individual (21:+2) and did not find it hard 
to remember what they were told (44:-2).   This was perhaps important in the 
light that they were not likely to read the information they were given.  
‘We hung on every word my partner, my sister, my brother, we are from the old 
school the consultants are God.’  
Sort number 5 2.8-2.9 
Table 5.8 presents the distinguishing factors for factor 3. 
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TABLE 5.6 
DISTINGUISHING STATEMENTS FOR FACTOR 3 *=P<0.05 **=P<.01       
 
 
The statements suggest that this group identified strongly with being ill, but just 
wanted something to be done.  They were, however, more irritable and didn’t 
feel they talked about different topics since their diagnosis.  They did think it 
was possible for them to be diagnosed with cancer (8:+2)  
‘I always thought it could happen to me.  Both my parents died of cancer so I’d 
be stupid not to think that after the CT scan.’  
Sort number  5: 2.33-2.35 
 
Despite having had close family members who had had cancer and been 
treated they did not think that any symptom they had was a recurrence of the 
disease (3:+1) but they admitted that it is hard to contemplate their own death 
(26:+2) and this also meant they thought that life would not be the same again 
(34 +1).   
They also thought that people cannot understand what has happened to them 
(7:+1).  They were ambivalent about feeling exhausted physically (41:0) or 
Statement 1 2 3 4 5 
I recovered much slower than I expected 2 1 4** -2 1 
Once I knew they could do something  
that’s all I needed to know 
2 -2 4* 2 -3 
If you didn’t want to die there was  
no choice but to have treatment 
5 -5 1** 3 5 
I am much more irritable than I used to be -1 3 -3* 0 -1 
I never think of myself as ill 3 0 -4** 1 2 
I’ll talk about things that I wouldn’t  
have done before my diagnosis 
-1 1 -4** -2 2 
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being isolated physically (32:0).  They were also ambivalent about others 
coping (40:0), or being grateful for different things (10:0).  
This factor, change and recovery, seemed to present an image of not 
researching the disease and treatment, being reliant on the MDT for the 
information, and accepting that it was perfectly possible for them to have 
cancer.  They were aware they had been through a quite terrible process but 
seemed to have recovered to a point where they were not preoccupied by 
insidious and pervasive symptoms.   
 
 
FACTOR 4: SURVIVING OR NOT   
Three subjects were significantly associated with this factor- two male one 
female.   All of the participants in this group underwent a single modality of 
treatment.   Therefore, after they were discharged from hospital from their 
definitive surgical treatment, they believed they were able to be on a trajectory 
of recovery.  
It is of note that the sort number 9, who did not load onto any of the factors, was 
closest to the factor four experience with a factor loading of .0627.These 
participants thought that honesty from the team was paramount (12:+5) and that 
being cured of cancer was the most important thing (28:+5). They had no 
regrets at all about having treatment (36: -5) and they were not in pain (45: -5).  
They thought strongly that you should not have to face the experience  
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alone (17:+4) and knew that when they had been told the diagnosis that they 
had to face it (4:+4). 
‘All I wanted to do was get it out of my body”…I had a choice I could have had 
radiotherapy and all I could think was no I just want it out of my body.’  
Sort number 11: 3.16-3.20  
 
‘I know I had to have the treatment, I didn’t want to die so no choice….but 
awkward to think about’  
Sort number 7: 2.23-2.24 
 
Being cured of cancer, they thought, was still the most important thing (28:+5), 
and they wanted the team to be honest with them (12:+5).  They could still be 
impulsive (37:-4) and they did not think that day-to-day life was exhausting 
physically (41:-4).  They thought they recovered quickly (1:-2) but did not think 
that they had appreciated how long it would take to recover (33:-2).  They did 
not feel alone and (32:-2) and did not think they needed to do things on their 
own terms (27:-2).  This group thought that it would never happen to them      
(8:+3) and thought that any symptom they experienced was likely to be a 
recurrence (3:+3).   
‘Once you’ve had it there’s a fear at the back of your mind..and you hear of 
people and talk to people that have had cancer and it comes back and I think 
will that be me?’   
Sort number 11: 1.11-1.15 
 
Physically it did not feel like them when they talked, (42:+2) but their 
appearance was much better than they expected (39:+2). This was an 
interesting idea because this factor had a participant who loaded to it who had 
had a laryngectomy.  It might have been assumed that they had had a great 
deal of body image changes to cope with, and yet this participant scored his 
treatment as leading him to have a better physical appearance than the factor 
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two group, overwhelmed by the cancer, who had had chemo-radiotherapy.  
They did not understand what was meant by the treatment until they had it 
(23:+2) and don’t have strong thoughts about reading the written information 
they were given, (18:0).   This aspect is also in stark contrast to factor two and 
factor five who did read the literature given to them.    
For some of the patients it was standard practice (from national guidelines) that 
they should have an opportunity to meet patients who have had a similar 
operation to the one that they are going to have.  However, even with this most 
tangible piece of information, one of the participants was unable to understand 
the reality of the operation, and in effect got little from the meeting.   
‘I didn’t understand what happened to me even when I spoke to a guy who had 
had it; (a laryngectomy) it went over my head, when I left the appointment I 
didn’t know where I was.  I met him and it made no sense.’  
Sort number 7:  1.11-1-13 
 
This group didn’t find it hard to be waiting to heal (14:-3) and did not feel that 
they recovered physically much more slowly than expected (1:-2).  They did not 
mind others knowing what had happened to them (6:-1) and they were not 
annoyed by the process of the health-care they received (11:-1).  They were 
ambivalent about life that life would never be the same again, (34:0) and of 
experiencing physical isolation (2:0) but there is still a sense of change and 
adjustment and reflecting on the impact of the disease and treatment. 
‘You do just have to get on with it.  I felt isolated to start with and then it got 
easier, but people I have known all my life you look at them and they have no 
idea and you think…..(looks into middle space) well it’s their choice.’  
Sort number 7:  7  2.3-2.5 
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The distinguishing factors for this group show elements of change and recovery 
and reflect the single modality treatment of surgery to recovery. 
 
TABLE 5.7 DISTINGUISHING STATEMENTS FOR FACTOR 4 *=P<0.05  
**=P<.01  
 
FACTOR 5: KEEP CONTROL - GREATER GOOD OF OTHERS 
Two subjects, both male, were associated significantly with this factor. This was 
the factor that had by a very small margin, an eigan value of less than one.  But 
review of the presentation of the statements suggested that they were a 
discrete group presenting a different story of the experience.   
 
TABLE 5.8 DISTINGUISHING STATEMENTS FOR FACTOR 5 **=P<.01 
                                                                           Factor   
Statement 1 2 3 4 5 
I felt very vulnerable in hospital -4 -4 1 1 4** 
I worried a lot how others would cope 0 0 0 1 3** 
 
 
This group strongly thought there was no choice but to have treatment (13: +5) 
and wanted the team to be honest with them (12:+5).  They read all the 
literature  
Statement 1 2 3 4 5 
When I talk it doesn’t feel like me 0 -3 0 2** -2 
I never appreciated how long it  
would take to get better 
3 4 5 -2** 1 
I recovered much slower than I expected 2 1 4 -2** 1 
Its so hard waiting to heal 1 2 3 -3** 2 
I am still in pain -1 1 -3 -5** -2 
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‘It was the easiest choice (to have treatment) I made because there was no 
choice.  Once I knew something could be done I wanted to know all the ins and 
outs of every little detail, all the jargon, I wanted to know, on the assumption I 
would get over it I wanted to know how I would be.’  
Participant 15 1.12-1.19 
 
They disagreed strongly with the thought of never being treated (36:-5) and 
were very active communicators such that they felt they could still have a good 
argument  (31:-5) even with a temporary tracheostomy in-situ, three days post 
surgery.  
‘I had a row using capital letters on my paper with the ward sister’  
Sort no 10: 4.39  
 
This group expressed a sense of vulnerability in hospital (22:+4).    
‘Coming out of hospital was frightening but I was equally frightened in hospital, 
because you had no control over what happened to you so you were totally 
reliant on other people you put your life literally in someone else’s hands.’   
Sort no 15: 1.31-1.35  
 
They don’t think that they are restricted from doing things on the spur of the 
moment (37:-4), read the written information they were given, (18:-4) and don’t 
think that ignorance would mean you could cope better with the experience 
(25:-3).  They were not frightened when they were discharged (20:-1) and 
worried how others would cope, (40:+3) a significant value, with an 
acknowledgement that those around them were upset (30:+2).  They are also 
amazed how much they have adapted to the physical changes (18:+2) but 
qualified this by saying: 
 
‘I’ve adapted and tried to adjust …It was slower than I would have liked I would 
have expected it to be physically exhausting but it’s not now and you get to 
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know your limitations you become much more aware and very wise but it’s so 
hard.’   
Sort number 15: 2.12 -2. 
 
They felt it was hard waiting to heal (14:+2) and agreed that you should not 
have to face the treatment on your own (17:+3). This factor talks about things 
that prior to their diagnosis they would not have done (15:+2).  
‘I have had 40 years of being a good corporate citizen somewhat 
repressed…but now I do not need to deal with the mundane and idiosyncratic 
parts  of the corporate world’  
Sort number 10: 2.8-2.12 
 
They did not think it could happen to them (8;+2) and do not think of themselves 
as ill (29+2) despite having extensive treatment.   
‘I never thought of myself as ill going in or coming out I limped around couldn’t 
open my mouth properly- all the accoutrements of illness- but without feeling 
particularly ill; so it’s not like I have a long-term disease even though I can still 
visualize a fixed chunk of time as opposed to a chronic condition…some people 
do define themselves by their illness this does not define me at all my values 
define me and none of those include being ill’  
Sort number 10: 2.31-3.9 
 
These participants do not see being cured of cancer as the most important 
aspect of their experience (28:+1).  They did not have such a strong sense of 
being treated as an individual (21:+1) by the clinical team.  They are not 
concerned that people stare at them (43:-1), did not think they were more 
irritable and were not irritated by changes of appointments (11:-1).   They did 
not think they were more irritable in general (38-1).   
However, there is the sense of a higher role within this system of needing to 
check for others that processes are working properly, keeping control. 
‘When an appointment gets cancelled and gets pushed back by 2 months I 
phone up and they say “oh no we can give you an appointment the next day …I 
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do get annoyed for other people who can’t do that (phone )and might think fine I 
don’t need to see him for 2 months- that’s fine meanwhile the condition might  
not be as controlled as mine and might cause a clinical risk.   I get wound up for 
other people, on behalf of the greater population -my desire to fix things’  
Sort number 10: 3.13-3.41  
 
This group seemed to struggle with handing over their health to others.  They 
found it difficult to trust the teams and this was to such an extent that they felt 
much more vulnerable in hospital (22:+4).  They were also, perhaps because of 
the lack of perceived control likely to question their care.  They seemed to find 
the need to test out the system and then comment on it from a system and 
future patients’ perspective. 
This chapter has presented the results from the Q study.  Chapter six discusses 
these results further and explores the clinical implications and its context in 
terms of current healthy policy. 
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CHAPTER 6 
DISCUSSION AND CLINICAL IMPLICATIONS OF THE STUDY 
This study has presented evidence to describe how patients experience both 
the disease and treatment of H&NC.  It has identified that these experiences are 
varied and described them in detail.  Patients who have had a diagnosis of 
H&NC have generated this detail.  The results counterbalance the remarks by 
Kennedy (2003) that health-care is provided by consulting HCPs, not patients, 
and by underlining the human aspects of the experience that Porter, (2003) 
suggested were being lost if hospitals performed medicine as medicine 
demands it, not as patients  need. 
 
 
DISCUSSION OF THE FACTORS 
The discussion of the five factors illustrates the relational aspects of the 
experience for patients, described in the document ‘What Matters to Patients’ 
(King’s Fund 2012).  The report suggested these aspects of care are under-
represented in research.  Seven participants loaded to the first factor labelled 
‘Meaning and Attachment to Illness’, they were in no doubt that their diagnosis 
was momentous and wanted to be treated for the disease.  They seemed to 
have weighed-up the impact of disease and treatment even though this was 
hard: 
“You might not want to believe it but that’s different from not having it explained 
to you”.  
Sort number 1: 1.15-1.16  
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They did not feel that anyone else understood what had happened to them, but 
they could relate the reactions of others to how they had felt prior to their 
diagnosis if they had heard of acquaintances had a diagnosis of  cancer.   They 
recognised the importance of their team being honest with them.  One 
participant qualified this by acknowledging that sometimes it was right that the 
team were not always honest.  He recalled having a surgical drain removed 
from his neck after his operation. 
“They said it wasn’t going to hurt when they took the drain out, it did, but what 
are they supposed to say?   This is going to hurt a great deal so just tense up 
and watch how painful it can be……….”(ironic laugh).  
Sort number 1: 1.22-1.24 
 Their expectations of the team were enhanced by them experiencing care that 
they felt was at an individual level.  This group seemed to have been able to 
manage to cope with both the information and the symptoms that they 
experienced so that they were able to be ambivalent around a change in 
themselves from the experience.  This meant they were not aware of talking 
about different things with their family after their treatment, and did not consider 
that this was the first time they had felt the need to contemplate their own 
mortality.   
“I fairly much believe tomorrow’s going to happen and you are going to have to 
get through tomorrow and the day and week after and thinking and curling in a 
corner and not facing it you know moaning about it won’t change a thing, and I 
s’pose if my mother used to say if moaning would change it I’d moan night and 
day but it won’t so get on with it and that was the sort of ethos I was brought up 
with ,……there is not a plan B” 
Sort number 6: 2.21-2.29 
 
These participants had adjusted to their experience so well that they were not 
likely to fear that a symptom they experienced after their treatment was 
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recurrence.  The surveillance out patient appointments were summed up by one 
participant as: 
 
“Seeing Mr P (participant’s surgeon) ……….if you like what ever will be will be if 
it’s going to come back seeing Mr P or not seeing Mr P won’t stop it, but me 
seeing Mr P might mean he can do something about it ……….”     
Sort number 6: 4.19-4.22 
 
There seemed to be a realistic decision made by the participant that there were 
limitations of what could be done by the MDT but that there was a need to stay 
engaged with the system in order that clinical decisions could be made.  Such 
an opinion could not be said to be a manifestation of denial around either the 
existence of the disease or treatment experienced.  They were aware that they 
took much longer to heal than they had expected, and used a lot of their 
energies to concentrate on recovery. 
 
The second factor, labelled ‘Overwhelmed by the Cancer’, is in stark contrast to 
all the other factors.  The two participants who loaded to it had symptoms that 
dominated their existence, which they felt no one understood.  They seemed 
frail both emotionally and physically and were unique in this study group in their 
belief that for them there had been a real choice about accepting or refusing 
treatment. It seemed the active aspect in their care extended to the ultimate 
choice of choosing to be treated 
 
“I can’t understand not being treated, ……on a bad day I can, I don’t feel guilty 
about that though – I don’t think about it a lot but to have no treatment being 
cured of cancer ….. when I was told the cancer was there I had to face it means 
there is no choice so I have to get on with it. The two paths are different alive or 
dead.”  
Sort number 9: 3.7-3.13  
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They trusted the clinical team and made the assumption that the team would be 
aware when they could cope with information. This trust extended into their 
hope that at times they might expect the team to choose not to tell them too 
much information too quickly, because they would be unable to deal with the 
consequences of it.  They felt that their care was individual and had a sense 
that the communication between team members was such that they felt 
supported well enough by the team.   Despite their evident frailties, they were 
not at all passive in their care and sought dialogue actively about their care.  
They demonstrated this active aspect by agreeing that they read and 
assimilated information prior to further consultations so that they could discuss 
their care with a general understanding of the topic.   
This group appeared overwhelmed by the day-to-day aspects of the symptoms 
that they could describe: 
“I need to be hopeful ……………..I still feel there is room for recovery so that’s 
why I am trying to be hopeful I don’t want to get carried away it’s trying to keep 
a balance    like my speech, now I have written very little down (during this 
interview), which is a surprise ……. I feel exhausted around my neck all the 
tightness the compression”.   
Sort number 9: 2.20-2.28 
 
These unremitting symptoms make it easier to understand why they might 
become irritated and worn out by processes.  They were exhausted physically, 
aware of a change of body image, in pain, unable to do things on the spur of the 
moment, felt very isolated and more irritated in general.  
 
Neither of these participants had needed extensive surgery and had not 
undergone surgical reconstruction; they had been treated with chemo-
radiotherapy but struggled with their change of body image.   This is an 
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important aspect to highlight.  Chemo-therapy has been described as an organ 
preserving technique and yet the participants, who had received this and not 
had reconstructive surgery reported a change in body image that was greater 
than the other participants.  The fibrosis (scarring from the treatment that alters 
the composition of the soft tissues in the head and neck region) had led the 
patients to feel that their body image had been altered.  
The third factor, labelled ‘Change and Recovery’, represents another distinct 
way of experiencing H&NC and its treatment.  This group of participants wanted 
to get on with the treatment with little information.  Knowing that something 
could be done and being cured of cancer were strong themes.  Unlike factor two 
they were not as engaged with what they thought were the nuances of 
treatment planning.  They seemed to have a day-at-a-time approach and tried 
to stay as resolute as possible during indescribable treatments.  They were not 
aware of people staring at them and were ambivalent that their appearance had 
changed.  This group seemed to deal only with situations as they arose, but 
when they arose they were sensitive to lots of different cues, verbal and non-
verbal.  Sort number 5 described her experience of ultra sound guided biopsy: 
“You are vulnerable to the non-verbals because you are looking for signs of 
what’s going on and if people are behaving differently with you and appearing to 
be hiding things in a way I’m just thinking if someone were to say “we can see 
something on the screen that’s what is on the screen”  because you knew there 
was going to be something on the screen because that was what they were 
trying to biopsy the issue was if we are looking for something that is in your 
neck is this malignant? Is it cancerous? or is it a cyst? So they could have at 
least got to the point of being able to describe to you “OK we can see what we 
are trying to get at” whatever -you knew that bit” 
Sort number 5: 6.24-7.8 
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Fear of recurrence was not a constant worry and in the context of other 
experiences was only thought about slightly.  This group presented an image of 
not researching the disease and treatment, being reliant on the MDT for the 
information, and accepting that it was perfectly possible for them to have 
cancer.  They were open about not reading the information: 
“I never read the info I guess I didn’t want to know …….my wife read up on it I 
just did not want to know, it was if the detail didn’t bother me I wanted to know a 
little bit but when they give you a book that thick (uses thumb and index finger 
to illustrate an inch) on neck dissection that was of no interest.”  
Sort number 18: 1.1-1.6 
 
 They were aware they had been through a terrible experience but seemed to 
have recovered to a point that they could see they would be as good as they 
could be but this did not mean back to pre-morbid levels.  The following excerpt 
illustrates that this participant recognised that. 
 
“I was walking up Kidderminster and people were coming out of Greggs eating 
sausage rolls and pasties and it was difficult I wouldn’t even have done that and 
it’s because it’s been taken off me its imposed on me and makes me feel very 
different.”  
Sort number 18 2.26-2.31 
 
This participant also knew he would not improve and realised that there had 
been a double dip from the surgery to radiotherapy.  There was sense that 
change and recovery did not mean back to normal.  Iit did mean back to 
functioning. 
 
“I thought I had been through the worst (after the surgery) and it turned out that 
there was worse (radiotherapy) and that you don’t get better.” 
Sort number 18: 2.12-2.14   
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Factor four, labelled ‘Surviving or Not’ was able to be categorical about some of 
their symptoms.  They were not in pain, had no regrets in having treatment, and 
felt that being cured of cancer was paramount.  They were not trying to avoid 
the news of their diagnosis and knew strongly that they had to deal with it.  This 
group seemed to have some normality in their lives.  They could be 
spontaneous and were not exhausted on a daily basis from their symptoms, but 
had insight into the fact that their life was different.  It seemed that despite their 
treatment they had returned to pre-morbid routines.  They admitted surprise that 
they had been diagnosed with cancer, something they had never contemplated, 
and had at the back of their minds the constant worry of any symptom they 
experienced being recurrence. 
 
Sort number 3, with the smallest of the oral tumours diagnosed, who had a 
primary closure rather than needing a flap, was fearful of recurrence and 
expressed it in the following comments: 
“This (looking at the statement 3) ‘Any symptom I have I think is the cancer 
coming back’ is obviously still an issue any symptom I get I think the cancer 
might be back…………………………..I always feel there is a possibility that it 
might come back and therefore  I feel in any pains down my neck or anything 
like that it does concern me, but my surgeon said I’m doing so well and instead 
of seeing me once a month he’s seeing me every 8 or 10 weeks, although 
originally he said I’ll see you once a month for the first 12 months and then 
stretch it out.” 
Sort number 3: 8.8-8.20 
There is a sense that he was disconcerted in the change of management in the 
review periods.  This group healed within their expected time-frame, and did not 
seem irritated by the health-care processes that might need altering.  
 
209 
 
The fifth and final factor, labelled ‘Keep Control -Greater Good of Others’, felt 
the need to challenge the health-care system.   A lot of their experience seemed 
to be driven by the need to question and improve the care for future patients.  
They did feel able to argue even when they might have to resort to writing 
instead of talking. They were anxious in hospital and recognised they felt at 
their most vulnerable when they were in-patients, having their surgery.   
Researcher “What made you feel vulnerable in hospital?”  
Sort number 10  “Most of it was around lack of nursing care lack of support 
especially at night I felt vulnerable mostly at night because there was an 
agitated patient who was not being cared for and that was very inappropriate.  I 
had a very bad experience on my second night in hospital I didn’t sleep for three 
or four nights which was not good it was a traumatic both of us thought that 
something was going to happen it wasn’t because I was in pain but I was 
refused medication because of inappropriate nursing care.”  
Sort number 10: 5.4-5.18 
 
They wanted to be back at home where they could have more control of their 
lives again.  They would worry if appointments were cancelled, not for 
themselves, because they knew they could interrogate and challenge the 
system, but for others, who might not appreciate the significance of not having a 
review appointment in a timely, frequent way. Both participants seemed to 
analyse and comment on their treatment and did not find relinquishing their 
health to others easy. Despite most significant amounts of surgery and 
oncological treatment they were not defined by their disease, and refuted the 
idea of being ill.   
Sort number 15 was able to crystalise his ideas with his final comments of his 
semi-structured interview. 
“I’ve been in hospital but I still don’t think I’m ill. Yes survivor and victim and 
choice you said it (pointing at statement 13) if you didn’t want to die you have 
treatment and patients say I don’t have choice, I’m not ill, you push me into a 
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group about physical symptoms, …..and they are in recovery rehab which is a 
big shift for a hospital system I came in and you made me better but I am not 
poorly.”  
Sort number 15: 2.27-2.36 
 
Like his counterpart who also loaded to factor five, this participant, despite all 
the context of being a patient, still did not see himself as ill but as recovering. 
 
 
DISCUSSION OF EXTREME AND CONSENSUS SCORES 
Q Methodology uses a process in which all of the statements are seen within 
the context of the others within the Q sample.  It would seem therefore, 
important to discuss specifically some of the extreme range or consensus 
scores that were evidenced through the eighteen Q sorts.   Despite, in 
quantitative terms, a small sample of participants some statements had a wide 
range of response scores.  Those with a range of nine  or more out of a 
possible eleven, are detailed in table 6.1 
 
TABLE 6.1  
STATEMENTS THAT REPRESENTED THE WIDEST RANGE OF SCORES 
BETWEEN Q SORTS 
                                            Statement Range 
(Scores) 
13 ‘If you didn’t want to die there was no choice but to have 
treatment’ 
  11(-5-+5) 
41 ‘Day to day life is physically exhausting’   10 (-4-+5) 
22 ‘I felt very vulnerable when I was in hospital’     9 (-4-+4) 
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None of these statements could be measured reliably without direct reference to 
participants.  This aspect of the experience seems essential to know if a team is 
going to be able to care for patients in a way that is individual and centred 
around them.  These statements demonstrate extremes participants might have 
felt relating to vulnerability, fatigue and how they felt when in hospital. These 
aspects, whilst unpredictable in terms of their possible responses, are 
imperative if teams are going to respond to patients in ways that are likely to be 
constructive to them at an individual level.  Not recognising these elements of 
the experience for patients might create barriers to communication because 
patients are not being helped to understand the treatment and their recovery 
through methods that they would prefer. 
 
The statements with the least range of responses, two, represent some 
consensus between the participants taking part in the study and are detailed in 
table 6.2.  
 
TABLE 6.2 CONSENSUS STATEMENTS BETWEEN THE Q SORTS 
Statement Range 
(scores) 
34  ‘Life will never be the same again’ 1(0-1) 
16 ‘I have to be careful not to upset people’ 1(-1--2) 
17 ‘‘You shouldn’t have to face this sort of thing on your own’ 2(2-4) 
36 ‘I wish I’d had never been treated’ 2(-5--3) 
4  ‘When I was told I had cancer I knew I had to face it’ 2(4-2) 
6  ‘I didn’t want people to know what had happened to me’ 2(-1--3) 
19 ‘No two patients are the same’ 2(1--1) 
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The responses to statements 34 and 16 would seem to suggest that for all the 
participants despite going through a diagnosis and treatment for H&NC, there 
was no real sense of life not returning to normal or a need for them to change 
their interpersonal behaviours.  It suggests that the disease has not 
overshadowed their lives and they are not guarded in the way they might 
interact with others.  Such a belief is a facet that can be emphasised more by 
members of the MDT when they meet patients prior to their treatment.  Patients 
who have not undergone definitive treatment will ask if they will be back to 
normal.  It would be informative to draw on the evidence of this research that 
suggests that as a group, participants did not feel that their lives would ‘never 
be the same again’.  This does not answer satisfactorily when will I be back to 
normal? but does demonstrate that they will adjust and cope with the 
experience of the disease and treatment.   
 
All participants agreed that no one should have to face this experience on their 
own. It is of note however, some of the participants, who lived on their own, felt 
they had support and were not alone because they identified the clinical team 
members as their support. This would suggest teams need to have knowledge 
around how much of an external support-network patients have in order to know 
whether there is a possibility that patients need to be more reliant on health 
professionals for their support.   It might also be that patients who appear to 
have support are looking for more external, professional support because of not 
wanting to burden their families.   The NICE guidelines (2004) acknowledge that 
patients who have a diagnosis of H&NC need psychosocial support at the time 
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of diagnosis, as well as during and after their treatment.  This recommendation 
becomes more forceful when it is known that H&NC patients are reluctant to 
seek specialist psychological services because of the many and specific 
symptoms that they might experience.  Moore et al(2004) suggested that for this 
patient group this was because of a fear of being overwhelmed by the 
identification of more losses that could not be rectified   Recent research has 
also indicated that in general terms cancer patients, as a group, are likely to 
experience anxiety and distress beyond the first year of their treatment (Carlson 
et al., 2011).  Such evidence implies that it is likely to be the MDT who work 
with patients in relation to physical symptoms, who should act as the support 
because they can help patients to recognise the emotional aspects as well as 
the physical that a patient is likely to experience.  Salender’s work, has 
suggested that patients will seek support to reduce their psychological burden 
and that this might be done through a reappraisal of their life (Salender, 2011).  
The statements would appear to be a medium through which the diagnosis and 
treatment can be explored by the patient. 
All participants strongly rejected the notion of wishing they had not been treated 
(statement 36), but perhaps this was in part due to their point in recovery and 
no recurrence of disease.  It would seem for these participants, having cancer 
was not a taboo topic of conversation and they did not object to people knowing 
of their diagnosis.  The final statement that only had a range of two, statement 
19, ‘no two patients are the same’ might be something that health teams should 
consider.  Given the tremendous range of presentation, aetiology and treatment 
choices that are possible, it would seem patients really hope that teams can 
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predict how they will respond to treatment.  They seem to believe an 
experienced group of health professionals can predict what might happen and 
will base their care on previous, similar patients.  Much of this thesis has 
developed the idea that it is not easy to predict the impact on patients of either 
the disease or treatment at an individual level. This, it would seem, is a hard 
notion for the participants to contemplate.   
 
 
ADVANTAGES OF Q METHODOLOGY 
The strength of this format and content is that a small sample of patients who 
have been treated for H&NC have generated all of the statements.  The process 
is objective, transparent and has validity.  No assumptions have been made in 
their creation, because the direct sources are the responses generated during 
semi-structured interviews at the stage of developing the concourse.     
Q methodology is not a method that requires a representative sample of a 
patient- population to be used. Q sorts are not influenced by bio-clinical 
qualities, although they are presented, in order to give detail to the subjects 
taking part in a study. The criteria for being in the study, is instead, set more 
broadly and aims to include a group of participants taken from all possible 
combinations of treatments in order to examine the experience of patients who 
had undergone treatment for H&NC with curative intent.  
This type of qualitative method also has a quantitative aspect, an advantage in 
a clinical environment that relates to absolute answers and definite correlations. 
The methodology has complimentary aspects therefore.  A consequence of 
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providing data that has both aspects is that it is intended that the results can 
influence clinicians and researchers who might more naturally be allied to a 
specific type of methodology.  The statistical results are exemplified by 
participants’ comments, which mean that the qualitative analysis adds more 
detail to the quantitative information.  The data is less open to misinterpretation 
by researchers because the participants are able to support the placement of 
the statements with explanations rather than researchers presuming a rationale 
for the statistical data.   
This methodology does seem to have advantages over qualitative ones that 
might use interviews as the way of collecting data.  The statements act as a 
consistent structure that all participants have to make a decision, and the 
process has output in the form of the ranked statements.   A participant might 
not have considered explicitly the issues represented by the statements until 
given the opportunity to do so from the finite list.    The process enables them to 
decide what is meaningful, valuable and significant, rather than the researcher 
(Ward, 2010).  The statements have to be viewed within the context of the 
whole group of statements. One statement in a position should be substantiated 
and evidenced by other statement placements - an active process for each 
participant and not one through which they can be passive.  The arrangement 
allows the patient to explain relevant experiences that influence their answer, 
rather than the researcher or health-care worker making assumptions on their 
behalf.  
The statements that have been used to form the Q set are a framework through 
which H&NC patients translate some of their experience of the disease and 
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treatment from their perspective.  The structure allows others who have not 
experienced the disease to understand what matters to them, in a format that 
they can relate to.  Sort number 9 commented on the statements as she 
reviewed them: 
“Written down they are very therapeutic and that is such a big help there is relief 
to just read it and realise you are not on your own.” (As the participant reads 
statement 7 again in reviewing the placement of the statements, which she 
placed at position +1).  
Sort number 9: 2.9-2.11 
“No one can understood what has happened to me- I have just one friend and I 
suppose she’s worried I am not going to get my speech back and be left like this 
she has insight………..I think she is voicing it, others don’t and until they hear it 
from me they’re holding back and that’s ok.  There’s no expectation I am not 
hiding anything we just don’t know.”  
Sort number 9: 2.9-2.19 
 
 
LIMITATIONS OF Q METHODOLOGY 
The results of any Q methodology study cannot be generalised to larger 
populations of patients in other locations.  The results have to be viewed within 
the context of the study environment, from which the participants were 
recruited, in this case a UK cancer centre.  The method of producing the 
concourse is both intensive and protracted, and this might explain why for many 
studies it is not feasible, to use as a methodology.  The time-intensive 
development of the concourse becomes more problematic because its creation 
is not reported routinely and is therefore not transparent.  In order to counteract 
this particular issue and to enable the study to be replicated more easily, the 
author chose a methodological technique that has beendescribed as a way of 
analysing data that is in a text format (Attride-Stirling., 2001).     
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The author collected the Q sort data and carried out the semi-structured 
interviews.  Her presence and identification as a member of the MDT and as the 
sole researcher for the study may have influenced and limited what the 
participants chose to reveal about their experiences and more specifically their 
quality of care.  However, all of the participants had completed their treatment 
and were on outpatient reviews.  They were not dependent on their teams for 
ongoing direct treatment, and the responses were such that frank discussion 
and reflection took place around the two global themes of quality of care and 
reality.   
The decision was taken by the research team that participants were likely to be 
more communicative if they had an opportunity for discussion, rather than being 
requested to write down their views.  It is possible that because the interviews 
were face to face the participants edited or chose not to disclose certain 
aspects of their care.  
All of the participants spoke and read English.  It is not possible to suggest that 
these experiences can be reframed or presented as the results that are likely for 
other cultures.  All of the participants for this study were English speaking and 
able to read and write.  The results cannot be generalised because, just like 
other Q methodology studies, these results cannot claim to go beyond this 
participant group.  The methodology captures and interprets points of view 
about the phenomenon investigated rather than back to the population studied 
(Ward, 2010). 
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IMPLICATIONS OF THIS STUDY IN RELATION TO HEALTH POLICY AND 
CLINICAL PRACTICE 
The clinical application and the way in which this research relates to health-care 
policy will now be considered.  It should be remembered that the Q 
methodology study was built upon from two previous studies by the author.  It 
has been demonstrated by the author (Reid et al, 2009) that health care 
professionals are unlikely to draw conclusions relating to quality of life 
measures for patients based on tumour size because they recognise that this 
information is not relevant or is not well aligned to such a subjective and 
dynamic concept as quality of life.  This means that patients should not have 
assumptions made on their behalf by the MDT who instead should seek to 
discuss the issues relating to experience with the patient.    The value of this Q 
methodology study is that the forty-five statements have originated from H&NC 
patients and were arranged by them in order to create a personal constellation, 
which has produced the five views of the experience of H&NC and its treatment.  
Such detailed results relating to the experience is not evident in the current 
literature relating to H&NC. 
 
Downie and Mcnaughton’s work (2000), discussed in chapter three page 107, 
had identified that there should be a fusion of technical and humane skills in 
order that clinical decisions can be made.  The technical skills of both the 
oncology and surgical specialities that treat H&NC patients have become more 
sophisticated, demonstrated by the increasing intricacy and complexity of 
surgical techniques, drug and radiotherapy regimes.  However, it is vital that 
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whilst these technical skills advance the humane aspects of care and decision-
making develops too.  This study starts to provide the detail on how this might 
happen because it has identified distinct views that patients have about their 
context and experiences.  The method has provided both an assessment of the 
patients’ experience and a medium through which patients might influence their 
care.  This means that the humane part of health care can become more refined 
and in so doing inform patients, clinicians and researchers of the experiences.  
HCPs can then be said to be responding to modern health care policy, in which 
it is stated that care should be patient centred, holistic and involve them 
throughout.  If this is not achieved then the experience is likely to be routine, or 
applied in a random and impersonal ways, i.e. as medicine wants it, rather than 
as patients need.   
Table 6.3 lists the different levels that the framework of the experience for 
patients with H&NC can be related to, and defines how this might be put into 
professional practice at clinical, service and political levels.   
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TABLE 6.3 LEVELS OF HEALTH-CARE AND DESCRIPTIONS WITH 
REFERENCE TO THE FRAMEWORK 
Level identified Description of issues at each level  
Translation of the 45 
statements and the five 
factors at a clinical level: 
The statements or factors can be represented by: 
1.The Development of questionnaire using the 
statements to explore the experience of treatment 
and disease 
2.A psychometric measure through which patients 
are able to compare their experience and reaction 
with that of the five factors by discussion relating to 
how similar or different they think they are to the 
factors 
3.The completion of a Q sort so that patients 
engage actively with the statements identified by 
participants in the study 
4.The statements act as framework through which a 
semi structured interview can elicit the experience 
for patients and influence their future care 
Profession Level:  
Speech and Language 
Therapy (SLT) 
 
SLTs in clinical practice treat patients from the pre 
treatment stage through to their recovery.  SLTs will 
assess a patient in order to establish a change in 
speech and swallowing function.  Discussion with 
patients using an impairment-based model enables 
patients to develop, through exercises and 
techniques, skills to improve their swallowing and 
communication. The interaction is likely to be task 
and process driven. In its extreme form this clinical 
relationship ignores how a patient is managing to 
respond emotionally to fundamental and personal 
functions.  Patients are likely to be vulnerable and 
can be supported in a patient-centred holistic way if 
there can be some identification of their concerns.  If 
this can be achieved they and the SLT will become 
aware of optimal ways that they experience their 
care.  This is relevant in relation to how patient 
assimilate information, and the ways patients 
interact successfully with the MDT.  If such concepts 
can be understood there is likely to be less distress 
which will enable patients to be more active in their 
rehabilitation.  
Such a method and framework should be taught to 
SLTs at both an undergraduate and post graduate 
stages of training.   
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Table 6.3 (continued) 
Level identified Description of issues at each level  
Service Level 
Advancing technical skills that are 
forgetting or overlooking the relational 
aspects of care 
Patients have treatments that are 
increasingly advanced, but if services 
cannot respond to patients at an 
individual and specific level they will be 
more vulnerable and dependent on 
services.  Such demands are not 
sustainable because of the demand to 
treat other patients who are more 
recently diagnosed.  The use of the 
results of this study, in one of the 
formats described at the clinical level, 
allows for their relational aspects to be 
represented and enables the service to 
respond to them in ways that are most 
suited to them, and account for many 
different aspects of their experience 
Political level  
 
More patients are surviving cancer 
(Maddens (2009).   
The budget available in real terms is 
diminishing whilst the expenditure 
continues to increase.  The NHS is 
projected, via financial reforms, to save 
20 billion pounds by 2014.  Resources 
will diminish and have to demonstrate 
that they can make a difference to how 
patients might cope at both a physical 
and emotional level.   
The nursing profession has re-
emphasised the relational aspect of 
care through ‘Compassion in Practice’ 
(Commissioning Board Chief Nursing 
Officer and DH Chief Nursing Adviser, 
2012) what have become known as 
the 6 Cs of the NHS constitution i.e. 
care, compassion, competence, 
communication, courage and 
commitment.  All these aspects remain 
vital and not ones that can be left out 
or reduced when caring for patients by 
any discipline 
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The different levels identified in table 6.3 can be demonstrated through a 
description of a patient that the author treated in December 2012.  Neil, (a 
pseudonym), worked as a university science lecturer.  He had not been seen by 
the author pre-treatment but had undergone surgery to remove his left maxilla 
(roof of mouth) which was replaced temporarily with an obdurator (soft acrylic 
plate, covering the left side of his roof of mouth).  The procedure was to be 
completed in eight weeks time by having a free flap reconstruction (fibula) that 
would include both bone and soft tissue.  The surgical team asked the author to 
review the patient’s swallowing and communication twenty-four hours after his 
operation because they had identified that he was neither swallowing nor 
communicating easily.  The author was able to assess the patient with 
reference to these two specific functions and discuss with him and his wife the 
impact that the diagnosis and treatment had had on them.  The patient was due 
to go home the next day and he wanted to know whether the stage he was at 
physically and emotionally was normal.  He expressed feelings of being very 
shocked at the diagnosis and being unable to make sense of what was 
happening in his oral cavity.  The author, at a point of immersion in writing up 
the results and discussion of the factors from the Q study, was able to suggest 
that he was behaving as someone who might be seeking to find the meaning 
and attachment to illness.  The author gave examples of what this might mean 
to the patient, which prompted the patient to question if he was in denial.  Again 
the author could reference what might be the evidence to demonstrate that the 
patient was not in denial, but instead trying to make sense of the treatment in 
relation to his symptoms.  This was achieved by using some of the statements 
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in the form of a semi-structured interview.  At the end of the discussion the 
patient declared that he felt so relieved because he was starting to recognise 
and interpret some of his feelings.   It appeared that the patient felt that his 
reaction was being validated and translated in ways that he could understand.  
He said it was first time that anyone had spent time to ask him how he felt.  This 
may or may not have been the case, but it appeared that the timing and way in 
which the information was presented was tailored to this patient’s needs.  The 
author was able to share with the patient that she had been working with the 
H&NC patient group for more than fifteen years and that she was completing 
this research.  The author was able to demonstrate attunement with the patient 
through the framework of the current study.  
 
This example illustrates the absolute importance of the current work at a 
clinical, educational and policy level.   No assumptions should be made, based 
on preconceived ideas, patients should be able to discuss their experience 
using the statements and factors as a framework to inform and guide the MDT 
about their experiences.  The statements and factors provide a structure for this 
discussion.  It is for this reason that it would not be the author’s intention to 
restrict patients’ discussion to a questionnaire on the experience of disease and 
treatment.  If a questionnaire was the medium, the process is open to the same 
criticism that has been used within this thesis, regarding the QoL 
questionnaires.   
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Reflection with specific reference to this patient meant that the author could 
identify that if the patient had gone home without a review of the current 
situation, after his first procedure, he would have been likely to have struggled 
to make sense of how he had been affected at both a physical and emotional 
level.  These two aspects of the reaction should be seen as being equally 
important and that the one will influence the other.  It is not unusual to fail to 
consider the emotional aspects for patients and how they might have reacted to 
the experience (Bultz and Carlson;2003) and any attempt to predict their mood, 
without direct reference to patients is inaccurate (Mitchell et al; 2008).   
Table 6.3 (P217-218) at the SLT clinical level acknowledges that within the 
author’s profession it is not routine practice to appraise how the emotional 
aspects of the diagnosis and treatment have impacted on the patient.  In 
relation to Neil and his wife the intervention by the author also meant that they 
could start to see how they might interpret information that they were given.  It 
had been vital for them to have an opportunity to explore how they felt.  If this 
can be achieved they are more likely to process the current events because 
they have been treated as complete entities.  
‘Patients who are treated considerately, who are not left to endure 
anxiety and worry, who are treated attentively, who are given full and prompt 
information, who understand what they are being told and who are given the 
opportunity to ask questions, are more likely to have better clinical outcomes. A 
good patient experience goes with good clinical care – and patients need both.’ 
(Patient-led NHS p8 2005). 
 
Whilst efficiency is implicit in order to respond to the volume of patients there is 
a need to improve the quality of the care.  The author was able to achieve the 
philosophy of this policy during her clinical interaction with Neil.  The author’s 
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intervention meant that the patient was discharged from hospital the next day 
able to drink, eat soft foods and communicate orally.  At his initial assessment 
he had been pipetting water into his mouth at a very slow rate.  Since the 
patient’s initial assessment he and his wife have been seen in pre treatment 
clinic to discuss the second operation.  He and his wife were able to recall that 
they did not want to read information or look on the internet.  They wanted to 
discuss with the team the next stage.  They asked if Neil would ever return to 
normal.  This prompted the author to recall the evidence from this study that 
patients seemed more concerned about other aspects of the experience than 
the impact it might have had on their lives.  In the context of the experience 
there are many other aspect of the experience that become more important, 
which creates the sense that the notion of ‘life will never be the same again’ 
having limited meaning.  
 
From an education and training perspective the framework could be explained 
and taught to SLT at both an undergraduate and post-graduate level.  It should 
be that in order to be effective clinically SLTs can use a framework that reviews 
how patients might experience disease and treatment and integrate these 
aspects with the technical expertise they need to help the patient achieve. 
Unless this aspect is accounted for, it is very possible that patients are less able 
to assimilate the technical aspects of their communication and swallowing 
management.   The implications of this are that SLT interventions are less 
effective because patients are not being managed in ways that respond to 
factors that might influence their experiences.  In the knowledge that the 
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author’s intervention is not standard, and has merits that should be identified in 
order that they can be generalised into the routine practice of other SLTs, a 
further study is being designed to describe and measure the impact of this style 
of intervention.     
 The health resources available to patients are finite and, as they are exposed 
regularly to HCPs, they should have the opportunity to challenge the purpose 
and effectiveness of the interventions they experience.  The intention is not to 
score or grade the experience, but to enable patients to understand how they 
are affected as well as provide a structure that can enable them to influence 
their care by appreciating how they react to the experience.  Through this 
method patients can be more engaged and responsive with their teams.  If 
patients are given the vocabulary, in terms they can understand, they are more 
likely to express what they want and how they feel, which will be described 
through the six global themes and represented by the forty-five statements.  
The arrangement of the statements and  responses to them through a semi-
structured interview does not mean that what a patient thinks is limited to 
predictable conclusions; instead the responses should act as a way of 
orientating the team to what matters to patients about their experience.  
Through this technique HCPs have a starting-point from which they might 
enquire further with the patient how they have experienced their disease and 
treatment.    It is likely that this work provides a structure that compliments the  
advanced communication training courses which  have been set up as a way of 
facilitating best practice for patients with cancer to discuss with HCPs specific 
issues they might have at the time of diagnosis and during their treatment. 
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Policies have recognised the importance of addressing the emotional, as well 
as physical aspects of care; table 6.4 lists some of these documents and 
describes the intended role of the patient.  
 
TABLE 6.4 HEALTH POLICIES RELATING TO THE EXPECTATION OF 
PATIENTS’ ROLES.    
Policy Expectation of patients’ roles. 
The Expert Patient, 
(2001) 
Patients’ independence facilitated by knowledge and 
information relating to their disease and possible 
treatments 
Creating a Patient-
Led Service (2005) 
Patients have a more thorough understanding 
information with dialogue 
High Quality for All 
(2008) 
Safety and effectiveness of treatments should also 
include the experience of care 
The Shared 
Decision Making 
Policy (2011) 
Development of the concept of decision making 
beyond treatment choices, to self-management and 
personalised care-planning 
Outcomes Strategy 
Framework (2012) 
Patients’ experience of care, with reference to 
relational aspects should be identified.  Patients should 
be active in deciding how they might want to engage 
with aspects of their care 
 
The five factors from this study evidence the personal experience of H&NC in a 
research arena that is dominated by quantitative approaches to research 
questions.  These quantitative aspects focus on survival intervals and other 
temporal descriptors, but there remains the need for research and clinical 
practice to assure them that the quality of their survival will be represented and 
can influence future experiences of patients.   
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In the introduction to this thesis three fundamental questions were asked in the 
knowledge that these areas of enquiry were not answered satisfactorily: 
 What is the experience for patients of the diagnosis and treatment of 
head and neck cancer?   
 Why do patients with apparently similar disease classification and 
treatment appear to have such different reactions to the treatment?  
 
This study gives detailed answers to these questions.  Five ways of 
experiencing the disease and treatment have been identified.  These factors are 
discrete from one another in their presentation and cannot be predicted by the 
disease classification or treatment used.   Instead, the way participants 
internalise the experience is the credible explanation as to how patients who 
have similar treatments might react differently. This also helps explain why 
patients diagnosed with small tumours can appear to be so limited in their 
function, whilst others with large disease and protracted treatments can do so 
well.  It is not possible yet to predict how a patient might work through the 
experience, but there is benefit in understanding how patients have dealt with 
previous life-changing experiences and used these to achieve some state of 
well being previously.  They might employ similar strategies or be able to 
understand why the experience is so difficult.     From these results the only 
aspect of the bio-clinical information that might be related to a particular factor 
was from the responses to factor four, ‘Surviving or Not’.  All of these 
participants had surgery only and might be said to have expected to be on a 
trajectory of recovery from the date of their surgery.  They did not receive dual-
modality treatment, and it could be that the other participants loaded onto the 
other factors as a reaction to intense, protracted treatments.  Unfortunately, as 
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described in chapter one, most patients present with late stages of the disease 
so that their treatment, if possible, needs to involve both surgical and 
oncological management.   
 
Whilst transcribing the recordings of the semi-structured interviews, the author 
could start to identify some of the missing gaps that she had suspected if QoL 
questionnaires were used.  The questionnaires were constraining the outcomes 
with pre-determined domains and gave little scope for patients to explain, 
across themes, the ways they responded to the experience.    The interviews, 
which were products of the Q sort, gave the participants a way of articulating 
some of their experiences.  Sort number 15 loaded onto factor five, ‘Keep 
Control -Greater Good of Others’, exemplifies his factor descriptor in part of his 
semi-structured interview.   
Participant “Once I knew something could be done I wanted to know all the ins 
and outs of it, every little detail all the jargon.  I wanted to know on the 
assumption I would get over the treatment I wanted to know how I would be 
……”  
Researcher: “So cure wasn’t the only issue?”  
Participant: “No it was the quality of life after and what I was told was 
remarkably accurate that ties in with the statement you wanted the team to be 
honest ………….I wanted to know [how it would be] not just about the length of 
life- it’s the quality …..its not at all costs…… take it to the extreme if I was a 
cabbage what’s the point?” 
Sort number 15:1.15-1.22 
 
The same participant demonstrated his tenacity when he got home (living alone 
and caring for himself). 
 
 “Having got from hospital to home under my own steam I proved I could 
do things - not as well as I did do physical areas, I was OK but mentally I wasn’t 
sure  because you look like you have done ten rounds with Mike Tyson and you 
can’t talk and that’s very daunting…….. I had to write everything down for 
months because of the voice- like through the glass screen (at the post office) 
230 
 
they couldn’t understand me because I had no voice its hard enough at the 
checkout but with a screen …..but the response I got was remarkably good 
people didn’t know what had happened but they were really sympathetic you 
saw the nicer side of people.”  
Sort number 15:  2.1-2.11 
 
The detail in such commentaries is neither shown nor assimilated in routine 
clinical practice by the MDT, despite the possibility that it could be used to 
influence patients’ ongoing or future care.    
Health-care systems will remain under tremendous process and budget 
pressures, and this might tempt clinicians and mangers of health to measure 
superficial aspects of the experience of disease and care.  Such a position 
means that the outcome of care is represented almost exclusively at a 
functional level, characterised by data generated from the satisfaction of care 
and efficiency of the service delivery.    
 
Defining what matters in the representation of their experience needs structure.   
The statements are a way of giving patients the vocabulary to express their 
individual experiences.  A limitation is that it is a finite list of patient experiences.  
There is therefore a skill in their use by HCPs to facilitate the patient in order to 
identify the key features of experience.  It cannot be suggested that this is the 
only way of achieving an understanding of a patient’s experience, but the way of 
producing the structure has been derived from patients and means that patients 
have consistent structure through which to express these.   
 
Cancer patients do not arrive at an initial consultation with knowledge of the 
terms used by HCPs or a dictionary to translate them. Hitchens, an intellectual 
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who died of oesophageal cancer in 2011, wrote a reflection of his NHS care.  
His remarks enabled some further reflection of the application of the current 
study into clinical practice beyond the H&NC specialty for the author.   His 
commentary relating his transition from being a member of the public to a 
cancer patient was so striking to the author, that it is quoted on the  title page of 
this study.  It captured the quintessential features that this study explores: 
 
 ‘..moving from the country of the well across the stark frontier 
that marks off the land of malady….The new land is quite welcoming in its way.  
Everybody smiles encouragingly……the country has a language of its own 
….you feel swamped with passivity and impotence’ (Hitchens, 2012) 
 
One might expect that an intellectual reflecting on his disease and treatment 
would have a good grasp of the health-phrases and assimilate the experience 
because of the adept language system he possesses.  Worryingly this was not 
the case, worryingly and like many other patients he was unable to grasp or 
assimilate the experience and felt unable to be active.  It is the job of clinicians 
to give patients, at their individual pace, the right phrase book that can decode 
their care.  This can be achieved by patients if they are able to isolate some of 
the key components of their experience for themselves.   
 
Many of the statements used in the Q-study are not disease-specific and go 
beyond the boundaries of disease categories, and are part of the human 
condition. The language, generated from H&NC patients, can inform the 
experiences of patients who have had different diseases or traumas. It could be 
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that these statements, with little translation, are meaningful to other patient 
groups.  Many questionnaires classify the physical aspects; this study has not 
intended to address this facet of care. Instead, the author’s work has created a 
unique tool that presents, at a personal level, the reality of the experience of 
disease and treatment.  Its achievement is that it does this by allowing patients 
to reflect and synthesize the information from their individual perspective, and 
compare aspects of their care that have been viewed as relevant by other H&NC 
patients.   
 
It is the intention of the author to work within her current trust to establish 
whether other similar, but different patient groups, have shared factors to the 
ones discovered by the current study.   The statements are a medium through 
which patients and medical teams can be clearer about patients’ needs and 
shared decision-making manifested.    The statements are prompts through 
which patients can be asked directly about their experience so that they do not 
become marginalised or under-represented by minimal easy-to-measure data 
sets.  Health-care workers have to have the energy to respond to patients as 
people who have their own particular concerns; these should be addressed 
rather than overlooked.  They cannot excuse themselves of the issue by stating 
that the complexity of the situation and the volume of patients have 
overwhelmed them. Teams have to have both technical and humane expertise 
(Downie and Mcnaughton., 2000) and to disregard patient views is not 
acceptable.  It is the belief of the author that this thesis adds detail to the 
experience and treatment of H&NC, which has not previously been investigated 
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using this methodological technique.  Here also is a framework through which 
ideas can be introduced and feelings expressed relating to the experience of 
disease and treatment.   Porter’s (2003) and Kennedy’s (2010)  observations 
relating to health care need to be reacted to by thorough and reasoned research 
so that the experience of patients with reference to their  disease and treatment 
can be known and influence their care.  This study has provided some of the 
detail that has been missing with particular reference to patients with H&NC.  It 
is a foundation from which more patients can be supported through the 
unfamiliar territory of health care, which Hitchens described as the land of 
malady. 
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 APPENDIX 1.1  
FIGURE 1 LATERAL SCHEMATIC DIAGRAM OF HEAD AND NECK DETAILING 
MAIN AREAS OF THE HEAD AND NECK.  (SIGN, 2006 PAGE 74) 
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FIGURE2 MAIN STRUCTURES OF THE ORAL CAVITY DORSAL ASPECT OF 
TONGUE (SIGN, 2006 PAGE75) 
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FIGURE 3 VENTRAL ASPECT OF TONGUE. (SIGN, 2006 PAGE 75) 
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APPENDIX 1.2TUMOUR CATEGORIES FOR ORAL, ORAL PHARYNGEAL AND 
HYPOHARYNGEAL CANCERS INCLUDING NODAL DESCRIPTORS FROM UICC 
TNM CLASSIFICATION OF MALIGNANT TUMOURS  (SIGN, 2006 PAGE 70) 
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TUMOUR CATEGORIES FOR LARYNGEAL CANCERS (SIGN 2006 PAGE 71) 
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NODAL AND METASTATIC CATEGORIES FOR H&NC TUMOURS  (SIGN, 2006 
PAGE 
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73)
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Appendix 2.1 DISTRESS THERMOMETER 
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Appendix 3.2  
 
Q methodology Gathering the concourse. 
LITERATURE SOURCES THAT GERERATED THE SEMI-STRUCTURED 
INTERVIEW QUESTIONS  
 
Below are the questions that were generated by an examination of the 
literature that had been reviewed when searching for “experience” and 
coping and head and neck cancer  
 
 
 
 
Did you suspect you had cancer when you first went to your doctor?  
 
 
If so, what made you suspect this? 
Scott S, McGurk M, Grunfeld E  
Patient delay for potentially malignant oral symptoms.. Eur J Oral Sci. 2008 
Apr;116(2):141-7. 
Scott SE, Grunfeld EA, Main J, McGurk M.  
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Patient delay in oral cancer: a qualitative study of patients' experiences. 
Psychooncology. 2006 Jun;15(6):474-85. 
SE, Grunfeld EA, McGurk M. 
Patient's delay in oral cancer: A systematic review.Scott Community Dent Oral 
Epidemiol. 2006 Oct;34(5):337-43.  
 
 
 
At the time of diagnosis, what mattered most to you? 
List MA, Rutherford JL, Stracks J, Pauloski BR, Logemann JA, Lundy D, 
Sullivan P, Goodwin W, Kies M, Vokes EE. 
Prioritizing treatment outcomes: head and neck cancer patients versus non-
patients. Head Neck. 2004 Feb;26(2):163-70. 
 
 
What expectations had you got of the treatment? 
Humphris GM, Field EA.  
The immediate effect on knowledge, attitudes and intentions in primary care 
attenders of a patient information leaflet: a randomized control trial replication 
and extension. Br Dent J. 2003 Jun 28;194(12):683-8; 
 
How do you feel about the care you’ve been given?  
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All the people that you have had to meet directly so you’re your care 
could take place?  
Recommendation of what assessments and people that the patient should meet 
pre treatment. Improving outcome Guidelines 2004 
 
 
 
How did having a diagnosis of H&NC impact on your life before you were 
treated?  
Hammerlid E, Bjordal K, Ahlner-Elmqvist M, Boysen M, Evensen JF, Bijorklund A, et al.  
A prospective study of quality of life in head and neck cancer     patients. Part 1:At diagnosis. 
The Laryngoscope 2001; 111: 669-680 
Colangelo LA, Logemann JA, Rademaker AW. 
Tumour size and pre treatment speech and swallowing in patients with resectable tumours. 
Otolaryngol Head Neck Surg 2000; 122:653-61 
Chen AM, Jennelle RL, Grady V, Tovar A, Bowen K, Simonin P, Tracy J, 
McCrudden D, Stella JR, Vijayakumar S   
Prospective Study of Psychosocial Distress Among Patients Undergoing 
Radiotherapy for Head and Neck Cancer.. 
Int J Radiat Oncol Biol Phys. 2008 May 28.  
 
Scharloo M, Baatenburg de Jong RJ, Langeveld TP, van Velzen-Verkaik E, 
Doorn-op den Akker MM, Kaptein AA.  
Quality of life and illness perceptions in patients with recently diagnosed head 
and neck cancer.  
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Head Neck. 2005 Oct;27(10):857-63. 
 
How do you feel about the information you’ve been given? You can 
always use prompts. 
Llewellyn C., McGurck M., Wineman J.  
Striking the balance a qualitative pilot study examining the role of information on 
the development of expectations in patients treated for head and neck cancer   
Psychology Health and Medicine 2005 10;(2) 180-19.   
IOG 2004 says that patients should be given written information at the time of 
diagnosis to take away with them.  
 
Can you explain the effect the amount of information had on you?  
 
What has been the best thing about the information?  
 
The worst thing? 
May be positive in outcome De Boer 1995, Yu et al 2001 Kreitler et al 1995 
Psychosocial effect of the information given can have a greater impact than the 
actual size and severity of the disease.  Mediation by the patient on the disease 
and the situation they find themselves in 
Scharloo M, Baatenburg de Jong RJ, Langeveld TP, van Velzen-Verkaik E, 
Doorn-op den Akker MM, Kaptein AA.  
264 
 
Quality of life and illness perceptions in patients with recently diagnosed head 
and neck cancer.  
Head Neck. 2005 Oct;27(10):857-63. 
 
Who did you feel the key people were… 
Five main factors were associated with varying degrees with HR-QoL, 
personality, social support, satisfaction with consultation and information, 
behavioural factors, such as consuming alcohol and smoking, and depressive 
symptoms.  
Llewellyn CD, McGurk M, Weinman J. Are psycho-social and behavioural 
factors related to health related-quality of life in patients with head and neck 
cancer? A systematic review.  
Oral Oncol. 2005 May;41(5):440-54.  
 
 
What helped you to cope with the pre treatment phase?   
Sharp HM, List M, MacCracken E, Stenson K, Stocking C, Siegler M.  
Patients' priorities among treatment effects in head and neck cancer: evaluation of a new 
assessment tool. Head Neck. 1999 Sep;21(6):538-46. 
 
What are your main concerns now? 
The positive association between psychological morbidity and fears of 
recurrence was significant at the majority of data collection points, with the 
exception that depression was more independent of these concerns.  
Humphris GM, Rogers S, McNally D, Lee-Jones C, Brown J, Vaughan D. 
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Fear of recurrence and possible cases of anxiety and depression in orofacial 
cancer patients.Int J Oral Maxillofac Surg. 2003 Oct;32(5):486-91. 
 
Fears of recurrence were not related to any socio-demographic factor (age, gender, 
ethnicity, marital status, and educational attainment) or disease, treatment, or symptom-
related factors. Path analyses demonstrated that fears of cancer recurrence after 
treatment were directly predicted by pre-treatment fears and optimism. CONCLUSION: 
Although components of the CSM (cognitive and emotional representations, coping 
strategies) were associated with fears of recurrence, optimism was found to be the 
strongest predictor of fear, independent of anxiety and level of fear reported prior to 
treatment. 
Llewellyn CD, Weinman J, McGurk M, Humphris G.J Can we predict which head and 
neck cancer survivors develop fears of recurrence? Psychosom Res. 2008 
Dec;65(6):525-32.  
 
Has the H&NC affected the way you see yourself? 
Aspiration, weight loss, and quality of life in head and neck cancer survivors. 
Campbell BH, Spinelli K, Marbella AM, Myers KB, Kuhn JC, Layde PM. 
Arch Otolaryngol Head Neck Surg. 2004 Sep;130(9):1100-3. 
 
While their main postoperative concern was the oral reconstruction site, after 
about 1 year, the donor site became more important to patients. However, the 
results were good. A 100 percent take of the FTSG at the donor site should 
produce good results. Surgeons should pay adequate attention not only to the 
outcome at the reconstruction site, but also to the closure of the donor site  
Ito O, Igawa HH, Suzuki S, Muneuchi G, Kawazoe T, Saso Y, Onodera M, Park 
S, Hata Y. Evaluation of the donor site in patients who underwent reconstruction 
with a free radial forearm flap  
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J Reconstr Microsurg. 2005 Feb;21(2):113-7. 
 
Huang CH, Chen HC, Huang YL, Mardini S, Feng GM  
Comparison of the radial forearm flap and the thinned anterolateral thigh 
cutaneous flap for reconstruction of tongue defects: an evaluation of donor-site 
morbidity. 
 Plast Reconstr Surg. 2004 Dec;114(7):1704-10. 
 
Long-term survivors of head and neck cancer continue to have both objective 
and subjective deficits in speech parameters five years after treatment. 
Objective deficits are associated with subjective concerns about speech, eating, 
and recreation.  
Meyer TK, Kuhn JC, Campbell BH, Marbella AM, Myers KB, Layde PM  
Speech intelligibility and quality of life in head and neck cancer survivors.  
Laryngoscope. 2004 Nov;114(11):1977-81 
 
 
When disfigurement/dysfunction is associated with treatment, quality of life may 
be profoundly and adversely affected. Findings from the studies presented 
indicate a significant correlation between postoperative self-care and reduction 
in level of anxiety.  
Dropkin MJ.  
Body image and quality of life after head and neck cancer surgery.  
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Cancer Pract. 1999 Nov-Dec;7(6):309-13. 
 
 
Although previous studies have shown that many of the effects of cancer 
treatment disappear between 1 and 3 years, this study shows that the dental 
status has a persistent impact on subjective quality of life.  
Duke RL, Campbell BH, Indresano AT, Eaton DJ, Marbella AM, Myers KB, 
Layde PM  
Dental status and quality of life in long-term head and neck cancer survivors. 
Laryngoscope. 2005 Apr;115(4):678-83 
 
 
What was the lowest point for you over the past year? 
Fatigue during head-and-neck radiotherapy: prospective study on 117 consecutive 
patients. Jereczek-Fossa BA, Santoro L, Alterio D, Franchi B, Fiore MR, Fossati P, 
Kowalczyk A, Canino P, Ansarin M, Orecchia R. Int J Radiat Oncol Biol Phys. 2007 
Jun 1;68(2):403-15.  
 
Has anything been particularly difficult to cope with?The incidence of 
anxiety and/or depression was 25% and the socio-demographic and medical 
characteristics showed poor correlation with the psychological outcome in this 
study. Deteriorated functional status and ineffective coping strategies are 
strongly associated with poor psychological outcome in patients with oral 
cancer.  
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Hassanein KA, Musgrove BT, Bradbury E. Psychological outcome of patients 
following treatment of oral cancer and its relation with functional status and 
coping mechanisms. J Craniomaxillofac Surg. 2005 Dec;33(6):404-9.  
 
The commonest coping mechanisms used were helplessness and fatalism. Resolution 
was noted in less than 40% of the frequent concerns. As compared to laryngeal cancer 
patients, those with oral cancer significantly more often had concerns about current 
illness, subjective evaluation of health, eating and chewing, social interactions, pain and 
disfigurement (P < 0.05). Most subjects had numerous unresolved concerns. Mainly 
ineffective coping mechanisms such as helplessness and fatalism were employed 
leading to incomplete resolution. Interventions to minimise these concerns and to 
handle associated anxiety and depression would improve their quality of life. 
Chaturvedi SK, Shenoy A, Prasad KM, Senthilnathan SM, Premlatha BS.Concerns, 
coping and quality of life in head and neck cancer patients.Support Care Cancer. 1996 
May;4(3):186-90. 
 
Are there particular symptoms that you continue to experience?  
Long-term survivors of head and neck cancer experience QOL effects well after 
completion of treatment. Effects are most pronounced in survivors who required 
combined surgery/radiation therapy  
Campbell BH, Marbella A, Layde PM. Quality of life and recurrence concern in 
survivors of head and neck cancer.Laryngoscope. 2000 Jun;110(6):895-906 
 
Almost half of long-term nonlaryngectomy head and neck cancer survivors 
demonstrated at least some degree of aspiration. The presence of aspiration is 
associated with substantial weight loss, advanced initial tumor stage, 
diminished oropharyngeal swallowing efficiency, and lower scores on a variety 
of QOL scales. Campbell BH, Spinelli K, Marbella AM, Myers KB, Kuhn JC, 
Layde PM 
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Aspiration, weight loss, and quality of life in head and neck cancer survivors.. 
Arch Otolaryngol Head Neck Surg. 2004 Sep;130(9):1100-3. 
 
Pain. 
 Hassan and Weymuller 1993; Ward et al 1993; Long et al 1996; Deleyiannis et 
al 1999; Grtz et al 1999; Chaplin and Morton 1999; Gellrich et al 2002 Talami 
2002). 
Zelefsky MJ, Gaynor J, Kraus D, Strong EW, Shaw JP, Harrison LB. Long-term 
subjective functional outcome of surgery plus postoperative radiotherapy for 
advanced stage oral cavity and oropharyngeal carconima. Am J Surg. 
1996;171:258-262. 
Hammerlid E, Silander E, Hornestam L, Sullivan M. Health related quality of life 
three years after diagnosis of head and neck cancer—a longitudinal study. 
Head Neck. 2001;23:113-125. 
Pandey M, Devi N, Thomas BC, Kumar SV, Krishnan R, Ramdas K.  
Distress overlaps with anxiety and depression in patients with head and neck 
cancer.  
Psycho oncology. 2007 Jun;16(6):582-6 
 
Attitudinal ratings appear to contribute an important aspect of the patients' perspective, 
with substantially different variances between function and attitude. Karnell LH, Funk 
GF, Tomblin JB, Hoffman HT. 
Quality of life measurements of speech in the head and neck cancer patient 
population.Head Neck. 1999 May;21(3):229-38. 
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How comfortable have you felt when discussing your situation with the 
team and why? 
This research attempts to redress the balance through exploring the patient experience 
postoperatively, in particular the issues related to communication for this patient group. 
The results also highlight the emotional trauma experienced by patients and the 
mechanisms healthcare staff employ to support these patients.  
Dobbins M, Gunson J, Bale S, Neary M, Ingrams D, Brown M.  
Improving patient care and quality of life after laryngectomy/glossectomy. Br J Nurs. 
2005 Jun 23-Jul 13;14(12):634-40. 
 
 
What has been the most difficult time or thing to deal with? 
Have you had any psychological symptoms since your treatment?  
(Kugaya 1999 High prevalence of depression post treatment in H&NC patients 
De Leeuw et al 2000  
continued impact of depression post treatment increased risk of suicide in this 
group Davies et al 1986 ) 
 
Are you still smoking or drinking -why?  Will they tell you? Will it make 
them feel bad? 
past and current smoking behaviour is associated with psychological distress in 
patients with oral and oropharyngeal malignancy in their first 15 months of 
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recovery following initial treatment. This behaviour successfully identified a 
psychologically at-risk group. 
Humphris GM, Rogers SN.  
The association of cigarette smoking and anxiety, depression and fears of 
recurrence in patients following treatment of oral and oropharyngeal malignancy  
Eur J Cancer Care (Engl). 2004 Sep;13(4):328-35 
 
Controlling for clinical and demographic variables, linear-regression analyses 
showed that depressive symptoms had a strong negative association with all 12 
quality-of-life scales; smoking had a negative association on all but one of the 
quality-of-life scales; and problem drinking was not associated with any of the 
quality-of-life scales. Interventions targeting depression, smoking, and problem 
drinking need to be integrated into oncology clinics.  
Duffy SA, Ronis DL, Valenstein M, Fowler KE, Lambert MT, Bishop C, Terrell 
JE. Depressive symptoms, smoking, drinking, and quality of life among head 
and neck cancer patients. Psychosomatics. 2007 Mar-Apr;48(2):142-8. 
 
 
Try -  Is there anything particular that the team can do to help you cope? 
Patients do not discuss with their team their feelings Chaplain and Morton 1999 
Moore 1990) 
 
 
Significant levels of frustration were associated with the nurses' goal of addressing the 
pain management needs of the speech impaired and the patients' pursuit of reporting the 
uniqueness of their pain experience.  
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Rodriguez CS, VanCott ML Speech impairment in the postoperative head and neck 
cancer patient: nurses' and patients' perceptions..Qual Health Res. 2005 Sep;15(7):897-
911. 
 
What enables you to cope with all that has happened? 
Few head and neck cancer survivors are participating in any moderate or 
vigorous exercise, and over half are completely sedentary. Meaningful and 
potentially beneficial associations between total exercise minutes, QoL, and 
fatigue were demonstrated.  
Rogers LQ, Courneya KS, Robbins KT, et al. Physical activity and quality of life 
in head and neck cancer survivors. Support Care Cancer 2006;14:1012–1019 
Results showed that the strongest independent correlates of physical activity were  
This study suggests that head and neck cancer patients with post-treatment 
psychosocial dysfunction can benefit from a problem-focused psychosocial 
intervention. Such evidence can inform practice, policy and future research, 
aimed at improving post-treatment quality of life for patients with head and neck 
cancer. 
 
Semple CJ, Dunwoody L, Kernohan WG, McCaughan E..Development and 
evaluation of a problem-focused psychosocial intervention for patients with 
head and neck cancer. Support Care Cancer. 2008 
The identification of positive outcomes from adversity has been commonly 
termed benefit finding. This cross-sectional questionnaire study aimed to 
identify the extent to which benefit finding occurs among head and neck cancer 
(HNC) patients and what factors are associated. HNC patients treated 6 months 
to 10 years previously (n = 76), completed the following measures: the LOT-R, 
HADS, the Brief COPE, and a measure of benefit finding. Moderate to high 
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levels of benefit finding were reported. Optimism and positive reappraisal were 
positively associated with benefit finding, with optimism acting independently of 
positive reappraisal coping. These findings have implications for the 
development of interventions to maximize positive psychological outcomes after 
treatment. Harrington S, McGurk M, Llewellyn CD Positive consequences of 
head and neck cancer: key correlates of finding benefit..J Psychosoc Oncol. 
2008;26(3):43-62 
 
How do you feel about being reviewed in outpatients, do you think that the 
team managing you have any idea how the treatment and disease has 
impacted on you?  Do you feel the team understands your problems and 
concerns? 
Both psychosocial and physiologic factors influence QOL in patients with head 
and neck cancer, but many QOL measures are most strongly influenced by 
psychosocial considerations. Physicians and surgeons caring for long-term 
head and neck cancer survivors should be cognizant of the importance of 
psychosocial risk factors in the QOL of their patients.  
Holloway RL, Hellewell JL, Marbella AM, Layde PM, Myers KB, Campbell BH. 
Psychosocial effects in long-term head and neck cancer survivors.  
Head Neck. 2005 Apr;27(4):281-8 
 
 
Mean length of time spent with each out-patient was 11 min. 
Birchall M, Brown PM, Browne J.The organisation of head and neck oncology services 
in the UK: The Royal College of Surgeons of England and British Association of Head 
and Neck Oncologists' preliminary multidisciplinary head and neck oncology audit.Ann 
R Coll Surg Engl. 2003 May;85(3):154-7. 
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Is there anything you wish you could tell the team that would make a 
difference to your care or others? The routine pre- and postoperative 
assessment of health-related quality of life may contribute to evaluate treatment 
effectiveness, which would otherwise rely exclusively on assessing end-point 
results such as survival and tumor relapse. This information is relevant to 
attenuate the prejudicial impact of surgery on the physical and psychosocial 
functioning of patients. 
Biazevic MG, Antunes JL, Togni J, de Andrade FP, de Carvalho MB, Wünsch-
Filho V.J Immediate impact of primary surgery on health-related quality of life of 
hospitalized patients with oral and oropharyngeal cancer. Oral Maxillofac Surg. 
2008 Jul;66(7):1343-50. 
 
What have been your feelings about undergoing the treatment? 
(Patients suffer irrational fears of damage and death because of erroneous 
preconceptions of radiation which doctors fail to correct.  
Peck A, Boland J.  
Emotional reactions to radiation treatment Cancer. 1977 Jul;40(1):180-4.) 
 
The importance of understanding the patients' situation during treatment and 
their desire for a return to normal living and normal mouth functions at treatment 
end. If possible, plans for oral rehabilitation should be considered in initial 
treatment planning. As the treatment of oral cancer is multiprofessional, this 
knowledge may be useful in guiding the organization of oral cancer care and 
multiprofessional collaboration. 
Röing M, Hirsch JM, Holmström I.The uncanny mouth - a phenomenological approach to oral 
cancer. Patient Educ Couns. 2007 Aug;67(3):301-6.  
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Since the treatment how do you think the disease and the treatment has 
impacted upon you psychologically? 
Feelings of reduced self esteem confidence fear of addictions to pain killers 
feelings of hopelessness and loss.  Moore RJ Chamberlain RM  Khuri RR 2004 
European Journal of cancer care 13 53-64. Communicating suffering in primary 
stage head and neck cancer 
 
What were the expectations you had of the disease and treatment and 
how did the realty compare?  
Llewellyn C., McGurck M., Wineman J. Striking the balance a qualitative pilot 
study examining the role of information on the development of expectations in 
patients treated for head and neck cancer  Psychology Health and Medicine 
2005 10;(2) 180-193 
 
 
 
 
Can  you explain how the information written or verbal impacted on your 
ability to cope with the situation?  
Llewellyn C., McGurck M., Wineman J. Striking the balance a qualitative pilot 
study examining the role of information on the development of expectations in 
patients treated for head and neck cancer  Psychology Health and Medicine 
2005 10;(2) 180-193 
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How has your disease and treatment impacted on those around you at home 
and socially?  Distress is often present in spouses and patients treated for head 
and neck cancer. Routine screening for psychologic distress is recommended.  
Verdonck-de Leeuw IM, Eerenstein SE, Van der Linden MH, Kuik DJ, de Bree 
R, Leemans CR. 
Distress in spouses and patients after treatment for head and neck cancer. 
Laryngoscope. 2007 Feb;117(2):238-41. 
Quality of life evaluation tools need to be improved. At present, most tools only 
partially evaluate patient quality of life, concentrating on the global impact of disease 
and its treatment on patients' physical and psychological condition. The "sociability" of 
individual patients is rarely evaluated, and the development of qualitative studies in this 
domain will enable improved understanding of the social factors involved in each 
patient's adaptability to disease, its treatment and after-effects. Babin E, Joly F, Vadillo 
M, Dehesdin D Oncology and quality of life. Study in head and neck cancer Ann 
Otolaryngol Chir Cervicofac. 2005 Jun;122(3):134-41.  
. 
The relationship between coping effectiveness and degree of postoperative 
disfigurement and dysfunction has been described. Current nationwide mandates for 
more cost-effective health care warrant continued efforts to describe this patient 
population in relation to coping patterns. Those patients who do not cope adequately 
should be considered for more intensive intervention while still in the therapeutic 
environment of the hospital. More creative and innovative solutions are needed to 
facilitate effectiveness of intervention and predictability of outcomes within an 
appropriate time frame and in a fiscally responsible manner. In the interim, inability to 
cope with disfigurement and dysfunction at discharge can predispose the patient to 
infection or non compliance with follow-up care, pathological obsession with or denial 
of the defect, depression, and social isolation.   
Dropkin MJ.Coping with disfigurement and dysfunction after head and neck cancer 
surgery: a conceptual framework. Semin Oncol Nurs. 1989 Aug;5(3):213-9.  
 
The findings reveal that the experience of lived relations changes from being spouse to 
supportive carer, the lived body is neglected and lived space and time becomes 
restricted. The essence of their lived experience can be described as living in a state of 
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suspension. This knowledge may be useful in the education and organization of 
supportive communication for multiprofessional caregivers. 
Röing M, Hirsch JM, Holmström I.Living in a state of suspension--a phenomenological 
approach to the spouse's experience of oral cancer. 
Scand J Caring Sci. 2008 Mar;22(1):40-7. 
Quality of life correlates stronger with the quality of relationship in spouses than in 
patients. Generally, marital satisfaction appears to be an important moderating factor 
regarding QoL and psychological distress 
Jenewein J, Zwahlen RA, Zwahlen D, Drabe N, Moergeli H, Büchi S. Quality of life 
and dyadic adjustment in oral cancer patients and their female partners.Eur J Cancer 
Care (Engl). 2008 Mar;17(2):127-35. 
 
Standardized measures of social support, depressive symptoms, well-being, and life 
happiness were used. RESULTS: The sample as a whole displayed high levels of life 
happiness, low levels of depression, and positive feelings of well-being. Women 
demonstrated higher levels of depression and lower life happiness; subjects with greater 
disfigurement were more depressed. Social support seemed to buffer the impact of 
greater levels of disfigurement on well-being for women but not for men. 
CONCLUSION: These results suggest that women with head and neck cancer who 
experience low social support and face disfiguring treatment are at greatest risk for 
psychosocial dysfunction. 
Katz MR, Irish JC, Devins GM, Rodin GM, Gullane PJ. Psychosocial adjustment in 
head and neck cancer: the impact of disfigurement, gender and social support. Head 
Neck. 2003 Feb;25(2):103-12. 
 
There appears to be some association between selected psycho-social factors 
and long-term survival from head and neck cancer. However this relationship is 
currently neither strong nor proven, requiring examination by multi centred trials 
with standardisation of research definitions and methodologies, and 
examination of post-treatment psycho-social factors. 
Mehanna HM, De Boer MF, Morton RP.  
The association of psycho-social factors and survival in head and neck cancer. Clin 
Otolaryngol. 2008 Apr;33(2):83-9.  
Questions I would like to have answers to but no literature on them relating to 
head and neck cancer. 
 
o Do you feel that you have had uncertainty and ambiguity, mixed messages or 
contradictory information during your care? 
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o What can you believe who can you trust? 
 
o Are there certain topics you find difficult or impossible to talk about? 
 
o How would you advise someone starting on the same experience that you 
have had? 
 
o Do you think opting for treatment was the right thing for you to do as you look 
back on your care?  
 
o Have you felt that the care you have received has given consistent messages, 
or have you felt when you have seen people they have given you different 
information which has been confusing.  
 
o In what way have you been changed by the cancer? 
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     APPENDIX 3.3 
1.Generating themes from QoL questionnaires  
Basic themes Organising Themes Global Themes 
Symptoms/function 
Disease and treatment  
 
Psychological balance 
Psychological symptoms 
 
Engagement with others  
 
Fear of Recurrence 
Physical impact of symptoms 
 
Psychological impact  
Impact on QoL 
 
Social relationships 
Purpose 
Fear 
 
Day to day physical comfort 
 
Emotional Well being  
 
 
Place in Society 
 
Own mortality  
 
2.Generating themes from literature associated with the literature review   
Basic themes Organising Themes Global Themes 
Symptoms/function 
Disease and treatment  
Health risk 
 
 
Psychological balance 
Psychological symptoms 
Coping 
Body image 
Character/Resilience 
Positive reframing 
 
Expectations/assumptions 
 
Engagement with others  
Alienation 
Role 
 
Fear of Recurrence 
Survival vs day to day existence 
Fatalism 
 
Humane aspects of care 
Individual adjustment to 
information 
Info timely  
Compliance 
Jargon 
Communication loss and needs 
Accessibility and demeanour of 
team 
Comprehensive /time intensive 
Physical impact of symptoms 
Unpredictability/uncertainty, risk 
appraisal 
 
 
Psychological impact  
Impact on QoL 
 
 
 
 
 
Social relationships 
Purpose 
Inter personal relationships 
 
 
 
Fear 
Internal personal struggle 
 
 
 
Team interaction with patient 
Day to day physical comfort 
 
 
 
 
Emotional Well being  
 
 
 
 
 
 
Place in Society 
 
 
 
 
 
Own mortality  
 
 
 
 
Quality of care 
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  3. Themes derived from semi-structured interviews 
Basic themes Organising Themes Global Themes 
Symptoms/function 
Disease and treatment  
Physical loneliness 
Health risk 
Addictive behaviours 
 
 
Psychological balance 
Psychological symptoms 
Coping 
Body image 
Character/Resilience 
Positive reframing/secondary gains 
 
Expectations/assumptions 
Engagement with others  
Alienation 
Legitimate review of life and  
roles 
 
Fear of Recurrence 
Survival vs day to day existence 
Fatalism 
Review other deaths known 
regrets 
 
Humane aspects of care 
Practical objective issues 
Tangible care 
Individual adjustment to information 
Info timely  
Compliance 
Jargon 
Communication loss and needs 
Accessibility and demeanour of team 
Comprehensive /time intensive 
Mismatch of outcome expectations and 
timescales 
 
Outcome of treatment vs no treatment not 
the same 
Survive at all costs  
 
poor rest/down time 
Physical and emotional loneliness 
Cyclical impact 
Accepting impact on life 
Observer role with poor control 
Alienation 
Engagement with others and control 
support network  
Physical impact of symptoms 
Unpredictability/uncertainty, 
risk appraisal 
 
 
 
 
Psychological impact  
Impact on QoL 
 
 
 
 
 
Social relationships 
Purpose 
Inter personal relationships 
 
 
 
Fear 
Internal personal struggle 
 
Review of life and future 
 
 
 
Team interaction with patient 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Stark choices  
 
Inner strength  
 
Unremitting symptoms 
 
 
 
Reactive state 
Day to day physical 
comfort 
 
 
 
 
 
 
Emotional Well being  
 
 
 
 
 
 
Place in Society 
 
 
 
 
 
Own mortality  
 
 
 
 
 
 
Quality of care 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Reality 
281 
 
    APPENDIX 3.4  
QUESTIONNAIRE COMPLETED BY THE MDT FOR T4 CASE STUDY    
    Kate’s Questionnaire. 
 
Attached is a fictitious case history of a patient that may present to the unit. Please 
read the case history and then rate the 20 statements with particular reference to the 
patient you have just read about.  Please do not ponder too long over each statement 
– it is your immediate response we are looking for. 
There is of course no right or wrong answer and you are not being tested. Please do 
not discuss this study or your answers with anyone else because we need each 
individual’s perspectives   Thank you for your help and happy reading! 
 
 
About you:-  Please fill in  
 
Job title:___________________________________ 
 
 
Grade if you are graded _____________ 
 
 
Number of years working with patients with head and neck cancer : (tick the box) 
282 
 
Less than 5yrs              5-10yrs                           10-15 years       
15-20 yrs                     more than 20 yrs  
            
 
 
 
Do you work with (tick the box)           inpatients,   outpatients        both 
 
Do you work mainly   (tick the box)     days              nights              both
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   Fictitious patient case history 
 
A 50 year old person who works behind a bar is married with 2 children  
They smoke 20 cigarettes a day and drink socially. 
There are no co morbidities 
 
Diagnosis:  T4 N1* moderately differentiated squamous cell carcinoma situated on 
the right lateral border of the oral tongue not crossing the midline 
(Note that in T2 example the scenario was identical, but the term T2 incorporated 
rather than T4) 
 
Management plan: partial glossectomy right selective neck dissection tracheostomy, 
           reconstruction with radial fore arm free flap 
 
 
Surgery is planned for two weeks time; the patient has not been in hospital for many 
years, and admits to being apprehensive to the planned admission. 
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Put a vertical line through the horizontal line to illustrate where on the scale you 
would expect this patient to be for each question. 
 
E.g.  
 
 How easily would you expect this patient to have found where the ward 
is? 
 
 Really difficult     no problems straight to it 
 
  
 
 This indicates that the ward was not too hard, but they got a bit lost! 
 
 
 
 
 
 
 
 
 
 
 
 
285 
 
 
 
Please try and make a judgement based on how the patient will have been in the last 
week 
 
 
 
  How tense do you think the patient has been? 
 
  Not at all tense     Very tense 
 
    
 In the past week how tired do you think this patient has been? 
 
  Utterly exhausted                 Extremely energetic 
 
 
 In the past week how well do you think the patient will have slept? 
      
 Very badly       Excellently 
 
 
 In the past week what do you think the patient’s appetite has been like? 
 
 Very poor        Excellent 
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 How difficult do you think it has been for the patient to remember 
things? 
 
Very poor        Excellent 
 
 
 How depressed do you think the patient will have been since diagnosis? 
 
 Not at all        Very depressed. 
 
 
 How limited do you think the patient has been at work by their disease? 
 
 Not at all         Very much  
 
 
 How much pain do you think the patient has been in? 
 
None at all                    Unbearable pain. 
 
 
 
 
 
287 
 
 
 How likely do you think it is that this patient will have choked when 
swallowing? 
  
 Not at all likely     very likely  
   
 
 Would you expect the patient to have been worried? 
 
 Not at all      A great deal 
 
 
 Would you expect the patient to have trouble talking on the telephone? 
 
 Not at all      A great deal 
 
 
 Would you expect the patient to have less sexual enjoyment? 
 
 Not at all       A great deal 
 
 
 Would you expect the patient to have problems swallowing solid food? 
  
 Not at all       A great deal 
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 Would you expect the patient to have trouble with sticky saliva? 
 
 Not at all      A great deal 
 
 
 Would you expect the patient to have trouble eating in front of other 
people? 
 
 Not at all      A great deal  
 
 
 Would you expect the patient to be using oral supplements? 
 
 Not at all      A great deal  
 
 
 Do you think the patient would have had a sore mouth  
 
 Not at all      very sore 
 
 
 
 Do you think they would have a dry mouth? 
 
 Not at all      A great deal 
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 How do you think the patient would rate their overall health in the last 
week? 
 
 Very poor      Excellent 
 
 
 How do you think the patient would rate their overall quality of life in the 
last week? 
 
 Very poor      Excellent 
 
 
 
 
 
 
 
Any comments that you want to add? 
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     APPENDIX 5.1 
Original quotes for the theme reality  
The reality was much better than what I imagined. 
I thought I would be much better sooner than I was. 
It’s part of life now. but i'll talk about things I wouldn't have 
There is no choice because the result of saying no to treatment would be certain death 
You never feel the same again 
You should never have to do this alone 
It doesn’t help to analyse things too deeply- You feel very different from other people 
and don’t need to burden them with that 
You might look similar but you feel very different you know that but no one else does 
Its very hard to keep going have the energy for things 
You have to believe the treatment is going to work you cannot start to think it won’t 
If the team think you are OK you think it is alright to have the symptoms so you don’t 
tell them in case they then notice others and become worried 
It all goes on for such a long time a long time to recover  
I still feel like a victim and you have to watch not to upset the relationships you have  
I still think it’s not fair and why me? 
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Final statements used to represent the global themes reality 
 
You should never have to face this sort of thing on your own  
If you didn’t want to die there was no choice but to have the treatment  
It’s so hard waiting to heal 
I have to be careful to not upset people  
I’ll talk about things that I wouldn’t have done before my diagnosis 
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     APPENDIX 5.2 
  CONCOURSE STATEMENTS NUMBERED. 
1 I recovered much slower physically than I expected  
2 I felt physically very isolated  
3 Any symptom I get I always think the cancer might be back 
4 When I was told I had the cancer I knew I had to face it 
5 It really affected my confidence  
6 I didn’t want people to know what had happened to me  
7 No one can really understand what has happened to me 
8 You never think it could happen to you  
9 Life is hard you just have to get on with it  
10 You just become really grateful for different things 
11 Little things like the car park or appointments being cancelled really irritate 
  me 
12 I wanted the team always to be honest with me  
13 If you didn’t want to die there was no choice but to have treatment 
14 It’s so hard waiting to heal  
15 I’ll talk about things that I wouldn’t have done before my diagnosis  
16 I have to be careful to not upset people  
17 You should never have to face this sort of thing on your own  
18 I never read the written information I was given 
19 No two patients are the same  
20 I was most frightened when I came out of hospital  
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21 I never felt like a number I was always treated as an individual 
22 I felt very vulnerable when I was in hospital  
23 I didn’t understand what was meant by the treatment until I experienced it 
24 Once I knew they could do something about it that’s all I needed to know 
25 It’s just as well you don’t know what’s going to happen you’d never cope 
26 It’s very hard to think about your own possible death  
27 I do things but on my terms  
28 Being cured of the cancer is still the most important thing 
29 I never think of myself as ill 
30 Everyone around me was so upset  
31 I cannot have a good argument now  
32 I felt very alone  
33 I never appreciated how long it would take to get better 
34 Life will never be the same again  
35 It’s amazing how much you can adjust to all the physical changes             
36 I wish I’d never been treated  
37 I cannot do things on the spur of the moment 
38 I am much more irritable than I used to be     
39 My appearance was much better than I expected 
40 I worried a lot how others would cope  
41 Day-to-day existence is physically exhausting 
42 When I talk it doesn’t feel like me anymore  
43 I always think that people are staring at me 
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44 It’s hard to remember things you’re told  
45 I am still in pain  
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APPENDIX 5.4 SEMISTRUCTURE INTERVIEW FOR SORT NUMBER 9 
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